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i. Table of abbreviations 
Abbreviation Explanation 
ACC Anterior Cingulate Cortex 
ACE III Addenbrooke’s Cognitive Examination 3rd revision 
ADAS-cog Alzheimer’s Disease Assessment Scale – cognitive subscale 
ALDS Academic Medical Center Linear Disability Score 
ALFF Amplitude Low Frequency Fluctuate 
AMNART American National Adult Reading Test 
ANOVA Analysis of the Variance 
APOE Apolipoprotein E 
ARIC Atherosclerosis Risk in Communities 
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AUD Alcohol Use Disorder 
BDNF Brain Derived Neurotrophic Factor 
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BOLD Blood Oxygen Dependent 
CaPs Caerphilly Prospective Study 
CBF Cerebral Blood Flow 
CCG Clinical Commissioning Groups 
CES-D Centre for Epidemiologic Studies Depression Scale 
CI Confidence Interval 




CMRO2 Cerebral Oxygen Metabolism  
CSF Cerebrospinal Fluid 
CVD Cardiovascular Disease 
dACC dorsal Anterior Cingulate Cortex 
DBP Diastolic Blood Pressure 
DMN Default Mode Network  
DSM-IV Diagnostic and Statistical Manual of Mental Disorders, 4th 
Edition 
DSM-V Diagnostic and Statistical Manual of Mental Disorders, 5th 
Edition 
DWI Diffusion Weighted Imaging 
DWMH Deep White Matter Hyperintensities 
EPAD European Prevention of Alzheimer’s Dementia 
EPHPP Effective Public Health Practice Project Quality Assessment 
FDA Food and Drug Administration 
FFQ Food Frequency Questionnaire 
FINGER Finnish Geriatric Intervention Study to Prevent Cognitive 
Impairment and Disability 
FLAIR Fluid Attenuation Inversion Recovery 
fMRI functional Magnetic Resonance Imaging 
FOAD Foetal Origins of Adult Disease 
GCP Good Clinical Practice 
GMV Grey Matter Volume 
HC Healthy Controls 




HR Hazard Ratio 
IADL Lawton Instrumental Activities of Daily Life 
ICD-10 International Statistical Classification of Diseases and Related 
Health Problems, 10h Revision  
ICV Intracranial Volume 
ICH International Council on Harmonisation 
IGD Internet Gaming Disorder 
MANOVA Multivariate Analyses of Variance 
MAPT Multidomain Alzheimer Preventive Trial 
MRS Magnetic Resonance Spectroscopy 




National Institute of Neurological and Communicative 
Disorders and Stroke and the Alzheimer’s Disease and 
Related Disorders Association 
NMDA N-methyl-D-aspartate 
NTB Neuropsychological Test Battery 
LCS Longitudinal Cohort Study 
LEQ Lifetime of Experiences Questionnaire 
OR Odds Ratio 
PCC Posterior Cingulate Cortex 
PSS Post Signal Slowing 
PSSI Power Spectrum Scale Invariance 
PSQI Pittsburgh Sleep Quality Index 




PVH Periventricular Hyperintensities 
RAPA Rapid Assessment of Physical Activity 
ReHo Regional Homogeneity 
ROI Regions Of Interest 
RR Relative Risk 
rsFC resting-state Functional Connectivity 
SBP Systolic Blood Pressure 
SD Standard Deviation 
SE Standard Error 
sMRI structural Magnetic Resonance Imaging 
SWI Susceptibility-Weighted Imaging 
WHO World Health Organisation 
WMV White Matter Volume 
WRAP Wisconsin Registry for Alzheimer's Prevention 
 
 




Introduction: Studies have demonstrated a relationship between 
neurodegeneration and lifestyle factors. Neurodegeneration in midlife (40 – 
59 years old) can be assessed using neuroimaging. The aim of the thesis 
was to evaluate the relationship between lifestyle factors and 
neurodegeneration in midlife as expressed on arterial spin labelling and 
structural magnetic resonance imaging. 
Methods: A systematic review of the relationship between lifestyle and 
neurodegeneration in midlife as expressed on functional magnetic resonance 
imaging (fMRI) was undertaken. Additionally, the impact of lifestyle on the 
arterial spin labelling (ASL) and structural magnetic resonance imaging 
(sMRI) expression of neurodegeneration in a midlife cohort was analytically 
assessed. 
Results: Seven lifestyle factors associated with neurodegeneration in midlife 
as expressed on fMRI were identified by the systematic review. Using data 
from the PREVENT Dementia cohort, linear regression analysis 
demonstrated multiple associations between lifestyle and neurodegeneration 
in midlife as expressed on ASL and sMRI.  
Discussion: The findings from this thesis can guide future analysis of 
PREVENT Dementia cohort data. Furthermore, the findings from this thesis 
could be shared with the public through the NHS Health Check in England 
and the Keep Well Programme in Scotland, to help promote lifestyle 
interventions to optimise brain health in midlife.
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iii. Lay summary 
This thesis focused on the effect of lifestyle factors on brain health in 
midlife as measured on brain scans. Lifestyle describes regular patterns of 
behaviour which people engage in and midlife has been defined as between 
the ages of 40 and 59 years. In the first part of the thesis, a medical literature 
review was undertaken. All published studies on the relationship between 
lifestyle and brain health in midlife (as measured on brain scans) were 
systemically reviewed and summarised. The medical literature review 
identified seven lifestyle factors; alcohol, cognitive training, excessive internet 
use, fasting, physical training, smoking and substance misuse associated 
with brain health in midlife. In the second part of the thesis, data from a group 
of 210 volunteers were analysed. The volunteers underwent brain scans and 
completed questionnaires about their health and lifestyle. The analyses 
showed associations between four lifestyle factors (substance misuse, 
smoking, alcohol and physical training) and brain health, as measured on 
brain scans. In summary, this thesis has shown a relationship between 
lifestyle and brain health, as measured on brain scans in midlife. The findings 
of this thesis should be shared with the public to help them better understand 
how lifestyle and brain health are interconnected. Looking to future, this 
thesis, forms an exciting platform for research in the field of lifestyle and brain 
health to build upon. 





Adopting a life course approach to the study of neurodegeneration, 
highlights a strong body of evidence suggesting an association between 
lifestyle and neurodegeneration in adulthood. Adulthood encompasses both 
midlife (40 -59 years old) and late life (60+ years old). Clinical trials have only 
recently begun to explore the relationship between lifestyle and 
neurodegeneration. The trials (preDIVA, MAPT and FINGER) have focused 
on late life risk factor modification and were either unsuccessful or of limited 
benefit. A logical next step in researching the relationship between lifestyle 
and neurodegeneration is to focus on an earlier life stage, namely midlife. In 
midlife, there is increasing evidence that early neurodegenerative changes 
associated with late life dementia can be assessed using neuroimaging. 
Therefore, the focus of my thesis will be the relationship between lifestyle 
factors and neurodegeneration in midlife as expressed on ASL and sMRI. In 
the study of lifestyle, there is much variation in medical literature about how 
lifestyle is defined. My thesis will assess lifestyle factors that are in 
accordance with the World Health Organisation (WHO) definition of lifestyle.
Lifestyle and neurodegeneration  
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1.1 The importance of adopting a life course approach in the 
study of neurodegeneration 
A life course approach considers factors that act during development 
and ageing, which might influence disease onset. When a life course 
approach is applied to the study of neurodegeneration, it may help identify if 
the accumulation of different types of risk factors such as maternal nutrition, 
childhood education and adulthood smoking, result in neurodegeneration. 
Furthermore, a life course approach can help identify if there is a critical 
period during which an exposure, such as obesity can have adverse or 
protective effects on neurodegeneration. A life course approach can also 
help identify sensitive periods. These are time periods when an exposure, 
such as diet, has a stronger effect on development and subsequent disease 
risk than it would at other times (1).  
Muller et al. (2) outlined a hypothetical model of risk factors for brain 
ageing (Figure 1) that demonstrates a life course approach. In this model, 
risk factors were broadly divided into different life stages- the prenatal period, 
childhood and adolescence, adulthood and old age. Using this model as a 
framework, the evidence for the presence of risk factors for 
neurodegeneration in the prenatal period, childhood and adolescence, 
adulthood and old age have been described and evaluated below. Based on 
the strength of current evidence, the relationship between lifestyle factors 
and neurodegeneration has been identified as the focus of this thesis. 
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Prenatal period: foetal origins of adult disease and dementia 
 The foetal origins of adult disease (FOAD) hypothesis proposes 
causal associations between a disadvantageous early foetal environment, 
indicated by low birthweight for date and later ischaemic heart disease, 
hypertension, obesity, and insulin resistance (3). The FOAD hypothesis could 
be applied to dementia through three possible pathways; firstly, directly 
effecting the brain during embryogenesis making dementia more likely; 
secondly, indirectly effecting the brain through a pathway that leads to adult 
cardiorespiratory disease and hyperglycaemia, and then to dementia in old 
age; or thirdly, increasing rates of ageing, causing age-dependent disorders 
to arise prematurely (1). However, it is worth reiterating that the FOAD 
pathways are hypothetical and yet to be proven. Long term follow-up studies 
are needed to see if the FOAD hypothesis could be applied to the study of 
neurodegeneration. 
Infancy: nutrition and neurodegeneration 
In early life, long-chain polyunsaturated fatty acids are required in 
large amounts for the rapid brain growth that occurs in the postnatal period 
(1). In the Helsinki Study of Very Low Birth Weight Adults (birthweight 
<1500g) there was an association between nutrition and adult neurocognitive 
outcomes at age 25 years old. A 10 kcal/kg/day higher total energy intake at 
3 to 6 weeks of age was associated with 0.21 standard deviation (SD) higher 
adult IQ (95% confidence interval (CI) 0.07–0.35). Higher carbohydrate and 
fat intake at 3 to 6 weeks, and higher energy intake from human milk at 3 to 6 
and at 6 to 9 weeks were also associated with higher adult IQ. (4). However, 
Lifestyle and neurodegeneration  
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there is a lack of long-term cohort studies linking childhood nutrition to 
neurodegeneration. 
Childhood: socioeconomic status and neurodegeneration  
In a longitudinal study of socioeconomic status and cognitive function 
in 463 individuals in the Seychelles, Kobrosly et al. demonstrated an 
associated between early life socioeconomic position and cognitive function 
at 17 years old, including the cognitive domains of calculation (P= 0.02) and 
language comprehension (P= <0.01) (5). In a case-control study of 239 
patients with Alzheimer’s dementia, Moceri et al. (6) investigated the risk of 
Alzheimer’s dementia associated with father’s occupation, parental age, 
household size, sibship size and birth order. The study demonstrated that 
subjects whose fathers were unskilled manual workers or labourers were at 
higher risk for Alzheimer’s dementia (odds ratio (OR) 1.80, 95% confidence 
interval (CI) 1.19 – 2.73). The investigators in the study postulated that 
father’s occupation reflects not only the level of family income but also the 
quality of nutrition and housing, and the family’s access to medical care. 
However, the Religious Orders Study, a prospective study of 859 elderly 
Catholic clergy, found no association between childhood social 
circumstances and subsequent Alzheimer’s dementia (7).  
In a review of the early life epidemiology of Alzheimer’s dementia, 
Seifan et al. (8) proposed that although multiple studies agree that a lower 
early life socioeconomic status is associated with reduced late life cognitive 
ability, evidence for an association with late life dementia is 
Lifestyle and neurodegeneration  
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equivocal. Further research is needed to clarify the relationship between 
socioeconomic status and dementia. 
Adolescence: education and neurodegeneration 
In a recent Lancet commission report on dementia, Livingston et al. (9) 
calculated that low education is associated with dementia (Relative Risk (RR) 
1·59, 95% CI 1·26 – 2·01). In the report, low education, was defined as no 
secondary school education. However, the evidence on the relationship 
between dementia and low education is inconsistent. Sharp et al. (10), 
conducted a systematic review of the relationship between education and 
dementia. The inclusion criteria were a measure of education, this included 
years of education and level of educational attainment and a dementia 
diagnosis by a standardised diagnostic procedure. A total of 88 study 
populations from 71 articles met the inclusion criteria. Overall, 51 (58%) 
reported significant effects of low education on risk for dementia, whereas 37 
(42%) reported no significant relationship (10).  
Mortimer (11) suggested that years of formal education may raise an 
individual’s level of cognitive reserve and thus exert a protective effect 
against developing dementia. Low education is thought to result in 
vulnerability to cognitive decline because it results in less cognitive reserve. It 
has been hypothesised that people with higher levels of education may 
develop a greater complexity and efficiency of neural networks, meaning as 
dementia pathology develops, they can actively compensate by drawing on a 
greater reserve of cognitive processing approaches (12). 
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A review paper found 22 papers reporting cohort studies of the effects 
of education, occupation, premorbid IQ and mental activities in incident 
dementia published up to 2004. The great majority of the studies 
demonstrated a significant protective effect of these lifetime exposures. The 
authors summarized all of the studies to calculate the protective effect of 
higher cognitive reserve and found that it decreased the risk of developing 
dementia by 46% (13). 
Adulthood and old age: cardiovascular risk 
 
Most dementia research largely overlooks vascular disease as a 
cause. This is thought to reflect the fact that many clinicians and researchers 
working on dementia, stroke, physical, or psychiatric manifestations are still 
too often segregated (14). However, there is now decades of data, including 
work from the Honolulu Asia Aging Study, the Rotterdam Study and the 
Religious Orders Study that highlights the significance of vascular 
contributions to dementia, including Alzheimer’s dementia (15-17). Over the 
past 50 years the control of vascular risk factors including diabetes and 
hypertension, has led to a major decline in the annual risk of stroke. Whether 
improved control of vascular risk factors has translated to decreased 
dementia risk is not known but has been suggested(18). 
In a meta-analysis of longitudinal studies looking at diabetes as a risk 
factor for dementia, Cheng et al. showed that subjects with diabetes have a 
higher risk for Alzheimer’s dementia (RR 1.46, 95% CI 1.20-1.77), Vascular 
dementia (RR 2.48, 95% CI 2.08 - 2.96), any dementia (RR 1.51, 95% CI 
1.31 - 1.74) and Mild Cognitive Impairment (RR 1.21, 95% CI 1.02 - 1.45) 
Lifestyle and neurodegeneration  
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than those without diabetes (19). However, in the review, there is no clear 
distinction between developing diabetes in midlife and late life. Furthermore, 
for many studies, diabetes was diagnosed using medical records, medication 
prescribed for diabetes or self-reported. This would miss many individuals 
with undiagnosed diabetes, who would have been correctly identified in those 
studies that had used an oral glucose tolerance tests in addition to the 
measures used to identify diagnosed diabetes.  
In a  review of modifiable risk factors for Alzheimer’s dementia, Barnes 
et al. (20) observed that midlife obesity is associated with Alzheimer’s 
dementia (RR 1.60, 95% CI 1.34-1.92). This is supported by the findings of a 
systematic review and meta-analysis of longitudinal cohort studies of the risk 
of obesity in midlife and late-life in the development of dementia by Pedditizi 
et al. (21). Inclusion criteria included epidemiological longitudinal studies, 
published up to September 2014, in participants without cognitive impairment 
and aged 30 or over at baseline assessment with at least 2 years of follow-
up. Of the 1,612 abstracts identified and reviewed, 21 met the inclusion 
criteria. Review of the 21 papers showed that being obese and below the age 
of 65 years, had a positive association with dementia (RR 1.41, 95% CI 1.20 
– 1.66), but the opposite was seen in those aged 65 and over, (RR 0.83, 95% 
CI 0.74 – 0.94). This study exemplifies the importance of adopting a life 
course approach to the study of neurodegeneration (21). There is a 
biologically plausible association between obesity and dementia.  Adiposity 
may have direct adverse effects on brain tissue through production of 
Lifestyle and neurodegeneration  
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inflammatory cytokines, advanced glycosylation end products and 
hyperinsulinaemia (22). 
Studies of the association of hypertension with the incidence of 
dementia, further support the necessity of adopting a life course approach. In 
a literature review, looking at the relationship between hypertension and risk 
of dementia in late life, Qui et al. identified seven cross-sectional studies that 
focused on the relationship between blood pressure and dementia in late-life. 
Of these seven studies, two studies reported an association between low 
blood pressure and high prevalence of dementia and Alzheimer’s 
dementia. Three studies identified an association of self-reported or clinically 
diagnosed hypertension with a lower prevalence of dementia and two studies 
found no association between blood pressure and prevalent dementia and 
Alzheimer’s dementia (23).  
In midlife, the association between hypertension and an increased risk 
of dementia is more robust than in late-life. In four out of five studies 
identified in a literature review by Qui et al, an association between raised 
midlife blood pressure and increased risk of late-life dementia and 
Alzheimer’s dementia was evident (23). Furthermore, using data from the 
Honolulu Heart Program, Stewart et al. (24) have demonstrated evidence 
supporting an association between midlife hypertension and an increased 
risk of dementia. A cohort of 3703 Japanese–American men were followed 
up and the risk for dementia associated with categories of systolic and 
diastolic blood pressure were assessed. The risk for dementia was greater 
for groups with a Diastolic Blood Pressure (DBP) of 90–94 mmHg (OR 3.8, 
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95% CI 1.6–8.7), and DBP of 95 mmHg and over (OR 4.3, 95% CI 1.7–10.8), 
compared to a DBP of 80 to 89 mmHg. The risk for dementia was greater for 
a Systolic Blood Pressure  (SBP) of 160 mmHg and higher compared to a 
SBP of 110 to 139 mmHg, (OR 4.8, 95% CI 2.0–11.0) (24).  
Adulthood and old age: lifestyle and neurodegeneration 
 
There is a strong body of evidence that lifestyle factors are associated 
with neurodegeneration. Smoking is associated with multiple health risks and 
is the chief preventable cause of death worldwide (25). The annual global 
number of deaths due to tobacco is six million and projected to rise to eight 
million by 2030 (26). More specifically, there is a robust evidence base for an 
association between smoking and Alzheimer’s dementia. In a systematic 
review and meta-analysis of modifiable factors associated with cognition and 
dementia by Beydoun et al., MEDLINE was searched for published literature 
from January 1990 through to October 2012. In total, 247 studies were 
retrieved for systematic review and 31 included in the meta-analysis. The 
study showed an association between being a smoker and Alzheimer’s 
dementia (RR 1.37, 95% CI 1.23-1.52) (27). This finding is supported by 
transgenic Alzheimer’s dementia animal model studies that suggest cigarette 
smoke increases amyloidogenesis, neuroinflammation and tau 
phosphorylation (28).  
In terms of dose response amongst smokers, the evidence is 
inconsistent. In the Honolulu Asia Aging Study, amongst current and ex-
smokers, the risk for dementia increased with increasing pack-years of 
exposure up to ‘heavy’ smoking levels (>40.5 to 55.5 pack-years), but the 
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risk in ‘very heavy smokers’ (> 55.5 pack-years) was similar to that in ‘light’ 
smokers (>0 to <26.7 pack-years) (29). Furthermore, in the Chicago Health 
and Aging Project cohort study there was no association between smoking 
pack-years with Alzheimer’s dementia amongst current smokers (p=0.88), 
but amongst ex-smokers there was a significant trend towards a lower risk of 
incident Alzheimer’s dementia with increasing pack-years of exposure 
(p=0.02); effect sizes were not reported (30).  
There are a large number of observational studies that show an 
association between physical activity and dementia. Sofi et al. (31) 
conducted a systematic review of epidemiological studies with a prospective 
design that assessed the association between physical activity and cognitive 
decline in people without dementia or cognitive impairment at baseline. There 
were 15 studies that met the inclusion criteria and the relative risks from the 
meta-analysis showed a lower risk of cognitive decline for those in the high 
(RR 0.62, 95% CI 0.54-0.70), and moderate (RR 0.65, 95% CI 0.57-0.75) 
physical activity level groups compared to those in the low-level group. In a 
systematic review of the prospective evidence for physical activity and risk of 
neurodegenerative disease, Hamer et al. (32), searched Medline, the 
Cochrane Database of Systematic Reviews and Web of Science databases 
from 1990 to 2007 for prospective epidemiological studies of physical activity 
and incident dementia, Alzheimer's and Parkinson's disease. There were 16 
prospective studies included in the overall analysis. These studies 
incorporated 163,797 participants without dementia at baseline with 3,219 
cases at follow-up. The highest physical activity group compared to the 
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lowest physical activity group had a smaller risk for dementia (RR 0.72, 95% 
CI 0.60–0.86) and Alzheimer's dementia (RR 0.55, 95% CI 0.36–0.84). The 
results suggest that physical activity is inversely associated with risk of 
dementia and Alzheimer's dementia.  
There is a body of evidence showing an association between midlife 
physical activity and subsequent dementia risk. Rovio et al. (33), assessed 
the association between leisure time physical activity in midlife and the 
subsequent development of dementia. Using regression analysis, Rovio et al. 
(33) demonstrated that leisure-time physical activity in midlife was associated 
with a decreased risk of dementia in later in life. From a population based 
cohort of 1449 persons, aged 65–79 years, 117 persons had dementia. Even 
after adjustments for age, sex, education, follow-up time, locomotor 
disorders, APOE genotype, vascular disorders, smoking, and alcohol 
drinking, leisure-time physical activity in midlife at least twice a week was 
associated with a reduced risk of dementia (OR 0·48, 95% CI 0·25–0·91) 
. Using evidence from a population based study of Swedish twins, Andel et 
al. (34) demonstrated that exercise in midlife may reduce the odds of 
dementia in late life. In the case-control analysis, light exercise such as 
gardening or walking were associated with a reduced odds of dementia 
compared to hardly any exercise (OR 0.63, 95% CI 0.43-0.91). Additionally, 
regular exercise involving sports were associated with a reduced odds of 
dementia compared to hardly any exercise (OR 0.34, 95% CI 0.16-0.72).  
Alcohol is implicated as a causal factor for more than 200 diseases 
and injuries, including major non-communicable diseases such as liver 
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cirrhosis, some cancers and cardiovascular disease (35). The 
neurodegenerative effects of alcohol on the brain are well established. It 
produces cerebral volume loss, including white matter changes related to 
memory processing and visuospatial functioning (36). Additionally, neuronal 
loss in alcohol dependent patients has also been described in the frontal 
association cortex, hypothalamus, cerebellum, hippocampus, amygdala and 
locus coeruleus (37).  
A ‘J’ shaped relationship has been reported between the volume of 
alcohol consumed and risk of dementia, where moderate drinkers are at 
lower dementia risk than abstainers and heavy drinkers (38).  A systematic 
review and meta-analyses by Anstey et al. (39) found alcohol drinkers in late 
life have reduced risk of dementia. Follow-up ranged from 2 to 8 years. Meta-
analyses were conducted on samples including 14,646 participants evaluated 
for Alzheimer dementia, 10,225 participants evaluated for vascular dementia 
and 11,875 followed for any type of dementia. Light to moderate drinkers 
were at lower risk for Alzheimer’s dementia, Vascular dementia and any type 
of dementia compared to non-drinkers; Alzheimer’s dementia (RR 0.72, 95% 
CI 0.61-0.86), Vascular dementia (RR 0.75, 95% CI 0.57-0.98), and any type 
of dementia (RR 0.74, 95% CI 0.61-0.91).  
In summary, there is a strong body of evidence supporting the notion 
that lifestyle factors in adulthood are associated with neurodegeneration. The 
evidence encompasses a variety of study designs and covers a range of 
lifestyle factors including smoking, physical activity and alcohol. Further 
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exploration of the association between lifestyle and a specific biomarker of 
neurodegeneration - MRI, is therefore the focus of this thesis. 
1.2 The importance of midlife risk factor modification to treat 
neurodegeneration 
Pharmacological developments 
The failure to develop new drug treatments to treat late life 
neurodegeneration, namely dementia, emphasises the importance of 
focusing on risk factor modification (40). There are four drugs approved for 
the treatment of Alzheimer’s dementia. These drugs have clinical effects as 
demonstrated on the Alzheimer’s Disease Assessment Scale – cognitive 
subscale (ADAS-cog) (41), however they do not modify the course of the 
disease. These four treatments are three cholinesterase inhibitors - 
donepezil, rivastigmine, galantamine and an N-methyl-D-aspartate (NMDA) 
receptor antagonist - memantine. Donepezil was approved by the Food and 
Drug Administration (FDA) in 1996, rivastigmine in 1998, galantamine in 
2001, and memantine in 2003. There have been no new drugs approved for 
Alzheimer’s dementia since 2003 (42). The drugs in development for 
Alzheimer’s dementia according to the most advanced phase of study and 
main therapeutic properties are shown in Figure 2. This shows that 113 drugs 
were being investigated for Alzheimer’s dementia in 2018 (40). Despite 
ongoing investigations, there has not been a significant advance in the 
development of drug treatments for dementia in 15 years.  
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Given the failure to develop pharmacological interventions, in addition 
to the strong body of evidence that demonstrates a relationship between 
lifestyle factors and neurodegeneration, three key recent studies, the 
preDIVA study (43), the Multidomain Alzheimer Preventive Trial (MAPT) (44) 
and the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment 
and Disability (FINGER) (45) have understandably sought to reduce 
dementia incidence through late life risk factor modification.  
The preDIVA study 
The preDIVA study aimed to reduce vascular risk factors to prevent 
dementia in a 6-year open-label, cluster-randomised control trial. Individuals 
aged 70–78 years were recruited through participating general practices in 
the Netherlands. The primary outcomes were cumulative incidence of 
dementia and disability score (Academic Medical Center Linear Disability 
Score (ALDS)) at 6 years of follow-up. Smoking habits, diet, physical activity, 
weight, and blood pressure were monitored and individually tailored lifestyle 
advice was given (43). Blood glucose and lipid concentrations were assessed 
every 2 years and if indicated, medication was given for hypertension, 
diabetes or dyslipidaemia. There were 3526 participants recruited and 
randomly assigned; 1890 participants to the intervention group and 1636 
participants to the control group. The primary outcome data were obtained for 
3454 (98%) participants and median follow-up was 6.7 years. Dementia 
incidence did not differ significantly between the intervention and usual care 
group. Dementia developed in 121 (7%) of 1853 participants in the 
intervention group and in 112 (7%) of 1601 participants in the control group 
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(hazard ratio (HR) 0∙92, 95% CI 0∙71–1∙19). Mean ALDS scores measured 
during follow-up did not differ between groups (85·7 [SD 6·8] intervention vs 
85·7 [SD 7·1] control). During the study, 309 (16%) of 1885 participants died 
in the intervention group, compared with 269 (16%) of 1634 participants in 
the control group (HR 0∙98, 95% CI 0∙80–1∙18). Incident cardiovascular 
disease did not differ between groups, 273 (19%) of 1469 participants in the 
intervention group and 228 (17%) of 1307 participants in the control group 
(HR 1∙06, 95% CI 0∙86–1∙31) (43). However, the trial did not specifically 
select a population with increased cardiovascular risk, potentially limiting the 
overall effect of the interventions. Furthermore the study population was aged 
70–78 years, whereas the majority of evidence shows an association 
between midlife (40–60 years old) hypertension and dementia (46). 
The Multidomain Alzheimer Preventive Trial 
MAPT assessed the efficacy of supplementation with omega-3 fatty 
acid, a multidomain intervention consisting of nutritional counselling, physical 
exercise, cognitive stimulation or a combination of the two interventions on 
the change in cognitive function of participants aged 70 years and older for a 
period of 3 years (44). There were 1680 subjects, mean age 75.3 years and 
64.8 % female enrolled by 13 memory clinics. Subjects were randomized into 
one of the following four groups: omega-3 supplementation alone, 
multidomain intervention alone, omega-3 plus multidomain intervention, or 
placebo. Participants underwent cognitive, functional and biological 
assessments at month 6, 12, 24 and 36. The primary endpoint was a change 
of memory function at three years, as assessed by the Free and Cued 
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Selective Reminding test (44). The results of MAPT showed no significant 
effects with any of the three treatment interventions compared with placebo 
on the primary outcome (47). In the context of increasing evidence that 
lifestyle and cardiovascular risk factors for neurodegeneration are prominent 
in midlife, it is noteworthy that the focus of this study was on individuals in 
late life (mean age 75 years old).  
The Finnish Geriatric Intervention Study to Prevent Cognitive 
Impairment and Disability  
The FINGER study (45), is a multicentre, multi-domain intervention 
double blind randomised control trial that is currently ongoing. To date, the 
trial has demonstrated that lifestyle intervention could maintain or even 
improve cognitive functioning in an elderly population. Between 2009 and 
2011, 2654 individuals aged 60 -77 years old, were screened and 1260 
individuals were entered into the study. Both the intervention group (n= 631) 
and the control group (n=629) received oral and written information and 
advice on healthy diet and level of physical, cognitive and social activities 
beneficial for vascular risk factors management and disability prevention from 
the study nurse. Additionally, the intervention group received nutritional 
guidance, physical training, cognitive training and social activity intervention 
in addition to intensive monitoring and management of metabolic and 
vascular risk factors. The nutritional intervention included individual sessions 
with a nutritionist. The physical training programme comprised of individually 
tailored, progressive muscle strength training and aerobic exercise program. 
The cognitive training targeted cognitive domains most sensitive to ageing 
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and with a central role in everyday situations (episodic memory, executive 
function, mental speed, and working memory). The training was competed in 
group sessions and individually using a computer-based program that was 
specially adapted for the FINGER from protocols previously shown to be 
effective in shorter term randomised controlled trials (48). The social activities 
were stimulated through the numerous group meetings of all intervention 
components. 
The primary outcome was change in cognition as measured by the 
comprehensive neuropsychological test battery (NTB). Estimated mean 
change in NTB total Z score at 2 years was 0·20 (SD 0·51) in the intervention 
group and 0·16 (SD 0·51) in the control group. The between group difference 
in the NTB total score per year was 0·022 (95% CI 0·002-0·042, p=0·030). In 
the study, 153 (12%) individuals dropped out overall. Adverse events 
occurred in 46 (7%) participants in the intervention group compared with six 
(1%) participants in the control group; the most common adverse event was 
musculoskeletal pain. Findings from this large, long-term, randomised 
controlled trial suggest that a multidomain intervention could improve or 
maintain cognitive functioning in individuals in late life. However, it is 
important to bear in mind that, no evidence-based model exists to link 
marginal changes in cognitive functioning to modification of dementia 
incidence.  
In summary, lifestyle modification may reduce an individual’s risk of 
developing dementia; however, it is important to recognise that the 
effectiveness of a lifestyle modification could be dependent on the stage of 
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an individual’s life at which it is made. The preDIVA study (43), MAPT (44) 
and FINGER (45) studies all focus on interventions that might have a limited 
impact in late life.  Further research is needed to assess if the critical period 
for intervention is midlife. 
Midlife lifestyle modification 
There are a number of trials worldwide, collecting biomarker data on 
asymptomatic individuals at risk of late life dementia. This includes the ALFA 
project (49), the Adult Children Study (50), Wisconsin Registry for 
Alzheimer's Prevention (WRAP) (51), the European Prevention of 
Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study (LCS) (52) and the 
PREVENT Dementia cohort (53). Both the ALFA project (49) and the Adult 
Children Study (50) assess cognitively normal individuals aged between 45 
and 74 years for biomarkers of Alzheimer’s dementia. WRAP is a longitudinal 
observational cohort study of people age 40 – 65 years old. It is enriched with 
people with a parental history of probable Alzheimer's dementia (51). EPAD 
is a longitudinal cohort study of asymptomatic individuals aged 50 years old 
and over with no diagnosis of dementia. From the longitudinal cohort study, 
subjects will be selected for proof-of-concept trials for secondary prevention 
of Alzheimer’s dementia (52). The PREVENT Dementia cohort is a 
prospective cohort study to identify midlife biomarkers of late life dementia 
(53). In the PREVENT Dementia cohort, midlife is defined as 40 -59 years 
old. In accordance with the PREVENT Dementia cohort, the same definition 
of midlife is used in my thesis. The use of this definition throughout my thesis 
gives the opportunity to directly use the systematic review findings to guide 
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the analysis of the PREVENT Dementia Cohort data. A comprehensive 
description of the PREVENT Dementia Cohort is given in Chapter 3.  
This thesis will look at the association between lifestyle and 
neurodegeneration in midlife. Neuroimaging will be used as a biomarker for 
neurodegeneration as a clinical trial would not be feasible for the purposes of 
this thesis.  
1.3 Functional Magnetic Resonance Imaging as a biomarker of 
neurodegeneration 
As part of this thesis, a systematic review was undertaken to explore 
the relationship between lifestyle and neurodegeneration as expressed on 
fMRI in midlife. FMRI encompasses a family of non-invasive imaging 
techniques that provide information on multiple aspects of brain function and 
physiology. FMRI does not directly image neuronal activity; instead, it targets 
the detection of changes in its various physiological correlates such as 
Cerebral Blood Flow (CBF). FMRI is established as a marker of 
neurodegeneration and it has been used in the study of Cerebral Amyloid 
Angiopathy, Parkinson’s disease, Amytropic Lateral Sclerosis and Dementia 
(54-57). The most studied neurodegenerative disease using fMRI is 
Alzheimer’s disease (57). In the study of Alzheimer’s disease, Asllani et al. 
(58) demonstrated that individuals with Alzheimer’s disease showed a 
decrease in global grey matter CBF, compared to age matched cognitively 
normal adults with mean and standard deviation values of 36.1 ± 7.8 ml/100g 
per min for the Alzheimer’s disease group and 62.4 ± 13 ml/100g per min for 
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the age matched cognitively normal adults group (t = 6.05, P < 0.0001). 
Additionally, alterations in resting CBF are associated with both first degree 
family history of Alzheimer disease and APOE 4. First degree familial history 
of Alzheimer’s disease can increase the risk of developing Alzheimer’s 
disease by up to 10 fold and possessing the APOE 4 allele has been shown 
to increase Alzheimer’s disease risk by up to 8 fold (59, 60). Okonkwo et al. 
(61) demonstrated that cognitively intact individuals with a first degree family 
history of Alzheimer disease and APOE 4 allele had reduced CBF in lateral 
frontal and superior parietal regions, hippocampus, precuneus and posterior 
cingulate. However, in a slightly younger group with first degree family history 
of Alzheimer disease and APOE 4 allele, Fleisher et al. (62) showed 
increased hippocampal CBF compared to adults with no known risk factors 
for Alzheimer’s disease. Chen et al. (57) proposed that in individuals at risk 
for Alzheimer’s disease, elevated CBF represents a possible vascular 
regulatory mechanism to compensate for an increased need for glucose and 
oxygen in order to achieve a similar level of cognitive performance. 
Subsequently, lower CBF seen in older asymptomatic adults at higher risk, 
such as in those with a first degree family history of Alzheimer disease and 
APOE 4 allele, suggests a breakdown in this early compensatory 
mechanism that may precipitate a decrease in neural activity and later 
degeneration and cognitive decline. 
Hypothetical models of the development and progress of Alzheimer’s 
disease suggest that fMRI is sensitive to the earliest neurodegenerative 
changes in the condition. In a hypothetical model of the dynamic biomarkers 
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of Alzheimer’s disease, Jack et al. (63) proposed that biomarkers become 
abnormal in a temporally ordered manner. Initially cerebrospinal fluid (CSF) 
Amyloid-Beta and then amyloid PET followed by CSF tau and 
fluorodeoxyglucose PET abnormalities. In a later stage of Alzheimer’s 
disease there are structural MRI (sMRI) abnormalities and then clinical 
symptoms become more evident. In an update to this model, Jack et al. (64) 
proposed that fMRI biomarkers may become abnormal before amyloid 
biomarkers become abnormal in Alzheimer’s disease. An adapted version of 
the Jack et al. (63)  model of the dynamic biomarkers of Alzheimer’s disease, 
taking into account the potential early fMRI changes in Alzheimer’s disease, 
is shown in Figure 3. The Jack et al. (63), model is complemented by the 
hypothetical model of the temporal ordering of physiological biomarkers of 
Alzheimer’s disease by Wierenga et al (65), as shown in Figure 4. In this 
model, CBF changes that can be measured by fMRI occur early in the 
development of Alzheimer’s disease. Changes in biomarkers measuring 
Amyloid-Beta, Tau mediated neuronal injury and dysfunction and Amyloid-
Beta occur later in the development Alzheimer’s disease. However, it is worth 
emphasizing that the models are based on assumptions rather than strong 
empirical data. Collection of empirical data is ongoing in studies such as the 
European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort 
Study (LCS) (52) and the PREVENT Dementia cohort (53).  
 




Figure 3: Adapted model of the dynamic biomarkers of Alzheimer’s dementia.  
 
Figure 4: Hypothetical model of the temporal ordering of physiological biomarkers of 
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CBF changes in Alzheimer’s dementia are thought to initially result in 
hyperperfusion and later in hypoperfusion (65).  The shift from 
hyperperfusion to hypoperfusion is consistent with the conclusions of a 
recent 8-year follow-up study of asymptomatic APOE ε4 carriers and controls 
who were 55 to 65 years of age at the time the study was initiated (66). At the 
initial examination, the APOE ε4 carriers showed significantly higher resting 
CBF values in a number of brain regions that are vulnerable to Alzheimer’s 
dementia pathology. Eight years later the APOE ε4 carriers had significantly 
larger CBF reductions in the affected regions (66).  
The capillary dysfunction hypothesis of Alzheimer’s dementia 
developed by Ostergaard (67)  offers a possible explanation for this biphasic 
response. It theorises that increases in the heterogeneity of capillary blood 
flow patterns occurs early in the preclinical stage of Alzheimer’s dementia 
and requires increases in CBF to maintain adequate brain oxygenation. The 
mechanisms by which the initial hyperperfusion is then suppressed remains 
poorly understood. It is thought to involve tissue hypoxia that gradually 
develops when vasodilation can no longer replenish tissue oxygen during 
episodes of increased oxidative metabolism (67). However, this model is 
hypothetical and needs further testing. 
1.4 What is lifestyle? 
There is a lack of a clear definition of lifestyle in medical literature and 
more specifically in literature on neurodegeneration. In the Caerphilly Cohort 
Study, Elwood et al. (68) assessed the effect of lifestyle on chronic diseases 
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and dementia. In regard to lifestyle, Elwood et al. (68) noted the following, 
‘lifestyle and health-related behaviours are powerful determinants of 
morbidity and mortality worldwide, and unhealthy behaviours lie at the root of 
many chronic and disabling diseases. Major concerns focus on smoking, 
body mass, physical activity, diet and alcohol consumption, and the concept 
of a healthy lifestyle is usually defined with reference to combinations of 
these factors.’ The ambiguity about what factors make up lifestyle, make it 
difficult to combine and summarise the findings from the current literature on 
lifestyle. In the Caerphilly Cohort Study (68), the factors which made up 
lifestyle were smoking status, Body mass index (BMI), portions of fruit and 
vegetables per day, regular exercise and alcohol intake. Contrastingly, in the 
World Alzheimer’s Report on Dementia and Risk Reduction (35), the factors 
which made up lifestyle were smoking, physical activity, diet, alcohol and 
cognitive stimulation. In an interventional study to prevent dementia, in the 
FINGER study (45) a different interpretation of the key factors that make up 
lifestyle was used. In the FINGER study, four intensive lifestyle-based 
strategies (diet, exercise, cognitive training, and vascular disease 
management) were used to enhance cognition in an intervention group 
versus controls who received general health advice.  
For my thesis, because of the lack of consensus in the published 
literature, I used the following definition of lifestyle from the World Health 
Organisation (WHO): ‘Lifestyle is a way of living based on identifiable 
patterns of behaviour which are determined by the interplay between an 
individual’s personal characteristics, social interactions, and socioeconomic 
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and environmental living conditions’ (69). Based on this definition, amongst 
the six factors (smoking status, BMI, portions of fruit and vegetables per day, 
regular exercise and alcohol intake) which made up lifestyle in the Caerphilly 
Cohort Study (68), five would be in keeping with the WHO definition of 
lifestyle (smoking status, portions of fruit and vegetables per day, regular 
exercise and alcohol intake) and one factor, BMI, would not. BMI is not an 
identifiable pattern of behaviour, it is the consequence of an individual’s 
lifestyle, in particular the frequency and intensity of physical activity and diet. 
All five lifestyle factors identified in the World Alzheimer’s Report on 
Dementia and Risk Reduction (35) (smoking, physical activity, diet, alcohol 
and cognitive stimulation) would be in keeping with the WHO definition of 
lifestyle. Amongst the four interventions used in the FINGER study (45) (diet, 
exercise, cognitive training, and vascular disease management), three would 
be in accordance with the WHO definition of lifestyle (diet, exercise and 
cognitive training). Vascular disease management would not be a pattern of 
behaviour and it therefore conflicts with the WHO definition of lifestyle. My 
thesis will aim to explore all factors that are in accordance with the World 
Health Organisation (WHO) definition of lifestyle (69).  
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Statement of aim and objectives 
Aim 
To evaluate the relationship between lifestyle factors and neurodegeneration 
in midlife as expressed on arterial spin labelling and structural MRI. 
Objectives 
1. To undertake a systematic review of the relationship between lifestyle 
and neurodegeneration in midlife as expressed on functional MRI in 
the published literature. 
2. Based on the findings of this systematic review, analytically assess the 
impact of lifestyle on cerebral blood flow in a midlife cohort. 
3. Assess the impact of lifestyle on the structural MRI expression of 
neurodegeneration in a midlife cohort. 
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2 Systematic review of the relationship between lifestyle 
and neurodegeneration in midlife as expressed on 
functional magnetic resonance imaging 
Chapter abstract 
INTRODUCTION: Lifestyle factors may influence brain health in midlife. 
FMRI is a tool, widely used to investigate early changes in brain health, 
including neurodegeneration. In this systematic review, the relationship 
between lifestyle factors and neurodegeneration in midlife, as expressed 
using fMRI is evaluated.  
METHODS: MEDLINE, EMBASE, and PsycINFO were searched by 
combining subject headings and free text terms adapted for each database. 
Articles were screened and their quality assessed independently by two 
reviewers before final inclusion in the review. 
RESULTS: 4116 studies were screened and 29 were included in the review. 
Seven lifestyle factors were identified in this review; alcohol, cognitive 
training, excessive internet use, fasting, physical training, smoking and 
substance misuse. 
DISCUSSION: Cognitive training and physical training appear to be 
associated with a neuroprotective effect, whereas alcohol misuse, smoking 
and substance misuse appear to be associated with neurodegeneration. 
Further research is required into the effects of excessive internet use and 
fasting. 




There is increasing recognition that neurodegenerative diseases, which 
manifest clinically as dementia in later life, have their origins in midlife, or 
even earlier (70). There is potentially a role for both pharmacological and 
non-pharmacological interventions such as lifestyle modification in the 
management of neurodegenerative diseases. In midlife, lifestyle modification 
may alter neurodegenerative disease progression and thereby reduce an 
individual’s risk of dementia in later life (71). If this were the case, it is critical 
to identify which potentially modifiable lifestyle factors are associated with 
neurodegeneration in midlife. Recent research on cognitive, neuroimaging 
and biological markers suggest that changes in several parameters may well 
precede overt clinical symptoms by not just many years, but decades (53). 
FMRI is an established marker for neurodegenerative disease. It could also 
be of value in monitoring disease progression and response to interventions. 
Therefore, in the absence of any previous systematic reviews, I evaluated the 
relationship between lifestyle factors and neurodegeneration in midlife as 
expressed on fMRI in the published literature. A shortened version of this 
systematic review was published in ‘Alzheimer's & Dementia: Translational 
Research & Clinical Interventions’ on 3rd April 2018 (72). The published 
manuscript is available in Appendix A. 




2.2.1 Identification of studies 
MEDLINE, EMBASE, and PsycINFO were searched via the OVID 
platform on 5th December 2016 with no limits on search dates. Therefore, 
EMBASE was searched from 1980 to November 2016, MEDLINE was 
searched from 1946 to November 2016, PsycINFO from 1806 to November 
2016. Additionally, there were no limits on language. A specific search 
strategy was constructed for each database using subject headings and free 
search terms. The search terms covered the areas of neuroimaging, lifestyle, 
and regional changes in cerebral metabolism or blood flow, blood volume, or 
oxygenation. Appendix B shows the search strategies for EMBASE, 
MEDLINE and PsycINFO. 
2.2.2 Eligibility 
The systematic review includes all published studies that assessed the 
relationship between lifestyle factors and neurodegeneration, neuroprotection 
or both as expressed on fMRI in midlife. A study was defined as having 
assessed individuals in midlife if it included individuals aged 40-59 years old 
or if two standard deviations around the mean reported age of participants 
fell within the 40-59 years age range.  Neurodegeneration was defined as 
any pathological condition primarily affecting neurons (73). Neuroprotection 
was considered to be an effect that may result in salvage, recovery or 
regeneration of the nervous system, its cells, structure and function (74). The 
exposure in the review was lifestyle factors, as defined by the World Health 
Organisation: ‘Lifestyle is a way of living based on identifiable patterns of 
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behaviour which are determined by the interplay between an individual’s 
personal characteristics, social interactions, and socioeconomic and 
environmental living conditions’ (69). The outcomes in the systematic review 
are the numerical outcome measures derived from the fMRI scan. FMRI is a 
brain imaging technique that captures regional changes in cerebral 
metabolism or in blood flow, volume or oxygenation in response to task 
activation or during rest (75). The systematic review aimed to include studies 
using both resting-state and task-based fMRI experimental protocols and 
studies assessing the general population as well as those conducted in a 
general medical setting.  
The inclusion criteria for the systematic review were: 
i. Original human research study. 
ii. Population includes a lifestyle factor in midlife. 
iii. Study includes an fMRI outcome in midlife. 
The exclusion criteria hierarchy for the systematic review were: 
i. Insufficient information. 
ii. Conference abstract. 
iii. Not an original human research study.  
iv. Study population has a diagnosis of dementia either in general or 
based on specific subtypes classified using standard diagnostic 
criteria, e.g. the National Institute of Neurological and Communicative 
Disorders and Stroke and the Alzheimer’s Disease and Related 
Disorders Association (NINCDS-ARDRA) (76). 
v. Study population does not include a lifestyle factor in midlife. 
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vi. Study population does not include individuals in midlife. 
vii. The aim of the study is not to look at the effect of a lifestyle factor on 
fMRI outcome. 
viii. FMRI outcome is not a proxy for neurodegeneration or 
neuroprotection. 
2.2.3 Study selection and data collection   
The titles and abstracts of all articles identified by the search were 
screened independently by two reviewers (Dr Hinesh Topiwala and Dr Lucy 
Stirland) against the inclusion and exclusion criteria with any disagreements 
in the final lists of included studies resolved by third party arbitration 
(Professor C. W. Ritchie). Potentially relevant articles were then retrieved 
and examined against the inclusion and exclusion criteria. Differences 
between reviewers’ selections were again resolved by discussion. Data were 
extracted from included articles by one reviewer (Dr Hinesh Topiwala) on the 
number of study participants, mean age, standard deviation and age range of 
participants, study methodology and design and the key findings from the 
study related to this systematic review.  
2.2.4 Quality of evidence 
The quality of studies was assessed independently by two reviewers 
(Dr Hinesh Topiwala and Dr Lucy Stirland) using a modified Effective Public 
Health Practice Project Quality Assessment Tool (EPHPP) (77) tailored to the 
literature being assessed in this review. The EPHPP was modified by adding 
‘cross-sectional study’ to the list of recognised study designs in section B. 
The EPHPP is available at: http://www.ephpp.ca/. The EPHPP tool has been 
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judged suitable for use in a systematic review and it is based on six 
component ratings: selection bias, study design, confounders, blinding, data 
collection method, withdrawals and dropouts (78). For each of these six 
components, a study is given a rating of strong, moderate or weak. The 
questions and key scoring guidelines for the modified EPHPP are shown in 
Table 1. On the scoring pro forma, a score is selected for each of the six 
component ratings and based on this, each individual study is given a global 
rating. When a study had no weak ratings, it was given a global quality rating 
of strong. When a study had one weak rating it was given a global quality 
rating of moderate. When a study had two or more weak ratings it was given 
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Table 1: Modified Effective Public Health Practice Project Quality Assessment Tool 
questionnaire and scoring system. 
Component 
Rating 




Question 1. Are the individuals 
selected to participate in the study 
likely to be representative of the 
target population? Answer: 1. Very 
likely | 2. Somewhat likely | 3. Not 
likely | 4. Can’t tell. 
Participants are more likely to be 
representative of the target population if 
they are randomly selected from a 
comprehensive list of individuals in the 




Question 2. What percentage of 
selected individuals agreed to 
participate? Answer: 1. 80 - 100% 
agreement | 2. 60 – 79% 
agreement | 3. Less than 60% 
agreement | 4. Not applicable | 5. 
Can’t tell. 
Refers to the percentage of subjects in 
the control and intervention groups that 
agreed to participate in the study before 





Section rating: 1. Strong | 2. 
Moderate | 3. Weak. 
Rating is strong when the selected 
individuals are very likely to be 
representative of the target population 
(Question 1 is 1) and there is greater 





Question 3: Indicate the study 
design: Answer: 1. Randomised 
controlled trial | 2. Controlled 
clinical trial | 3. Cohort analytic 
(two group pre + post) 4 Case-
control | 5. Cohort (one group pre 
+ post) | 6. Interrupted time series | 
7. Cross-sectional | 8. Other | 9. 
Can’t tell. 
The type of design is a good indicator 
of the extent of bias - in stronger 
designs, an equivalent control group is 
present and the allocation process is 
such that the investigators are unable 




Section rating: 1. Strong | 2. 
Moderate | 3. Weak. 
Rating is strong when the study 
describes a randomised controlled trial 
or case controlled trial. 
Section C. 
Confounders 
Question 4: Were there 
confounders between groups prior 
to the intervention? Answer: 1. Yes 
| 2. No | 3. Can’t tell. 
A confounder is a variable that is 
associated with the intervention or 
exposure and causally related to the 
outcome of interest. 
Section C. 
Confounders 
Question 5: If yes, indicate the 
percentage of relevant 
confounders that were controlled 
for? Answer: 1. 80 – 100% | 2. 60 
– 79% | 3. Less than 60% | 4. 
Can’t Tell. 
Even in a robust study design, groups 
may not be balanced with respect to 
important variables prior to the 
intervention. The authors should 
indicate if confounders were controlled 
for. 





Question Key scoring guidelines 
Section C. 
Confounders 
Section rating: 1. Strong | 2. 
Moderate | 3. Weak. 
Rating is strong when the study 
controlled for at least 80% of relevant 
confounders (question 1 is 2); or 
(question 2 is 1). 
Section D. 
Blinding 
Question 6: Were the outcome 
assessors aware of the 
intervention or exposure status of 
participants? Answer: 1. Yes | 2. 
No | 3. Can’t tell. 
Assessors should be described as 
blinded to which participants were in 
the control and intervention groups. The 
purpose of blinding the outcome 




Question 7: Were the study 
participants aware of the research 
question? Answer: 1. Yes | 2. No | 
3. Can’t tell. 
Study participants should be blinded to 
the research question. The purpose of 
blinding the participants is to protect 
against reporting bias. 
Section D. 
Blinding 
Section rating: 1. Strong | 2. 
Moderate | 3. Weak. 
Rating is strong when the outcome 
assessor is not aware of the 
intervention status of participants 
(question 1 is 2); and the study 
participants are not aware of the 





Question 8: Were data collection 
tools shown to be valid? Answer: 
1. Yes | 2. No | 3. Can’t tell. 
Tools for primary outcome measures 





Question 9: Were data collection 
tools shown to be reliable? 
Answer: 1. Yes | 2. No | 3. Can’t 
tell. 
Tools for primary outcome measures 





Section rating: 1. Strong | 2. 
Moderate | 3. Weak. 
Rating is strong when the data 
collection tools have been shown to be 
valid (question 1 is 1) and the data 
collection tools have been shown to be 





Question 10: Were withdrawals 
and drop-outs reported in terms of 
numbers and/or reasons per 
group? Answer: 1. Yes | 2. No | 3. 
Can’t tell | 4. Not Applicable. 
Score yes if the authors describe both 
the numbers and reasons for 





Question 11: Indicate the 
percentage of participants 
completing the study. Answer: 1. 
80 -100% | 2. 60 - 79% | 3. Less 
than 60% | 4. Can’t tell | 5. Not 
Applicable. 
The percentage of participants 
completing the study refers to the 
percentage of subjects remaining in the 
study at the final data collection period 





Section rating: 1. Strong | 2. 
Moderate | 3. Weak. 
Rating is strong when withdrawals and 
drop-outs are reported (question 10 is 
1) and the follow-up rate is 80% or 
greater (question 11 is 1). 
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Protocol and registration 
The systematic review protocol was registered on the PROSPERO 
International Prospective Register of Systematic Reviews, registration 
number CRD42016045237, (https://www.crd.york.ac.uk/PROSPERO/) on 5th 
August 2016. Please see Appendix C for the systematic review protocol. 
2.3 Results 
2.3.1 PRISMA flow diagram 
The PRISMA diagram (Figure 5) for the screening and selection of 
studies, shows 4116 records were identified through database searches. 
Following deduplication and title and abstract screening, 255 full-text articles 
were assessed for eligibility. After excluding 226 articles, a total of 29 articles 
were included in the systematic review.




Figure 5: PRISMA diagram showing the selection of studies from search to inclusion. 
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2.3.2 Articles excluded at full-text screening 
Of the 226 articles excluded during full text screening, three articles 
were excluded for having insufficient information. For these articles, the 
authors were contacted with a request for further information. The authors 
did not provide sufficient information to determine if the articles were eligible 
for inclusion in this systematic review. There were 40 conference abstracts 
identified by the systematic review search strategy. The conference abstracts 
had minimal information on methods and results; they were therefore 
excluded. The search strategy also identified letters, reports and animal 
studies, which led to 14 articles being excluded for not being an original 
human research study. This systematic review focuses on midlife dementia 
prevention, therefore 15 articles were excluded as the study population did 
not include a lifestyle factor in midlife, 52 were excluded as the study 
population did not include individuals in midlife and 10 were excluded as the 
study population did not include an fMRI outcome in midlife. There were 62 
articles that were excluded as the aim of the study was not to look at the 
effect of a lifestyle factor on fMRI outcome. For example, Blum et al. (79) 
assessed the effect of an anti-craving treatment, KB220ZTM, in individuals 
with a heroin addiction. There were 30 studies that were excluded as the 
fMRI outcome in the study was not a proxy for neurodegeneration or 
neuroprotection. For example, Asensio et al. (80) evaluated relapse 
behaviour in substance misusers, by measuring acute changes in neural 
responsivity as expressed on fMRI, in response to erotic, unpleasant and 
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neutral images. The reasons that individual studies were excluded at full text 
screening are shown in Appendix D. 
2.3.3 Studies included in qualitative synthesis 
Of the 29 articles included at full text screening, six studies reported 
on the relationship between alcohol and neurodegeneration in midlife as 
expressed on fMRI, three studies reported on cognitive training, one study 
reported on excessive internet use, one study on fasting, seven studies on 
physical training, three studies on smoking and 12 studies reported on 
substance misuse. The lifestyle factors assessed by the studies included in 
the qualitative synthesis is shown on the Venn diagram in Figure 6. This 
highlights that some of the studies looked at more than one lifestyle factor. Of 
the 29 articles included in the systematic review, two studies looked at 
cognitive training and physical training, one study looked at alcohol and 
excessive internet use and one study looked at alcohol and smoking.




Figure 6: Venn diagram of the lifestyle factors assessed by the studies included in the 
qualitative synthesis. The size of the circles represents the number of studies 
identified by the systematic review. The overlap between the circles represents 
studies that assessed more than one lifestyle factor. 
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The EPHPP global quality assessment rating of the studies was weak 
for 9 studies, moderate for 9 studies and strong for 11 studies. Table 2 
shows the EPHPP component ratings and global quality assessment ratings 
for studies included in the systematic review. It is noteworthy, that none of 
the studies were rated as strong for the selection bias component rating or 
blinding component rating. The selection bias component rating is strong if 
the participants in the study are very likely to be representative of the target 
population. For this to be the case, participants would need to be randomly 
selected from a comprehensive list of individuals in the target population and 
the percentage of individuals that agreed to participant in the study needs to 
be greater than 80%. This information was not stated for studies identified by 
this systematic review.  The blinding component rating is strong if the 
outcome assessor is not aware of the intervention status of participants and 
the study participants are not aware of the research question. This 




Lifestyle and neurodegeneration  
49 
Systematic Review 
Table 2: Modified Effective Public Health Practice Project Quality Assessment Tool 
global rating for individual studies reporting on the relationship between lifestyle 









































































































































































Bednarski et al. 
(81) 
3 2 1 2 1 2 2 
Belaich et al. (82) 3 2 NA 2 1 3 3 
Castelluccio et al. 
(83) 
3 2 3 2 1 2 3 
Chapman et al. (84) 2 1 1 2 1 1 1 
Chapman et al. (85) 2 1 1 2 1 1 1 
Chapman et al. (86) 2 1 1 2 1 2 1 
Durazzo et al. (87) 3 2 1 2 3 2 3 
Gazdzinski et al. 
(88) 
2 2 3 2 1 2 2 
Hart et al. (89) 2 2 1 2 1 2 1 
Hermann et al. (90) 3 2 3 2 1 3 3 
Hotting et al. (91) 2 1 1 2 1 2 1 
Hu et al. (92) 3 2 1 2 1 2 2 
Ide et al. (93) 3 2 1 2 1 2 2 
Jiang et al. (94) 2 2 1 2 1 2 1 
Kelly et al. (95) 2 2 1 2 1 2 1 
Kim et al. (96) 2 2 3 2 1 2 2 
Lee et al. (97) 3 2 3 2 3 2 3 
Liu et al. (98) 3 2 3 2 3 2 3 
MacIntosh et al. 
(99) 
2 2 NA 2 3 1 2 
May et al. (100) 3 2 3 2 1 2 3 
McFadden et al. 
(101) 
3 2 NA 2 1 1 2 
Mitchell et al. (102) 2 2 2 2 1 1 1 
Mon et al. (103) 2 2 1 2 1 2 1 
Murray et al. (104) 2 2 2 2 1 2 1 
Rogers et al. (105) 2 2 3 2 3 2 3 
Sullivan et al. (106) 2 2 3 2 1 2 2 
Wang et al. (107) 2 2 3 2 1 2 2 
Weiland et al. (108) 3 2 3 2 1 2 3 
Xu et al. (109) 2 2 NA 2 1 2 1 
1 = Strong, 2 = Moderate, 3 = Weak, NA = Not applicable. 




Table 3 summarises the lifestyle factors and global quality 
assessment ratings of the 29 articles included in the systematic review. The 
table is arranged alphabetically by lifestyle factor. Of the six studies that 
assessed alcohol, three studies had a rating of weak and three studies had a 
rating of moderate. The three studies that assessed cognitive training all had 
a rating of strong, the one study that assessed excessive internet use had a 
quality rating of moderate and the one study that assessed fasting had a 
quality rating of weak. Of the seven studies that assessed physical training, 
two studies had a rating of moderate and five studies had a rating of strong. 
Of the three studies that assessed smoking, one study had a rating of weak, 
one study had a rating of moderate and one study had a rating of strong. Of 
the twelve studies that assessed substance misuse, four studies had a rating 
of weak, four studies had a rating of moderate and four studies had a rating 
of strong. 
Table 3: Summary of identified lifestyle factors and modified Effective Public Health 
Practice Project Quality Assessment Tool global ratings for studies reporting on the 
relationship between lifestyle factors and neurodegeneration in midlife as expressed 
on fMRI. 
Lifestyle Factor Number of studies Global rating 
Alcohol 6 Weak: 3 studies 
Moderate: 3 studies 
Cognitive training 3 Strong: 3 studies 
Excessive internet use 1 Moderate: 1 study 
Fasting 1 Weak: 1 study 
Physical training 7 Moderate: 2 studies 
Strong: 5 studies 
Smoking 3 Weak: 1 study 
Moderate: 1 study 
Strong: 1 study 
Substance misuse 
 
12 Weak: 4 studies 
Moderate: 4 studies 
Strong: 4 studies 
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Table 4 shows the demographic information for the individual studies 
reporting on the relationship between lifestyle factors and neurodegeneration 
in midlife as expressed on fMRI. From the table it is notable that other than 
the study by Weiland et al. (108) which had 470 participants, all the studies 
had a relatively small number of participants, ranging from 12 to 163. For 16 
or the 29 studies identified by this review, the mean age of individuals was 
outwith the 40-59 years old category, however two standard deviations 
around the mean reported age of participants fell within the 40-59 years old 
category.  
Table 4: Demographic information for the individual studies reporting on the 
relationship between lifestyle factors and neurodegeneration in midlife as expressed 
on fMRI.  
Study Lifestyle Factor N Mean Age (SD) /  Range 






healthy controls 27). 
Cocaine dependence: 36.2 
(6.3) / NA.  
Healthy controls:  34.9 (6.5) 
/ NA. 
Belaich et al. (82) Fasting 6 males. 41 (NA) / 34 – 48. 




94 (cocaine users 
30/ former users 29/ 
healthy controls 35). 
Cocaine users: 37.6 (7.3) / 
21-45.  
Former users: 40.3 (6.4) / 
22-50.  
Healthy controls: 35.8 (10) / 
21-58. 
Chapman et al. 
(84) 
Physical Training 37 (physical training 
18/ control 19). 
64 (3.9) / 57-75. 
Chapman et al. 
(85) 
Cognitive Training 37 (cognitive 
training 18/ control 
19). 
62.9 (3.6) / 56-71. 




36 (physical training 
18/ cognitive 
training 18). 
Physical training: 64 (4.3) / 
56-75. 
Cognitive training: 61.8 
(3.3) / 56-75. 
Durazzo et al. 
(87) 
Smoking 61 (smokers 34/ 
non-smokers 27). 
Smokers: 47.3 (10.5) / NA. 
Non-smokers: 47.3 (11.9) / 
NA. 










Non-smoking light drinkers: 
47 (7.9) / 26-66.  
Non-smoking alcoholics: 
50.9 (10) / 26-66.  
Smoking alcoholics: 48 
(9.9) / 26-66.  
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Study Lifestyle Factor N Mean Age (SD) /  Range 
Hart et al. (89) Physical Training 52 (ex-NFL players 
26/ healthy controls 
26). 
Ex-NFL players: 61.8 (NA) / 
41-79.  
Healthy controls: 60.1 (NA) 
/ 41-79. 









Alcohol dependence: 40.2 
(5.6) / NA. 
Healthy control: 41.8 (13.2) 
/ NA. 
Hotting et al. (91) Physical and 
Cognitive Training 
33 (cycling and 
spatial 8, cycling 
and perceptual 8, 
stretching and 
spatial 9, stretching 
and perceptual 8). 
Cycling and spatial: 50.25 
(4.2) / 40-55. 
Cycling and perceptual: 49 
(4.28) / 40-55. 
Stretching and spatial: 
50.22 (2.91) / 40-55. 
Stretching and perceptual: 
46 (3.89) / 40-55. 
Hu et al. (92) Substance 
Misuse 
112 (cocaine users 
56/ healthy controls 
56). 
Cocaine users: 39.86 (6.71) 
/ NA. 
Healthy controls: 38.70 
(10.9) / NA. 




healthy controls 88). 
Cocaine dependent: 39.9 
(7.6) / NA. 
Healthy controls: 38.7 
(10.9) / NA. 
Jiang et al. (94) Substance 
Misuse 
48 (chronic heroin 
users 24 / normal 
controls 24). 
Chronic heroin users: 35.67 
(5.66) / NA. 
Normal controls: 35.38 
(6.02) / NA. 






Cocaine dependent adults: 
35.0 (8.8) / NA.  
Healthy comparisons: 35.1 
(7.5) / NA. 
Kim et al. (96) Excessive 
Internet and 
Alcohol Use  
45 (internet gaming 
disorder 16 / alcohol 
use disorder 14 / 
healthy controls 15). 
Internet gaming disorder: 
21.63 (5.92) / NA. 
Alcohol use disorder: 28.64 
(5.92) / NA. 
Healthy controls: 
25.40 (5.92) / NA. 
Lee et al. (97) Substance 
Misuse 
23 (chronic cocaine 
abusers 13/ healthy 
controls 10). 
Chronic cocaine abusers: 
38 (6) / 28-45. 
Healthy controls: 
36 (6) / 27-44. 
MacIntosh et al. 
(99) 
Physical Training 30 men with 
coronary artery 
disease. 
65 (7) / 55-80. 











38.84 (9.16) / NA. 
Healthy controls: 38.77 
(9.40) / NA. 
McFadden et al. 
(101) 
Physical Training 12 overweight/ 
obese adults. 
38.2 (9.5) / NA. 
Lifestyle and neurodegeneration  
53 
Systematic Review 
Study Lifestyle Factor N Mean Age (SD) /  Range 






healthy controls 16). 
Cocaine dependence: 39 
(10.4) / NA. 
Healthy controls: 
40 (7.4) / NA. 
Mon et al. (103) Smoking 69 (non-smoking 




Non-smoking light drinker: 
44 (8.2) / 28-68. 
Non-smoking alcoholic: 
52.1 (9.4) / 28-68. 
Smoking alcoholic: 
47.8 (9.2) / 28-68. 







20, light or non-
drinkers 31). 
Alcohol dependent: 
54 (10) / NA. 
Polysubstance use: 45 (9) / 
NA. 
Light or non-drinkers: 47 
(11) / NA. 
Rogers et al. 
(105) 
Alcohol 20 (alcoholic 10/ 
healthy controls 10). 
 
Alcoholic: 43 (12) / 18-70. 
Control: 40 (13) / 18-70. 
Sullivan et al. 
(106) 
Alcohol 24 (alcoholics 12/ 
control subjects 12). 
Alcoholics: 45.7 (4.4) / 38-
54.  
Control subjects: 
46.3 (5.2) / 38-54. 
Wang et al. (107) Substance 
Misuse 
39 (cocaine addict 
20/ healthy controls 
19). 
Cocaine addict: 42.15 (4.3) 
/ NA. 
Healthy controls: 39.9 (4.5) 
/ NA. 
Weiland et al. 
(108) 
Alcohol 470 (problematic 
alcohol use 383/ 
controls 87). 
Problematic alcohol use: 
31.1 (9.3) / 21-56. 
Controls: 
25.8 (8.3) / 21-53.3.  
Xu et al. (109) Physical Training 59 healthy adults. 66.68 (9.63) / NA. 
NA = Not available, SD = Standard Deviation. 
 
Table 5 outlines the key features of the methodology of the individual 
studies reporting on the relationship between lifestyle factors and 
neurodegeneration in midlife as expressed on fMRI. Of the 29 studies 
included in the systematic review, 23 used a cross-sectional in design, two 
were clinical controlled trials, two were cohort studies and one was a 
randomised control trial. Furthermore 18 of the 29 studies used resting state 
fMRI and 11 of the 29 studies used a task based fMRI for neuroimaging. A 
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wide variety of statistical methods were used to analyse the data generated 
by the studies included in the systematic review.
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Table 5: Key features of the methodology of the individual studies reporting on the 
relationship between lifestyle factors and neurodegeneration in midlife as expressed 
on fMRI. 
Study Lifestyle Factor Key features of methodology 
Bednarski et al. 
(81) 
Substance Misuse Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: One sample & two sample t-
tests. 
Belaich et al. (82) Fasting Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: ANOVA test. 
Castelluccio et al. 
(83) 
Substance Misuse Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: Regression analysis. 
Chapman et al. 
(84) 
Physical Training Study type: Controlled clinical trial. 
fMRI type: Resting-state. 
Statistical method: General statistical linear 
model. 
Chapman et al. 
(85) 
Cognitive Training Study type: Controlled clinical trial. 
fMRI type: Resting-state. 
Statistical method: General statistical linear 
model. 




Study type: Randomised control trial. 
fMRI type: Resting-state. 
Statistical method: General statistical linear 
model. 
Durazzo et al. 
(87) 
Smoking Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: Multivariate analysis of 
covariance (MANCOVA). 




Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: MANOVA; Wilks' λ. 
Hart et al. (89) Physical Training Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: NA. 





Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: General statistical linear 
model. 
Hotting et al. (91) Physical and 
Cognitive Training 
Study type: Controlled clinical trial. 
fMRI type: Task-based. 
Statistical method: One and two sample t-tests, 
a flexible factorial model and full factorial 
model. 
Hu et al. (92) Substance Misuse Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: ANOVA test. 
Ide et al. (93) Substance Misuse Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: Two sample t-tests and 
multiple regression. 
Jiang et al. (94) Substance Misuse Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: Two sample t-tests and a 
Pearson correlation analysis. 
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Study Lifestyle Factor Key features of methodology 
Kelly et al. (95) Substance Misuse Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: NA. 
Kim et al. (96) Excessive Internet 
& Alcohol Use  
Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: two-sample t-tests. 
Lee et al. (97) Substance Misuse Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: ANOVA, Post hoc t-test, 
Pearson product moment correlations. 
Liu et al. (98) Substance Misuse Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: Kolmogorov–Smirnov test, 
Mann–Whitney U test, linear regression. 
MacIntosh et al. 
(99) 
Physical Training Study type: Cohort study. 
fMRI type: Resting-state. 
Statistical method: linear regression analysis. 
May et al. (100) Substance Misuse Study type: Cross-sectional Study. 
fMRI type: Task-based. 
Statistical method: Linear mixed effects 
analysis.  
McFadden et al. 
(101) 
Physical Training Study type: Cohort Study. 
fMRI type: Resting-state. 
Statistical method: t- test. 
Mitchell et al. 
(102) 
Substance Misuse Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: two-sample t-tests. 
Mon et al. (103) Smoking Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: Generalized linear model. 
Murray et al. 
(104) 
Substance Misuse Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: Analyses of covariance 
(ANCOVA). 
Rogers et al. 
(105) 
Alcohol Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: Two-sample t-test. 
Sullivan et al. 
(106) 
Alcohol Study type: Cross-sectional study. 
fMRI type: Task-based. 
Statistical method: ANOVA. 
Wang et al. (107) Substance Misuse Study type: Cross-sectional study. 
fMRI Type: Resting-state. 
Statistical method: Two sample t-test and 
simple regression. 
Weiland et al. 
(108) 
Alcohol Study type: Cross-sectional Study. 
fMRI Type: Resting-state. 
Statistical method: Multivariate analysis of 
variance (MANCOVA) 
Xu et al. (109) Physical Training Study type: Cross-sectional study. 
fMRI type: Resting-state. 
Statistical method: General linear model. 
ANOVA = Analysis of the Variance, fMRI = functional Magnetic Resonance Imaging, 
MANOVA = Multivariate analyses of variance, NA = Not available. 




Table 6 outlines the key findings of the individual studies reporting on 
the relationship between alcohol and neurodegeneration in midlife as 
expressed on fMRI. Of the 6 studies looking at the effect of alcohol as 
expressed on fMRI, 3 used a task-based fMRI protocol (90, 105, 106) and 3 
studies used a resting-state protocol (88, 96, 108). Of the resting-state 
studies, Gazdzinski et al. (88) demonstrated evidence that concurrent alcohol 
dependence and chronic cigarette smoking is associated with regional grey 
matter hypoperfusion. Kim et al. (96) showed increased regional 
homogeneity (ReHo) in the posterior cingulate cortex (PCC) executive 
control, basal ganglia, and primary visual networks. Weiland et al. (108) 
found significantly lower network connectivity strength than controls in the left 
executive control, basal ganglia, and primary visual networks. For the task-
based studies, Hermann et al. (110) described significantly lower blood 
oxygen dependent (BOLD) signal in an extended bilateral occipital area as 
compared with healthy controls during a visual and acoustic simulation task. 
Rogers et al. (105) described a pattern in recently abstinent alcoholic 
patients of specific deficits in functional connectivity and recruitment of 
additional brain regions for the performance of a simple finger-tapping task. 
Sullivan et al. (106) demonstrated that alcoholics have selective differences 
from control subjects in the cerebral blood flow (CBF) pattern in the anterior 
precuneus and CBF level in the insula, a hub of the salience network.  
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Table 6: Key findings of the individual studies reporting on the relationship between 








Alcoholics, as a group, showed lower frontal grey matter 
perfusion and lower parietal grey matter perfusion than 
non-smoking light drinkers.  
In smoking alcoholics, a higher number of cigarettes 
smoked per day was associated with lower perfusion. 





Alcohol dependent patients showed a significantly lower 
BOLD signal in an extended bilateral occipital area as 
compared with healthy controls. 
Kim et al. (96) Excessive 
Internet & 
Alcohol Use  
There were distinctive functional changes in the resting-
state of patients with internet gaming disorder, in addition 
to common ReHo changes in the internet gaming 
disorder and alcohol use disorder group.  
Rogers et al. 
(105) 
Alcohol Recently abstinent alcoholic patients showed deficits in 
functional connectivity and recruitment of additional brain 
regions for the performance of a simple finger-tapping 
task. 
Sullivan et al. 
(106) 
Alcohol Alcoholics showed selective differences from control 
subjects in the CBF pattern in the anterior precuneus and 
CBF level in the insula, a hub of the salience network. 
Weiland et al. 
(108) 
 
Alcohol Individuals with problematic alcohol use had significantly 
lower network connectivity strength than controls in the 
left executive control network, basal ganglia, and primary 
visual networks. 
BOLD = Blood Oxygenation Level Dependent, fMRI = functional Magnetic Resonance 
Imaging, ReHo = regional homogeneity. 
 
Cognitive training 
Table 7 outlines the key findings of the individual studies reporting on 
the relationship between cognitive training and neurodegeneration in midlife 
as expressed on fMRI. There were 3 studies that looked at the effect of 
cognitive training as expressed on fMRI.  Chapman et al. (85) examined 
changes in brain health, pre, mid, and post training in 37 adults who received 
12 weeks’ strategy based cognitive training versus a control group. They 
found increases in global and regional CBF, particularly in the default mode 
network and the central executive network. Additionally, they found greater 
connectivity in these same networks. In a follow-up, randomised control trial 
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comparing the effects of two training protocols, cognitive training and 
physical training, Chapman et al. (86) describe preliminary evidence 
that increased cognitive and physical activity improves brain health in distinct 
ways. Cognitive reasoning training enhanced frontal networks shown to be 
integral to top-down cognitive control and brain resilience. In a controlled 
clinical trial, Hotting et al. (91) compared effects of cognitive training (spatial 
vs. perceptual training) and physical training (endurance training vs. non-
endurance training) on spatial learning in 33 adults. Spatial learning was 
assessed with a virtual maze task, and at the same time neural correlates 
were measured with fMRI. Only spatial training improved performance in the 
maze task. This improvement was accompanied by a decrease in frontal and 
temporal lobe activity.  
Table 7: Key findings of the individual studies reporting on the relationship between 








There was increased global and regional CBF 
particularly in the default mode network and the central 
executive network in the cognitive training group. 





There were multiple distinct changes on fMRI that 
suggest that aerobic exercise and cognitive reasoning 
training contribute differentially to brain health. 





Participants of the spatial training group showed lower 
activity than participants of the perceptual training group 
in a network of brain regions associated with spatial 
learning, including the hippocampus and 
parahippocampal gyrus. 
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Excessive internet use 
Kim et al. (96) assessed the resting-state brain of individuals who 
were diagnosed with internet gaming disorder (IGD), as defined by DSM-V 
(111), who scored over 70 on Young’s Internet Addiction Test (112) and who 
spent who spent more than four hours per day and 30 hours per week using 
the internet. These individuals were compared to patients with alcohol use 
disorder (AUD) and healthy controls (HC). Using ReHo measures, Kim et al. 
(96) found increased ReHo in the PCC of the IGD and AUD groups, and 
decreased ReHo in the right superior temporal gyrus of those with IGD, 
compared with the AUD and HC group. Scores on internet addiction severity 
were positively correlated with ReHo in the medial frontal cortex, 
precuneus/PCC, and left inferior temporal cortex among those with IGD.  
Fasting 
Belaich et al. (82) assessed the effect of daytime fasting on six healthy 
male volunteers during Ramadan. Two task-based BOLD-fMRI scan 
sessions were performed, the first scan between the fifth and tenth days 
preceding the start of fasting and the second scan between the 25th and 
28th day of the fasting month. The study demonstrated a significant 
difference in the activated brain area between maximal BOLD-fMRI signal 
before and during fasting. Additionally, there was an increase in the volume 
of the activated brain area in all subjects during fasting. The authors 
suggested that the results of the study demonstrate an activation of adaptive 
mechanisms that may be beneficial for neuronal health and plasticity. 




Table 8 outlines the key findings of the individual studies reporting on 
the relationship between physical training and neurodegeneration in midlife 
as expressed on fMRI. There were five interventional and two observational 
studies that looked at the effect of physical training on brain health in midlife, 
as expressed on fMRI. Chapman et al. (113) assessed brain blood flow in 37 
sedentary adults, in a clinical control trial of physical training versus a wait-list 
control group. Over 12 weeks, the physical training group received 
supervised aerobic exercise for three one-hour sessions per week. The study 
found higher resting CBF in the anterior cingulate region in the physical 
training group as compared to the control group from baseline to post-
training. In a follow-up randomised control study, Chapman et al. (86) 
compared the effects of two training protocols, cognitive training and physical 
training on brain function. The study indicates that increased cognitive and 
physical activity improves brain health in distinct ways. Aerobic exercise 
improved CBF flow in hippocampi of those with memory gains.  
MacIntosh et al. (99) assessed 30 men with Coronary Artery Disease, 
before and after a six-month cardiac rehabilitation programme consisting of 
aerobic and resistance training. CBF was associated with fitness level at 
baseline and greater fitness gains with exercise. McFadden et al. (101) 
assessed the effects of a six-month exercise intervention on intrinsic activity 
in the default mode network (DMN) in 12 overweight or obese individuals. 
The intervention was associated with a reduction in DMN activity in the 
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precuneus. This finding is thought to represent a normalisation of DMN 
function secondary to exercise. 
  In a controlled clinical trial, Hotting et al. (91) assessed the effects of 
cognitive training (spatial vs. perceptual training) and physical training 
(endurance training vs. non-endurance training) on spatial learning and 
associated brain activation in 33 adults. Spatial learning was assessed with a 
virtual maze task, and at the same time neural correlates were measured 
with fMRI. The two physical intervention groups did not improve performance 
in the maze task.  
The findings of the two observational studies related to physical 
training focused on specific population groups. Hart el al. (89) assessed 
ageing former National Football League (NFL) players. They found that 
cognitive deficits and depression appear to be more common in ageing 
former NFL players than healthy controls.  Additionally, altered CBF patterns 
are concordant with brain regions associated with abnormal findings of 
neuropsychological testing in ageing former NFL players. It is noteworthy, 
that of the 34 ex-NFL players included in the study, 32 reported a history of 
at least one concussion and 26 undertook neuroimaging; 8 were 
claustrophobic and did not undergo an MRI scan. In a cross sectional study 
of 59 adults recruited through a Rhode Island newspapers and an outpatient 
cardiology office, Xu et al. (109) found that women who engaged in strength 
training (weight lifting or calisthenics) at least once per week exhibited 
significantly greater cerebrovascular perfusion than women who did not.  
Lifestyle and neurodegeneration  
63 
Systematic Review 
Table 8: Key findings of the individual studies reporting on the relationship between 








There is higher resting CBF in the anterior cingulate 
region in the physical training group compared to the 
control group. 





There were multiple distinct changes on fMRI that 
suggest that aerobic exercise and cognitive reasoning 
training contribute differentially to brain health. 
Hart et al. (89) Physical 
Training 
Altered CBF patterns in retired NFL players are 
concordant with brain regions associated with abnormal 
findings on neuropsychological testing. 





Participants of the spatial training group showed lower 
activity than participants of the perceptual training group 
in a network of brain regions associated with spatial 






Perfusion was associated with fitness at baseline and 





A six-month exercise intervention was associated with a 
reduction in default mode network activity in the 
precuneus. 
Xu et al. (109) Physical 
Training 
Women who engaged in strength training at least once 
per week exhibited significantly greater cerebrovascular 
perfusion than women who did not. 




Table 9 outlines the key findings of the individual studies reporting on 
the relationship between smoking and neurodegeneration in midlife as 
expressed on fMRI. There were three cross-sectional studies identified in this 
systematic review that assessed the effect of smoking on brain health as 
expressed on fMRI. Durazzo et al. (87) investigated the chronic effects of 
smoking on brain perfusion. Smokers showed significantly lower perfusion 
than non-smokers in multiple brain regions (bilateral medial and lateral 
orbitofrontal cortices, bilateral inferior parietal lobules, bilateral superior 
temporal gyri, left posterior cingulate, right isthmus of cingulate, and right 
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supramarginal gyrus) as assessed on fMRI. Additionally, greater lifetime 
duration of smoking (adjusted for age) was related to lower perfusion in 
multiple brain regions. Gazdzinski et al. (88) assessed one week abstinent 
alcohol dependent individuals in treatment (19 smokers and 10 non-smokers) 
and 19 healthy light drinking non-smoking control participants, to assess the 
concurrent effects of chronic alcohol and chronic smoking on cerebral 
perfusion. This study found that chronic cigarette smoking adversely affects 
cerebral perfusion in frontal and parietal grey matter of one-week abstinent 
alcohol dependent individuals. Mon et al. (114) evaluated cortical grey matter 
perfusion changes in short-term abstinent alcohol dependent individuals in 
treatment and assessed the impact of chronic cigarette smoking on perfusion 
changes during abstinence. At one week of abstinence, frontal and parietal 
grey matter perfusion in smoking alcoholics was not significantly different 
from that in non-smoking alcoholics. After five weeks of abstinence, perfusion 
of frontal and parietal grey matter in non-smoking alcoholics was significantly 
higher than that at baseline. However, in smoking alcoholics, perfusion was 
not significantly different. Cigarette smoking appears to hinder perfusion 
improvement in abstinent alcohol dependent individuals. 
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Table 9: Key findings of the individual studies reporting on the relationship between 




Durazzo et al. 
(87) 
Smoking Smokers showed significantly lower perfusion than non-
smokers in multiple brain regions including regions 
implicated in early Alzheimer’s dementia (cingulate, right 
isthmus of the cingulate, right supramarginal gyrus, and 





Alcoholics, as a group, showed lower frontal grey matter 
perfusion and lower parietal grey matter perfusion than 
non-smoking light drinkers.  
In smoking alcoholics, a higher number of cigarettes 
smoked per day was associated with lower perfusion. 
Mon et al. 
(103) 
Smoking After five weeks of abstinence, perfusion of frontal and 
parietal grey matter in non-smoking alcoholics was 
significantly higher than that at baseline.  
The total number of cigarettes smoked per day was 
negatively correlated with frontal grey matter perfusion. 
 
Substance misuse  
Table 10 outlines the key findings of the individual studies reporting on 
the relationship between substance use and neurodegeneration in midlife as 
expressed on fMRI. Of the 12 cross-sectional studies assessing the 
relationship between substance misuse and neurodegeneration, nine of the 
studies focused on the effect of cocaine, one on heroin, one on 
methamphetamine and one on polysubstance misuse. 
There were five task-based fMRI studies that looked at the effect of 
cocaine on brain health. Bednarski et al. (81) used a stop signal task to 
demonstrate differences in performance between cocaine dependent 
individuals and healthy controls. Castelluccio et al. (83) assessed individuals 
with a Go/No-Go task to show differences in BOLD response between 
cocaine users, former cocaine users and healthy controls. Ide et al. (93) used 
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power spectrum scale invariance (PSSI) of BOLD signals as a marker of 
cerebral activity to show disrupted connectivity dynamics in the fronto-
parietal region of cocaine addicts. Lee et al (97) evaluated BOLD response to 
photic visual stimulation to demonstrate evidence of cerebral dysfunction in 
chronic cocaine abusers. Mitchell et al. (102) used a Stroop task to 
demonstrate reduced intrinsic connectivity in cocaine dependent individuals 
compared to healthy controls. Of the four resting-state fMRI studies 
assessing the effect of cocaine on brain health, both Hu et al. (92) and Kelly 
et al. (95) assessed resting-state functional connectivity (rsFC). Hu et al. (92) 
found cocaine addiction is associated with disturbed rsFC in striatal-cortical 
circuits. Kelly et al. (95) observed reduced prefrontal interhemispheric rsFC 
in cocaine-dependent participants relative to control subjects. Liu et al. (98) 
used cerebral oxygen metabolism (CMRO2) as a marker of neural activity 
and found significantly lower levels in cocaine addicted subjects compared to 
healthy controls. In a multimodal MRI study, Wang et al. (107) identified 
hypoperfusion in the prefrontal cortex, anterior cingulate cortex (ACC), 
insula, right temporal cortex and dorsolateral prefrontal cortex in cocaine 
addicts compared to controls. 
Other than the nine studies focusing on cocaine and 
neurodegeneration, there were three more cross-sectional studies (one on 
heroin, one on methamphetamine and one on polysubstance misuse) 
identified in the systematic review focusing on substance misuse. Jiang et al. 
(94) investigated amplitude low frequency fluctuate (ALFF) abnormalities in 
heroin users. Comparing healthy controls and heroin addicts, this resting-
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state fMRI study found differing spontaneous neural activity patterns in 
multiple regions, in the heroin addict group. Heroin addicts had decreased 
ALFF in the bilateral dorsal anterior cingulate cortex (dACC), bilateral medial 
orbit frontal cortex, left dorsal lateral prefrontal cortex, left middle temporal 
gyrus, left inferior temporal gyrus, posterior cingulate cortex and left cuneus 
as well as increased ALFF in the bilateral angular gyrus, bilateral precuneus, 
bilateral supramarginal gyrus, left post cingulate cortex and left middle frontal 
gyrus. Using a task-based fMRI protocol, May et al. (100)  found that 
methamphetamine dependent individuals exhibited altered responses to 
mechano-receptive C fiber stimulation in brain regions important for 
interoception. Murray et al (115) assessed brain perfusion in polysubstance 
users. They found that the combination of cigarette smoking and 
polysubstance use is strongly related to hypoperfusion in cortical and 
subcortical regions.
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Table 10: Key findings of the individual studies reporting on the relationship between 








The cocaine user groups exhibited significantly increased 
BOLD activity relative to healthy controls in several a 
priori regions of interest. 
Hu et al. (92) Substance 
Misuse 
Compared with healthy controls, the cocaine user group 
showed differing patterns of rsFC in multiple brain 
regions.  
Ide et al. (93) Substance 
Misuse 
Compared to healthy controls, cocaine dependent 
individuals showed decreased PSS and PSSI in multiple 
frontoparietal regions.  
Jiang et al. (94) Substance 
Misuse 
Compared with controls, heroin addicts had altered ALFF 
in multiple brain regions.  
Kelly et al. (95) Substance 
Misuse 
Reduced prefrontal interhemispheric rsFC in cocaine 
dependent participants relative to control subjects and a 
cocaine dependence related reduction in 
interhemispheric RSFC among nodes of the dorsal 
attention network. 
Lee et al. (97) Substance 
Misuse 
Chronic cocaine abusers showed significantly enhanced 
positive BOLD response to photic stimulation when 
compared to control subjects. 
Liu et al. (98) Substance 
Misuse 
In cocaine addicted subjects, cerebral metabolic rate of 
oxygen, a surrogate marker of aggregated neural activity, 
was significantly lower than that in controls. 




Methamphetamine dependent individuals exhibited lower 
anterior insula, dorsal striatum, and thalamus activation 
than healthy controls, across anticipatory and stimulus-
related processing. 




Cocaine dependent patients displayed less overall 
intrinsic connectivity compared with healthy controls. 




Regional perfusion was significantly lower in alcoholics 
compared to light or non-drinkers. Greater smoking 
severity correlated with lower perfusion in alcohol 
dependent individuals. 




Compared with controls, cocaine addicted participants 
showed hypoperfusion and reduced irregularity of 
resting-state activity in multiple brain regions. 
ALFF = Amplitude of Low-Frequency Fluctuation, ANOVA = Analysis of the Variance, BOLD 
= Blood Oxygenation Level Dependent, CBF = Cerebral Blood Flow, MANOVA = Multivariate 
analyses of variance, PSS = Post Signal Slowing, PSSI = Power Spectrum Scale Invariance, 
rsFC = resting-state Functional Connectivity 
 
 




2.4.1 Main findings 
This systematic review identified seven lifestyle factors - physical 
training, cognitive training, fasting, substance misuse, alcohol, smoking and 
excessive internet use – which had been researched adequately for our 
purposes, assessing their impact on neurodegeneration in midlife as 
expressed on fMRI.  
2.4.2 Comparison with other literature and ongoing projects  
In late life, the impact of lifestyle factors on brain health has already 
been studied in multimodal non-pharmacological interventional studies like 
the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and 
Disability (FINGER) (45). The findings from this double-blind randomised 
control trial suggest that a 2-year multi-domain intervention that included 
agreed lifestyle factors (diet, exercise and cognitive training) could maintain 
or even improve cognitive functioning in an elderly population. In midlife, 
gathering evidence on the interplay between lifestyle and a broad range of 
markers of brain health is ongoing in projects like the European Prevention of 
Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study (LCS) (116). The 
study is aiming to develop a well phenotyped probability spectrum population 
for Alzheimer’s dementia. More specifically data on lifestyle factors and 
neurodegeneration in midlife as expressed on fMRI is currently being 
collected in the PREVENT Dementia cohort (53). This is a prospective cohort 
study to identify midlife biomarkers of late-onset Alzheimer's dementia. The 
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EPAD LCS (116) and PREVENT Dementia cohort (53) are yet to publish on 
the relationship between lifestyle factors and neurodegeneration in midlife.  
2.4.3 Strengths and limitations 
This systematic review used a robust methodology, including a 
comprehensive search strategy with search terms tailored to each database 
examined in the review. Additionally, all stages of article screening and 
quality assessment were undertaken independently by two reviewers. Thus, 
we can be confident that we identified all the extant studies in the published 
literature. However, the systematic review has a number of limitations: it did 
not include grey literature and therefore may have missed unpublished 
studies such as doctoral theses assessing the relationship between lifestyle 
and neurodegeneration as expressed on fMRI. There was a marked 
inconsistency in both study design and methodology of the included studies. 
Study populations with different demographics were assessed, different fMRI 
protocols were used by the studies (18 task-based and 11 resting-state), 
different statistical approaches to analyse the data and different fMRI 
outcome measures all added to the heterogeneity and meant a meta-
analysis could not be conducted. Additionally, caution is necessary when 
interpreting fMRI outcome measures and how they relate to underlying 
neural activity. More studies are needed to provide a firmer understanding of 
situations when fMRI outcome measures and neural activity are coupled and 
when they dissociate (117). 




This systematic review contributes to our endeavour to gain a better 
understanding of what lifestyle factors could be optimised to help improve 
brain health in midlife and therein reduce an individual’s risk of later life 
dementia. More specifically, in chapter 3, the information retrieved by this 
systematic review has guided the analysis of existing lifestyle and ASL data 
in the PREVENT Dementia cohort (53). Additionally, this systematic review 
could help shape future multimodal non-pharmacological midlife dementia 
prevention studies which target lifestyle modification. 
2.4.5 Conclusions 
From this systematic review, common themes have emerged on the 
effect of lifestyle on brain health in midlife as expressed on fMRI. The 
findings are summarised in Table 11, which shows all the cognitive training 
studies demonstrated what could be considered a neuroprotective effect, 
whereas all the alcohol, smoking and substance misuse studies 
demonstrated an effect that could reflect an early phase of 
neurodegeneration. Studies on physical training showed more variation in 
results. The majority of physical training studies showed a potential 
neuroprotective effect and one study showed no effect. One study described 
a possible neurodegenerative effect associated with physical training; in this 
study by Hart et al. (89), the majority of the ex-NFL players assessed, had a 
history of concussion.  The evidence from studies on the effects of excessive 
internet use and fasting on brain health in midlife is too limited to allow any 
conclusions to be drawn.  
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Table 11: Interpretation of the findings from the individual studies reporting on the 





Interpretation of the 





Neurodegeneration Gazdzinski et al. (88), Hermann et al. (90), Kim et 
al. (96), Rogers et al. (105), Sullivan et al. (106) 
and Weiland et al. (108). 
Cognitive 
Training 
Neuroprotection Chapman et al. (85), Chapman et al. (86) and 
Hotting et al. (91). 
Excessive 
internet use  
Neurodegeneration Kim et al. (96) 
Fasting Neuroprotection Belaich et al. (82) 
Physical 
Training 
Neuroprotection Chapman et al. (84), Chapman et al. (86), 
MacIntosh et al. (99),  McFadden et al. (101) and 
Xu et al. (109). 
Physical 
Training 
No effect Hotting et al. (91) 
Physical 
Training 
Neurodegeneration Hart et al. (89) 




Neurodegeneration Bednarski et al. (81), Castelluccio et al. (83), Hu 
et al. (92), Ide et al. (93), Jiang et al. (94), Kelly et 
al. (95), Lee et al. (97), Liu et al. (98),  May et al. 
(100), Mitchell et al. (102), Murray et al. (104) and 
Wang et al. (107). 
 
2.4.6 Implications of results 
The findings of the systematic review will be used to guide the analysis of 
the PREVENT Dementia cohort baseline data and could be used as the 
basis for the future analysis of the yet to be released two year follow-up data 
from the PREVENT Dementia cohort (53). However it is worth noting that the 
systematic review it based only on published studies. Therefore the results 
and conclusions drawn from the systematic review are significantly 
influenced by publication bias. Of note, there is evidence to suggest this bias 
is increasing. An investigation covering more than 4600 publications from 
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different countries and disciplines found strong evidence for a steady and 
significant increase in publication bias over the years. The frequency of 
papers declaring significant statistical support for their a priori formulated 
hypotheses increased by 22% between 1990 and 2007 (n = 4656, p < 0.001) 
(118). 
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3 Analysis of the relationship between lifestyle and arterial 
spin labelling cerebral blood flow in midlife using data 
from the PREVENT Dementia cohort 
Chapter abstract 
INTRODUCTION: The findings from the systematic review (chapter 2) were 
used to guide the linear regression analysis exploring the relationship 
between lifestyle factors and neurodegeneration in midlife as expressed on 
arterial spin labelling using data from the PREVENT Dementia cohort.  
METHODS: Linear regression models were used to evaluate the relationship 
between lifestyle factors (physical training, alcohol, smoking and substance 
misuse) and neurodegeneration in midlife as expressed on arterial spin 
labelling. Regional cerebral blood flow was used as an outcome measure. 
RESULTS: Across the unadjusted and adjusted linear regression models, 
compared to being a non-substance misuser, being a current or ex-
substance misuser was associated with a reduction in anterior cingulate 
cortex cerebral blood flow. Additionally, adjusted model 2 showed that 
compared to being a moderate alcohol drinker, being a non-drinker was 
associated with a decreased anterior cingulate cortex cerebral blood flow.  
DISCUSSION: The analysis of the data from the PREVENT Dementia cohort 
has added to the evidence that lifestyle factors are associated with cerebral 
blood flow in the anterior cingulate cortex. It may well be that the anterior 
cingulate is a sensitive marker for the effect of lifestyle on neurodegeneration 
in midlife as expressed on arterial spin labelling. 
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3.1 Background 
In the systematic review of the relationship between lifestyle and 
neurodegeneration in midlife as expressed on fMRI (chapter 2) (72), seven 
lifestyle factors (physical training, cognitive training, fasting, substance 
misuse, alcohol, smoking and excessive internet use) associated with 
neurodegeneration in midlife as expressed on fMRI were identified. Physical 
training and cognitive training have a likely neuroprotective effect. Substance 
misuse, alcohol and smoking have a likely neurodegenerative effect. Further 
studies are needed to clarify the effects of fasting and excessive internet use 
on fMRI outcomes in midlife. The findings of this systematic review have 
been brought forward to analyse the impact of lifestyle on cerebral blood flow 
(CBF) in a midlife cohort using the data from the PREVENT Dementia cohort 
(53). The following hypothesis was tested: Physical training, cognitive 
training, substance misuse, alcohol and smoking in midlife are associated 
with regional cerebral blood flow as expressed on arterial spin labelling 
(ASL). 
3.2 Method 
3.2.1 The Prevent Dementia cohort 
Aims and Objectives 
Baseline assessment data from a single site, the Imperial College London 
recruitment site for the PREVENT Dementia cohort (119) were used to 
assess the relationship between lifestyle and neurodegeneration in midlife as 
expressed on ASL. The data were for individuals in midlife, aged 40-59 years 
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old at baseline. Recruitment for the PREVENT Dementia cohort (119) is now 
ongoing across five research centres - Edinburgh, Dublin, London, Oxford 
and Cambridge in the United Kingdom. However at the time of undertaking 
my thesis, data were only available from the original research centre at 
Imperial College London.  
The primary aim of the PREVENT Dementia cohort (119) is 
understanding the interplay between risk factors for neurodegeneration, 
identifying markers for the biological expression of neurodegenerative 
disease, developing surrogate markers for measuring future reductions in 
dementia incidence and developing secondary prevention intervention 
studies in midlife. Ethical approval was obtained by the St Giles and 
Camberwell (London) Ethics Committee. 
Recruitment into the PREVENT Dementia cohort 
Participants were recruited to the PREVENT Dementia cohort (119) 
baseline assessment at the Imperial College London recruitment site from a 
variety of different sources: NHS clinical appointments; the Join Dementia 
Research website (https://www.joindementiaresearch.nihr.ac.uk/); marketing 
materials such as leaflets about the study; or social media such as the 
PREVENT Dementia cohort (119) website (http://preventdementia.co.uk/). 
Additionally, potential participants were drawn from the electronic patient 
record system in the West London Mental Health NHS trust and asked 
whether they would like to participate in the programme. Alternatively, with 
the approval of a GP practice, a GP database was accessed to search for 
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potential participants. Between September and December 2019, I had 
ongoing contact with the Imperial College London recruitment site to clarify 
how many people were approached to take part in the study and how many 
individuals were recruited by each of the methods outlined above. 
Unfortunately the Imperial College London recruitment site were unable to 
provide the requested information before the publication of this thesis. 
Following initial contact, information about the PREVENT Dementia 
cohort (119) was discussed and screening for eligibility took place either face 
to face or on the telephone. If the participant was still eligible and interested, 
study related information was given to them. This included participant 
information sheets, a consent form and the MRI eligibility checklist. Once the 
participant returned their consent form to the research unit, the participant 
was contacted by the study coordinator who then scheduled an appropriate 
time slot for the participant to attend the research unit. The MRI scan was 
completed within one month of the clinical visit. 
Inclusion and Exclusion Criteria 
The inclusion and exclusion criteria for the PREVENT Dementia cohort (119) 
are as follows; 
Inclusion  
1. Aged 40-59 years old at time of consent.  
2. Participant fluent in English.  
Exclusion  
1. Known diagnosis or report of subjective cognitive impairment or 
dementia using standard clinical criteria (DMS IV(120), ICD 10 (121)). 
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2. Participant has a known contraindication to MRI.  
Clinical Assessment 
Participants were consented according to the International Council on 
Harmonisation (ICH) good clinical practice (GCP) guidelines (122). Data 
were collected using a range of assessments administered by a member of 
the PREVENT Dementia cohort (119) team. The following sources were 
reviewed for demographic and lifestyle data.  
i. PREVENT case report form – This is a comprehensive protocol driven 
document to collect participant data and includes a physical 
examination of the patient.  
ii. Simpson Angus Scale (123) – This is a rating scale to assess for 
extrapyramidal disturbance.  
iii. Apathy inventory (124) – This is a rating scale for global assessment 
of apathy and separate assessment of emotional blunting, lack of 
initiative, and lack of interest. 
iv. Lawton instrumental activities of daily life (IADL) scale (125) – This 
rating scale assesses how a person is functioning at the present 
time and can be used to monitor for improvement or deterioration 
over time.  
v. National Adult Reading Test (NART) (126) – This test is a widely 
accepted and commonly used method for estimating premorbid 
intelligence of English speaking participants in neuropsychological 
research.   
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vi. Addenbrooke’s Cognitive Examination 3rd revision (ACE III) (127) – 
This is a screening test to assess five cognitive domains; attention, 
memory, verbal fluency, language and visuospatial abilities. 
vii. Supermarket task (128) - This is a test of spatial orientation and 
memory. It is completed by the participant using the iPad tablet. 
The task requires the participant to follow a route through a virtual 
supermarket from behind a trolley and involves a series of 90° 
turns. The subject is then required to point in the direction of the 
supermarket entrance.  
viii. Four Mountains task (129)  - This is a test of spatial orientation and 
memory. The Four Mountains task is also completed on the iPad. 
The test assesses memory for places, by showing a picture of a 
landscape that contains four mountains and testing people’s ability 
to identify the same landscape when seen from a different angle. 
Additionally, the participant completed the following self-report 
questionnaires: 
i. Pregnancy and Menstruation – this questionnaire collects data related 
to women’s menstrual cycle, history of pregnancy and use of hormone 
replacement therapy.  
ii. Lifetime of Experiences Questionnaire (LEQ) (130) -  this 
questionnaire assesses a range of complex mental pursuits and 
physical activity during middle age years. In the LEQ, middle age 
years is defined as after the age of 30 years and until the end of 
working life / present.  
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iii. Centre for Epidemiologic Studies Depression Scale (CES-D) (131) – 
This is a short self-report scale designed to measure depressive 
symptomatology in the general population. 
iv. Spielberger state scale (132)-  This is a self-report scale designed to 
measure anxiety. 
v. Pittsburgh Sleep Quality Index (PSQI) (133) – This self-rated 
questionnaire assesses sleep quality and disturbance over a one 
month time period.  
vi. Connor-Davidson Resilience scale (134) – This is a 25 item scale to 
measure an individual’s ability to cope with stress.   
vii. Life Stressor Checklist – Revised (135) – This self-rated questionnaire 
assesses traumatic or stressful life events. The measure has a focus 
on events relevant to women such as abortion, although it can also be 
used with men. The questionnaire includes 30 life events, including 
experiences with natural disasters, physical or sexual assault and the 
death of a relative. 
viii. Brain Injury Screening Questionnaire (BISQ) (136) - This self-rated 
questionnaire is a screening tool used to document lifetime history of 
self-reported traumatic brain injury and the presence of current 
symptoms. 
ix. Food Frequency Questionnaire (FFQ) (137) – This is a semi 
quantitative questionnaire designed to estimate daily intake of a wide 
range of nutrients. 
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x. Visual Short term memory binding test (138)- Short-term memory 
binding is a memory function that underpins the temporary retention of 
complex objects e.g. shapes with colours. This test assesses the 
recognition of shapes, colours or shape-colour bindings. 
xi. COGNITO: Computerized Assessment of Information Processing 
(139) – This neuropsychological battery primarily assesses attentional, 
linguistic, amnesic and visuospatial processes. 
Figure 7 shows the sources that lifestyle and demographic data were 
extracted from. It shows that demographic, alcohol, smoking and substance 
use data were extracted from the Prevent case report form. Additionally, 
physical training data were extracted from the LEQ. 
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Figure 7: Data sources for demographic and lifestyle data. 
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In addition to completing questionnaires, a clinical assessment was 
made of each person’s physical and mental health. This confirmed that they 
do not have dementia and that they were fit to participate in the longitudinal 
cohort study. Furthermore, saliva, blood and urine samples were collected to 
assess for biomarkers of neurodegeneration in midlife and APOE genotyping.  
MRI acquisition 
As part of the assessment for the PREVENT Dementia cohort (119), 
all participants underwent an 80 minute MRI scan. 
MRI protocol  
i. Whole brain volumetric T1 and T2 weighted images for segmentation 
and volumetric analyses.  
ii. Fluid attenuation inversion recovery (FLAIR) sequences to allow 
identification and quantification of deep white matter hyperintensities. 
iii. Diffusion weighted imaging (DWI) for identification of changes in 
normal appearing white matter and major tracts.  
iv. Susceptibility-weighted imaging (SWI) for identification of microbleeds. 
v. Magnetic Resonance Spectroscopy (MRS) for assessment of early 
metabolic changes.  
vi. FMRI; both task-based and resting-state, including ASL for 
assessment of CBF.  
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PREVENT fMRI Task 
The PREVENT fMRI task is an encoding and retrieval task. In the 
encoding stage, images of indoor and outdoor scenes are displayed on a 
screen for the participant to view whilst the participant is in the MRI scanner. 
The task is to judge if the image represents an ‘indoor’ or ‘outdoor’ scene. 
After each image, a question mark is seen in the centre of the screen, in 
addition to buttons in the left and right-hand corner of the screen denoting the 
‘indoor’ and ‘outdoor’ answer options. The button in the participant’s left hand 
corresponds to the button on the left-hand side of the screen and the button 
in the participant’s right hand corresponds to the button on the right-hand 
side of the screen. The participant makes a response as quickly as possible, 
before the next image appears.  
In the retrieval stage, the task is now to indicate whether or not the 
image on the screen was previously seen in the encoding task. If the 
participant thinks the image was in the previous indoor/outdoor task, the 
button is pressed that corresponds to “old”. If the participant does not think 
they saw the scene in the previous task, the button is pressed that 
corresponds to "new".  
Imaging Data Analysis 
The imaging data from the PREVENT Dementia cohort (119) were 
acquired at Imperial College London and transferred to Cambridge University 
for processing. All the imaging data analysis was undertaken by the 
Department of Neuroscience, Cambridge University using the Freesurfer 
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image analysis suite (www.surfer.nmr.mgh.harvard.edu/). Processing 
included motion correction and averaging (140) of multiple volumetric T1 
weighted images, removal of non-brain tissue using a hybrid watershed and 
surface deformation procedure (141) and automated Talairach 
transformation. Segmentation of the subcortical white matter and deep grey 
matter volumetric structures (142), intensity normalization (143) and 
tessellation of the grey and white matter boundary were undertaken. Finally 
automated topology correction (144) and surface deformation following 
intensity gradients to optimally place the grey, white and cerebrospinal fluid 
borders were completed (145). 
Individual CBF maps were co-registered to the processed individual 
T1 images using a boundary-based registration algorithm (146). Volume to 
surface normalisation and smoothing were undertaken using FreeSurfer 
(147). Regions of interest (ROI) were defined according to the Desikan-
Killiany atlas (148). For each participant, mean CBF values for each region of 
interest were extracted.  
Data access and extraction 
The systematic review of the relationship between lifestyle and 
neurodegeneration in midlife as expressed on fMRI, identified five lifestyle 
factors associated with neurodegeneration in midlife – physical training, 
cognitive training, alcohol, smoking and substance misuse. Therefore the 
available data from the PREVENT Dementia cohort (119) on these five 
lifestyle factors were extracted. The PREVENT Dementia cohort (119) 
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interview questions on physical training, alcohol, smoking and substance 
misuse are outlined in Table 12, 13, 14 and 15. The tables show that in the 
Lifetime of Experiences Questionnaire, data had been collected on the 
frequency of mild, moderate and vigorous physical activity. In the Prevent 
case report form, data had been collected on medical conditions related to 
alcohol and alcohol intake. Additionally, data were collected on smoking, 
medical conditions related to substance misuse and the type of substances 
that an individual had used. There were no data on cognitive training 
available.
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Table 12: PREVENT Dementia cohort physical training data. 
Physical training questions  Source 
Question: How often would you take part in sports or activities that are mildly 
energetic? E.g. walking, woodwork, weeding, hoeing, bicycle, repair, playing 
pool, general house work. Responses: Never | Less than monthly | Monthly | 
Fortnightly | Weekly | Daily. 
LEQ (130) 
Question: How often would you take part in sports or activities that are 
moderately energetic? E.g. scrubbing, polishing car, dancing, golf, cycling, 
decorating, lawn mowing, leisurely swimming. Responses: Never | Less than 
monthly | Monthly | Fortnightly | Weekly | Daily. 
LEQ (130) 
Question: How often would you take part in sports or activities that are 
vigorous? E.g. running, hard swimming, tennis, squash, digging, cycle racing. 
Responses: Never | Less than monthly | Monthly | Fortnightly | Weekly | Daily. 
LEQ (130) 
Table 13: PREVENT Dementia cohort alcohol data. 
Alcohol questions  Source 
Question: Alcoholism - has had condition? 
Response: Yes | No. 
PREVENT case report form (medical 
history) 
Question: Alcoholism - currently active? 
Response: Yes | No. 
PREVENT case report form (medical 
history) 
Question: Alcoholism - hospitalised for condition? 
Response: Yes | No. 
PREVENT case report form (medical 
history) 
Question: Alcohol intake status? Response: Non-
drinker | Ex-drinker | Current drinker | Unknown. 
PREVENT case report form (lifestyle 
interview) 
Question: Number of glasses of wine / beer per 
week? Response: XXX glasses.  
PREVENT case report form (lifestyle 
interview) 
Question: Number of glasses of stronger alcohol 
per week? Response: XXX glasses. 
PREVENT case report form (lifestyle 
interview) 
Question: Total number of units per week? 
Response: XXX units. 
PREVENT case report form (lifestyle 
interview) 
Table 14: PREVENT Dementia cohort smoking data. 
Smoking questions  Source 
Question: Smoking status? Response: Non-
smoker | Ex–smoker | Current smoker | Unknown. 
PREVENT case report form (lifestyle 
interview) 
Question: Number of years smoked? Response: 
xxx years. 
PREVENT case report form (lifestyle 
interview) 
Question: Number of cigarettes / cigars per day? 
Response xxx cigarettes / cigars 
PREVENT case report form (lifestyle 
interview) 
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Table 15: PREVENT Dementia cohort substance misuse data. 
Substance misuse questions  Source 
Question: Substance abuse - has had 
condition? Response: Yes | No. 
PREVENT case report form (medical 
history) 
Question: Substance abuse - currently active? 
Response: Yes | No. 
PREVENT case report form (medical 
history) 
Question: Substance abuse - hospitalised for 
condition? Response: Yes | No. 
PREVENT case report form (medical 
history) 
Question: Substance misuse status? Response: 
Never | Ex–user | Current user | Unknown. 
PREVENT case report form (lifestyle 
interview) 
Question: Type of drug used? Response: 
Sedatives-hypnotics-anxiolytics |Cannabis | 
Stimulants | Opioids |Cocaine | Hallucinogens | 
Other. 
PREVENT case report form (lifestyle 
interview) 
3.2.2 Statistical Analysis 
Statistical analysis plan 
The aim of the statistical analysis was to test the following hypothesis: 
Physical training, cognitive training, substance misuse, alcohol and smoking 
in midlife are associated with regional cerebral blood flow as expressed on 
ASL. R Studio Version 1.0.143 was used to carry out the statistical analysis. 
In accordance with guidance by Goldacre (149), to enhance transparency 
and reproducibility, all analytic code used in this analysis has been made 
available. Please see Appendix E for the analytic code used in this analysis. 
As missing data were limited to a small number of observations, individuals 
with missing ASL data were excluded from analysis by listwise deletion.  
Univariate and multivariate linear regression were undertaken to 
analyse the relationship between lifestyle factors and ASL CBF. In keeping 
with convention, the reference group for a lifestyle factor was the group with 
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the largest number of individuals. For example, the reference group for 
physical training was the high physical training score (N=114) group. 
Therefore the medium physical training score group (N=84) and low physical 
training score group (N=12) were compared against the high physical training 
score group in the linear regression models. The dependent variable was 
CBF and the independent variables were known risk factors for Alzheimer’s 
dementia and lifestyle factors. For multiple regression analyses, the p-value 
was set at 0.05. Effect size is an objective and standardised measure of the 
magnitude of observed effect (150).  Pearson’s correlation coefficient (151) 
was used to measure effect size.  
Covariates identified from the systematic review 
In the systematic review, 29 studies were identified that assessed the 
relationship between lifestyle and neurodegeneration in midlife as expressed 
on fMRI. Of these 29 studies, there were 11 studies with a global quality 
rating of strong based on the Effective Public Health Practice Project Quality 
Assessment Tool (EPHPP) (77). Nine of these studies assessed lifestyle 
factors identified in the PREVENT Dementia cohort (119). All nine studies 
adjusted for age, five studies adjusted for gender, six studies adjusted for 
education, four studies for IQ and two for cognition. Additionally, five studies 
also adjusted for other factors including body mass index (BMI) and ethnicity. 
The factors adjusted for in the nine studies with an EPHPP rating of strong 
are shown in Table 16 and 17. Based on these findings - age, gender and 
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education were chosen as covariates in the analysis of the relationship 
between lifestyle and neurodegeneration in midlife as expressed on ASL.
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Table 16: Key factors adjusted for in statistical analysis of the nine strong quality 
studies identified in the systematic review of the relationship between lifestyle and 





























































training   ×   × 
Hart et al. 
(89) 
Physical 
training  ×   × × 
Xu et al. 
(109) 
Physical 
training   × × ×  
Mon et al. 
(103)  
Alcohol & 
smoking  ×  × × × 
Jiang et al. 
(94) 
Substance 
misuse  ×  × ×  
Kelly et al. 
(95) 
Substance 
misuse    × ×  
Mitchell et al. 
(102) 
Substance 
misuse     ×  
Murray et al. 
(115) 
Substance 
misuse  ×  × ×  
Total  9 5 6 4 2 5 
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Table 17: Other factors adjusted for in statistical analysis of the 11 strong quality 
studies identified in the systematic review of the relationship between lifestyle and 
neurodegeneration in midlife as expressed on fMRI. 
Study Lifestyle factor Other factors adjusted for in statistical analysis 
Xu et al. 
(109) 
Physical training Body mass index (BMI), cardiovascular disease (CVD) 
status, cardiovascular medications, cardiac index, 
physical limitations, self-reported physical health, 
participation in aerobic activity, flexibility training and 
whole brain volume. 
Jiang et al. 
(94) 
Substance misuse Head motion and cigarette smoking.  
Kelly et al. 
(95) 
Substance misuse Employment status. 
Mitchell et 
al. (102) 
Substance misuse Ethnicity.  
Murray et 
al. (115) 
Substance misuse Body mass index (BMI), American National Adult 
Reading Test (AMNART) score and drinking variables. 
 
Covariates based on established non-modifiable risk factors for 
Alzheimer’s dementia 
Apolipoprotein E (APOE) allele and family history alter an individual’s 
risk of Alzheimer’s dementia (152). The APOE gene that lies on chromosome 
19 has a major impact on Alzheimer’s dementia risk (59). The APOE gene 
has three alleles, the APOE 4 allele increases risk and APOE 2 allele 
decreases risk. The APOE 3 allele is associated with average risk (153). 
Family history of dementia is an important risk factor for Alzheimer’s 
dementia independently of known genetic risk factors for Alzheimer’s 
dementia (154). Given that early Alzheimer’s dementia may well present as 
neurodegeneration in midlife (70), data on the number of parents with 
dementia and APOE status were included in the data analyses. 
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Conceptualization of lifestyle factors 
The decision on how best to conceptualise the lifestyle data from the 
PREVENT Dementia cohort (119) were based on the findings from the 
systematic review (chapter 2) and is outlined below. 
Physical Training 
In the systematic review, different physical training programmes were 
used by different studies. Studies by Chapman et al. (86, 113) used a three 
month aerobic training programme, whilst Hotting et al. (91) used a six month 
aerobic training programme. Participants in a study by MacIntosh et al (99) 
undertook a six month aerobic and resistance training programme and 
participants in a study by McFadden et al. (101) adhered to a six month 
treadmill walking protocol. Hart et al. (89) assessed brain health in retired 
professional National Football League players and in a cross-sectional study, 
Xu et al. (109) measured levels of physical training in the general population 
using the Rapid Assessment of Physical Activity (RAPA) questionnaire (155). 
The RAPA questionnaire (155) is an evidence based tool that assesses 
physical activity. The RAPA questionnaire has two sections, RAPA 1 and 
RAPA 2. RAPA 1 takes into account the frequency and intensity of physical 
training to give a single summative score. RAPA 2 assesses whether 
strength training and flexibility training are undertaken. Based on RAPA 1, 
the physical training data from the PREVENT Dementia cohort (119) has 
been transformed into a single summative score taking into account the 
frequency and intensity of physical training. 
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The scoring system for the PREVENT physical training score is 
outlined in Table 18. The PREVENT physical training score is based on the 
frequencies that three different intensities of training - mildly energetic 
training, moderately energetic training and vigorously energetic training are 
undertaken. Depending on the frequency of training, a score ranging from 0 
to 5 can be obtained for each intensity of training. These three scores were 
then combined to give a physical training score. A score of 0 to 5 would 
suggest a low level of physical fitness, 6 to 10 would suggest a moderate 
level of physical fitness and a score of 11 to 15 would suggest a high level of 
physical fitness. 
























































0 1   2 3 4 5 0-5 
Moderately 
energetic 
0 1   2 3 4 5 0-5 
Vigorously 
energetic 
0 1   2 3 4 5 0-5 
Physical training score (mildly energetic score + moderately energetic score + 
vigorously energetic score). 
0-15 
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Alcohol 
In the systematic review of the relationship between lifestyle and 
neurodegeneration in midlife as expressed on fMRI, seven studies assessed 
the effect of alcohol. Of the seven studies, six assessed alcohol drinkers who 
had a diagnosis of alcohol abuse or alcohol dependence as defined by DSM-
IV (156) or ICD-10 (121). In one study, Weiland et al. (108) assessed 
individuals who partook in alcohol binge drinking. In the PREVENT Dementia 
cohort (119), data is collected on alcohol dependence, although the 
frequency of this diagnosis is likely to be low as participants for the study are 
recruited from the general population. Data is not collected on the frequency 
of alcohol binge drinking in the PREVENT Dementia cohort (119). Therefore, 
for the purposes of data analysis, the PREVENT alcohol data has been split 
into two groups; non-drinkers and current or ex-drinkers. The current or ex-
drinkers group has been further divided, based on whether individuals drink 
within the recommended limits as outlined in the new alcohol guidelines 
launched by the Department of Health (157) in the United Kingdom on 8th 
January 2016. PREVENT Dementia cohort (119) participants that drink less 
than 14 units per week have been defined as moderate alcohol drinkers and 
participants who drink more than 14 units per week have been defined as 
heavy alcohol drinkers.  
Smoking 
In the systematic review of the relationship between lifestyle and 
neurodegeneration in midlife as expressed on fMRI, three studies looked at 
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the relationship between smoking and neurodegeneration. Durazzo et al. (87) 
defined smokers as individuals who were actively smoking at the time of 
assessment and who have smoked at least ten cigarettes per day for at least 
five years. Gazdzinski et al. (88) and Mon et al. (103) both divided 
participants in their studies into two groups; non-smokers and smokers. 
For the purposes of further analysis, participants in the PREVENT 
Dementia cohort (119) have also been divided into two groups; non-smokers 
and current or ex-smokers.  
Substance misuse 
There were twelve studies identified by the systematic review that 
looked at the relationship between substance misuse and neurodegeneration 
in midlife as expressed on fMRI. All the studies looked at individuals who met 
the DSM-IV (156) criteria for substance dependence. Nine of the studies 
focused on the effect of cocaine, one on methamphetamine, one on opiates 
and one on the effect of polysubstance misuse on brain health in midlife.  
In the PREVENT case report form, data is collected on whether 
participants have been diagnosed with a substance abuse disorder, whether 
they misuse substances and the type of substances that they misuse. In the 
PREVENT Dementia cohort (119), the frequency of a diagnosis of substance 
misuse is likely to be low, as participants for the study are recruited from the 
general population. For data analysis, participants in the PREVENT 
Dementia cohort (119) were broadly divided into two groups, those that have 
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never misused substances in the past and participants who are current or ex-
substance misusers.   
MRI data 
MRI measures were received from the PREVENT Dementia cohort 
(119) as analysed imaging data became available from Cambridge 
University. The following MRI measures were available for analysis:  
i. Cerebral microbleeds present (yes / no). 
ii. Total number of cerebral microbleeds. 
iii. Region of cerebral microbleed. 
iv. Total white matter volume hyperintensity percentage. 
v. Regional white matter volume hyperintensity percentage. 
vi. Periventricular hyperintensities (PVH) Fazekas score (158). 
vii. Deep white matter hyperintensities (DWMH) Fazekas score 
(158). 
viii. Total brain volume.  
ix. Grey matter volume (GMV). 
x. White matter volume (WMV). 
xi. CSF volume. 
xii. Hippocampal grey matter volume. 
xiii. Parahippocampal grey matter volume. 
xiv. Hippocampus mean CBF. 
xv. Anterior cingulate cortex (ACC) mean CBF. 
xvi. Mean cortex CBF.  
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Arterial Spin Labelling Cerebral Blood Flow 
Arterial Spin Labelling (ASL) Cerebral Blood Flow (CBF) refers to the 
rate of delivery of arterial blood to the capillary bed in brain tissue and is 
typically quantified in millilitres of blood per 100 grams of tissue per minute 
(159). In ASL, arterial blood water is magnetically labelled just below the 
region of interest. After a period of time to allow the blood to travel to the 
tissue (post-labelling delay), the magnetically labelled arterial blood water 
flows into slice of interest where it exchanges with tissue water. During this 
time, an image is taken (tag image). The experiment is then repeated without 
labelling the arterial blood to create another image (control image). The 
control image and the tag image are subtracted from each other to produce a 
perfusion image. This image will reflect the amount of arterial blood delivered 
to each voxel in the tissue slice within the transit time (160). 
In my thesis, the three ASL regions of interest chosen for analysis were 
hippocampus CBF, ACC CBF and cortex CBF. These regions were chosen 
based on three factors. Firstly, the findings of the systematic review of the 
relationship between lifestyle and neurodegeneration as expressed on fMRI. 
In addition to this, studies showing that ASL CBF is a promising biomarker for 
neurodegeneration and discussion with the PREVENT Dementia 
Neuroimaging team.  
The systematic review of the relationship between lifestyle and 
neurodegeneration in midlife as expressed on fMRI identified three studies 
from the Centre for Brain Health, University of Texas that looked at the 
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relationship between lifestyle factors and CBF measured using 
pseudocontinous arterial spin labelling (85, 86, 113). All three studies had an 
EPHPP quality rating of strong. In the first study, Chapman et al. 
demonstrated higher resting ACC CBF in a physical training group compared 
to a control group. The study hypothesised that ACC CBF may be a sensitive 
marker in older adults of gains in brain health (113). In the second study, 
Chapman et al. demonstrated that complex cognitive training increases 
global CBF compared to a control group (85). In a third study, by Chapman et 
al, looking at the benefits of cognitive training vs physical training, the study 
found that increased cognitive and physical activity improves brain health in 
distinct ways. Of note, increased physical activity was associated with 
increased hippocampus CBF (86).  
Studies have shown that ASL CBF is a promising biomarker for 
neurodegeneration. Compared to age-matched cognitively normal adults, 
individuals with Alzheimer’s dementia show an approximately 40% global 
decrease in CBF (58). Furthermore, possessing the APOE 4 allele has been 
shown to increase Alzheimer’s disease risk by 3 to 8 fold (59). The effect of 
APOE on CBF appears to be mediated by age, with evidence that older 
APOE 4 adults display greater hypoperfusion and younger APOE 4 adults 
show greater hyperperfusion in the ACC (161). The hyperperfusion observed 
in younger APOE 4 carriers was correlated with better executive functioning, 
suggesting compensatory mechanisms may be engaged many years prior to 
symptom onset (161). 
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The research outlined above was discussed with the PREVENT 
Dementia Neuroimaging team at Cambridge University before the PREVENT 
Dementia Cohort ASL CBF data was chosen for further analysis.  As a 
biomarker for neurodegeneration, ASL confers specific benefits, it is non-
invasive and it is safe to repeat over time. ASL can therefore be used to track 
changes in CBF such as those due to disease progression or drug therapy 
(162). However there are multiple limitations associated with ASL. The 
specificity of ASL CBF to distinguish between Alzheimer’s dementia 
pathology and other vascular aetiologies has not been firmly established, as 
reduced CBF has also been reported in vascular dementia and in a post-
stroke non-dementia group (163, 164). This cautions against the use of CBF 
measures in isolation, without considering other information such as 
neuropsychological performance and clinical assessment (65).  
3.3 Results 
3.3.1 Participant Characteristics 
The baseline assessment data for the Imperial College London 
recruitment site for the PREVENT Dementia cohort (119) descriptive 
characteristics are shown in Table 19. Of the 210 participants, the average 
age of participants was 52 years old. There were 75 (29.5%) participants who 
had at least one APOE 4 allele and 133 (63.9%) participants had no APOE 
4 allele. It is notable that the mean number of years of education was 16, 
this would suggest a high level of education amongst participants in the 
PREVENT Dementia cohort (119). There were 62 (29.5%) male and 148 
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(70.5%) female participants. The participants’ characteristics were similar for 
men and women subgroups and are shown in Table 19. 
Of the 210 participants, there were 161 participants with no missing 
data and ASL outcome data. The participant characteristics were similar for 
ASL subgroup (N=161) compared to the Prevent Dementia cohort (N=210) 
(119). For the ASL subgroup, the mean age was 52 years. Of these 
participants, 44 (27.3%) were male and 117 (72.7%) were female. At least 
one APOE 4 allele was present for 100 (62.1%) participants and 61(37.9%) 
had no APOE 4 allele.  
In comparison with the ASL subgroup (N=161), the individuals not 
included in the analysis due to missing data (N=49) were more likely to be 
male. In the ASL subgroup, 27.3% of the participants were male compared to 
36.7% in the data set that was not included in analysis. Furthermore in the 
ASL subgroup, the mean number of years of education was higher than that 
in the data set for individuals not included in analysis. In the ASL subgroup, 
the mean number of years of education was 16 years compared to 15.5 
years in the data set not included in analysis. 
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Table 19: Summary of Prevent Dementia cohort demographic characteristics. 

















Age - mean ± SD 52.0 ± 5.5 52.0 ± 5.6 51.9 ± 5.5 51.8 ± 5.5 52.3 ± 5.2 
Gender: M / F - N (% 
of total sample) 
62 (29.5) / 
148 (70.5) 
NA NA 44 (27.3) / 
117 (72.7) 
18 (36.7) / 
31 (63.3) 
APOE 4 allele: No 
APOE 4 / APOE 4 ≥ 
1 – N (% of total 
sample) 
133 (63.9) / 
75 (36.1) 
40 (64.5) /  
22 (35.5) 
93 (63.7) /  
53 (36.3)  
100 (62.1) / 
61 (37.9) 
35 (71.4) / 
14 (28.6) 
Race: Caucasian / 
other - N (% of total 
sample) 
188 (89.5) / 
22 (10.5) 
50 (80.6) /  
12 (19.4) 
138 (93.2) / 
10 (6.8) 
146 (90.7) /  
15 (9.3) 
42 (85.7) / 
7 (14.3) 
Number of years of 
education: mean + 
SD 
15.9 ± 3.4 15.8 ± 3.5 15.9 ± 3.4 16.0 ± 3.4 15.5 ± 3.4 
Domiciliary status: 
lives with others / 
lives alone  
– N (% of total 
sample) 
180 (85.7) / 
30 (14.3) 
58 (93.5) / 
4 (6.5) 
122 (82.4) /  
26 (17.6) 
136 (84.5) / 
25 (15.5) 
45 (91.8) / 
4 (8.2) 
APOE = Apolipoprotein, N = Number, SD = Standard deviation, NA=Not applicable 
 
 
3.3.2 Neuroprotective lifestyle factor 
Physical training 
The PREVENT Dementia cohort (119) physical training data are 
summarized in Figure 8. The data shows that 136 participants engage in 
mildly energetic activity on a daily basis, 36 participants engage in 
moderately energetic activity on a daily basis and 10 participants engage in 
vigorously energetic activity on a daily basis. There were 114 participants 
with a high physical training score, 84 participants with a medium physical 
training score and 12 participants with a low physical training score. The 
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physical training scores ranged from 1 to 15 and the mean score is 10.7 (SD 
2.9). This indicates the majority of participants had a medium or high level of 
physical fitness. 
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Neurodegenerative lifestyle factors 
Alcohol  
Figure 9 shows the PREVENT Dementia cohort (119) alcohol data. 
The PREVENT case report form, medical history assessment identified four 
participants with a diagnosis of alcoholism. The PREVENT case report form, 
lifestyle assessment identified 183 current drinkers, 5 ex-drinkers and 22 
non-drinkers. For current and ex-drinkers, the mean amount of alcohol units 
consumed per week is 11.7 (S.D 13.2), which is in accordance with being a 
moderate alcohol drinker, although the large standard deviation indicates that 
the amount of alcohol units consumed are spread over a wide range of 
values. This is demonstrated in Figure 9 that shows that the distribution for 
the number of alcohol units consumed per week is positively skewed. 
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Smoking 
Figure 10 shows the PREVENT Dementia cohort (119) smoking data. 
Only a small number of participants (5%) were current smokers at the time of 
the PREVENT Dementia cohort (119) baseline assessment. There were 10 
current smokers, 80 ex-smokers and 119 non-smokers. For the current and 
ex-smokers, the mean number of cigarettes smoked per week is 10.9 (SD 
8.0) and the range is 1 to 30.  
Substance misuse 
Figure 10 shows the PREVENT Dementia cohort (119) substance 
misuse data. In the PREVENT case report form medical history assessment, 
5 participants with a diagnosis of substance abuse were identified. From the 
the PREVENT case report form lifestyle assessment, 4 current substance 
misusers, 66 ex-substance misusers and 139 participants who had never 
misused substances were identified. To be categorised as an ex-substance 
misuser, participants only had to misuse substances on at least one 
occasion. In the PREVENT programme (119), the substances most 
commonly misused were cannabis by 63 participants, stimulants by 21 
participants, cocaine by 19 participants and hallucinogens by 12 participants. 
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3.3.3  Arterial Spin Labelling descriptive statistics 
Of the 210 participants in the PREVENT Dementia cohort (119), 193 
had MRI scans including ASL for assessment of CBF completed and 
analysed. There were 17 participants who did not have MRI scans 
completed. Of note, there were eight participants that did not have MRI scans 
due to claustrophobia.  
Of the 193 who had MRI scans completed; 31 ASL scans were 
excluded at the image processing stage. There were 18 ASL scans excluded 
due to having an inadequate field of view where regions of interest were not 
clearly visualised; six scans were excluded due to the presence of artefact; 
three scans were excluded as the image files did not open; three were 
excluded as individual CBF maps did not co-register with the processed 
individual T1 images; one scan was excluded due to the presence of a 
meningioma. Therefore, ASL data was available for 162 PREVENT Dementia 
cohort (119) participants.  
The mean value for the mean cortex CBF is 40.1 mL/100g/min and 
standard deviation 10.2 mL/100g/min. This is in line with the global CBF 
values identified in the systematic review. In studies by Chapman et al. (85, 
86, 113) the mean global CBF values were 47.1 mL/100g/min (113), 47.2 
mL/100g/min (85) and 47.0 mL/100g/min(86). The hippocampal CBF mean is 
48.3 mL/100g/min and standard deviation is 13.0 mL/100g/min. The ACC 
CBF mean is 16.9 mL/100g/min and standard deviation is 13.7 mL/100g/min. 
The CBF data is shown in Figure 11. 
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3.3.4 Missing data 
Table 20 summarises the missing data from the PREVENT Dementia 
cohort (119). There was little missing data related to demographics and 
lifestyle.  
Category Number of participants with missing data 
Demographic   
Age 0 
Gender 0 
APOE 4 allele 2 
Race 0 
Number of years of education 0 
Domiciliary status 0 
Lifestyle   
Physical training score 0 
Alcohol intake status 0 
Smoking status 1 
Substance misuse status 1 
Table 20: Missing data from the PREVENT Dementia cohort 
3.3.5 Statistical Analysis 
The variables used in the statistical models to assess the relationship 
between lifestyle and neurodegeneration in midlife as expressed on ASL are 
summarized in Table 21. Taking into account the individuals for whom there 
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Table 21: Covariates for the statistical models used to assess the relationship 
between lifestyle and neurodegeneration in midlife as expressed on ASL. 
Statistical model Covariates 
Unadjusted model  
Adjusted linear regression model 1 Age + gender + years of education + APOE 4 
allele + number of parents with dementia. 
Adjusted linear regression model 2 Age + gender + years of education + APOE 4 
allele + number of parents with dementia + 
physical training score + smoking status + 
alcohol drinking status + substance misuse 
status. 
 
3.3.6 Linear regression assumptions 
Assumptions were checked for all statistically significant linear 
regression models and were acceptable. Of note, cases 81, 82 and 175 are 
outliers, however Cook’s distance is less than one and therefore the cases 
have been included in the analysis. The diagnostic plots (Residuals vs Fitted, 
Normal Q-Q, Scale-Location, Residuals vs Leverage) are shown in Appendix 
F. 
3.3.7 Linear regression model findings 
Physical Training 
The results from the linear regression models for physical training are 
presented in Table 22. Although estimates of the univariate association 
between physical training and midlife ASL outcomes do not emerge as 
statistically significant, there is a positive trend in the direction of the 
association between a low physical training score and all midlife ASL 
outcomes (Mean cortex CBF, Hippocampal CBF and ACC CBF). This could 
represent an early neurodegenerative effect or a neuroprotective effect 
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associated with a low physical training score. The results regarding the 
association between medium physical training and midlife ASL outcomes do 
not emerge as statistically significant, nor do they show a clear direction of 
association. 
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ASL measure Model β coefficient 
(S.E) 
p 
Low Mean cortex CBF  Unadjusted Model 0.23 (3.35) 0.94 
  Adjusted (Model 1) 0.88 (3.24) 0.79 
  Adjusted (Model 2) 0.39 (3.32) 0.91 
High Mean cortex CBF   0 (Reference)  
Low Hippocampal CBF Unadjusted Model 2.99 (4.24) 0.48 
  Adjusted (Model 1) 3.68 (4.20) 0.38 
  Adjusted (Model 2) 2.94 (4.33) 0.50 
High Hippocampal CBF  0 (Reference)  
Low ACC CBF   Unadjusted Model 3.93 (4.47) 0.38 
  Adjusted (Model 1) 4.59 (4.43) 0.30 
  Adjusted (Model 2) 4.72 (4.46) 0.29 
High ACC CBF    0 (Reference)  
Medium Mean cortex CBF  Unadjusted Model 0.08 (1.68) 0.96 
  Adjusted (Model 1) -0.92 (1.67) 0.58 
  Adjusted (Model 2) -1.14 (1.74) 0.51 
High Mean cortex CBF   0 (Reference)  
Medium Hippocampal CBF Unadjusted Model -1.30 (2.13) 0.54 
  Adjusted (Model 1) -2.16 (2.17) 0.32 
  Adjusted (Model 2) -2.17 (2.27) 0.34 
High Hippocampal CBF  0 (Reference)  
Medium ACC CBF   Unadjusted Model 1.02 (2.25) 0.65 
  Adjusted (Model 1) 0.65 (2.30) 0.78 
  Adjusted (Model 2) 1.87 (2.33) 0.42 
High ACC CBF    0 (Reference)  
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Alcohol 
The results from the linear regression models for alcohol are 
presented in Table 23. The results regarding the association between being a 
high consumption alcohol drinker and midlife ASL outcomes do not emerge 
as statistically significant. On adjusted model 2, the results show that 
compared to being a moderate consumption alcohol drinker, individuals who 
do not drink alcohol have a statistically significant (p = 0.04) reduction in ACC 
CBF value of -7.62 mL/100g/min (S.E 3.64). The effect size is medium 
(Pearson’s correlation coefficient = 0.37). This could represent a possible 
neuroprotective effect associated with moderate alcohol intake.
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Table 23: The relationship between alcohol drinking status and ASL outcomes in 
midlife 
 
ACC = Anterior cingulate cortex, CBF = Cerebral blood flow 
*=P ≤0.05 
Alcohol drinking status ASL measure Model β coefficient 
(S.E) 
p 
Alcohol drinker – high Mean cortex CBF  Unadjusted Model -1.12 (2.02) 0.58 
  Adjusted (Model 1) -1.82 (2.00) 0.36 
  Adjusted (Model 2) -2.25 (2.06) 0.28 
Alcohol drinker - 
moderate 
Mean cortex CBF   0 
(Reference) 
 
Alcohol drinker – high Hippocampal CBF Unadjusted Model -2.40 (2.56) 0.35 
  Adjusted (Model 1) -2.94 (2.59) 0.26 
  Adjusted (Model 2) -3.35 (2.69) 0.22 
Alcohol drinker - 
moderate 
Hippocampal CBF  0 
(Reference) 
 
Alcohol drinker – high ACC CBF   Unadjusted Model -0.36 (2.71) 0.90 
  Adjusted (Model 1) -1.88 (2.74) 0.49 
  Adjusted (Model 2) -2.36 (2.77) 0.40 
Alcohol drinker - 
moderate 
ACC CBF    0 
(Reference) 
 
Non-drinker Mean cortex CBF  Unadjusted Model -2.90 (2.69) 0.28 
  Adjusted (Model 1) -3.11 (2.63) 0.24 
  Adjusted (Model 2) -3.49 (2.71) 0.20 
Alcohol drinker - 
moderate 
Mean cortex CBF   0 
(Reference) 
 
Non-drinker Hippocampal CBF Unadjusted Model -2.08 (3.42) 0.55 
  Adjusted (Model 1) -1.71 (3.43) 0.62 
  Adjusted (Model 2) -2.18 (3.54) 0.54 
Alcohol drinker - 
moderate 




Non-drinker ACC CBF   Unadjusted Model -5.71 (3.58) 0.11 
  Adjusted (Model 1) -5.86 (3.59) 0.10 
  Adjusted (Model 2) -7.62 (3.64) 0.04* 
Alcohol drinker - 
moderate 
ACC CBF    0 
(Reference) 
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Smoking 
The results from the linear regression models for smoking are 
presented in Table 24. The results do not emerge as statistically significant. 
The p values range from 0.23 to 0.70. Of note, there is a negative trend in the 
direction of the association between being a smoker and all midlife ASL 
outcomes, a result that suggests that smokers have worse ASL outcomes. 
However a significant result may not have resulted from the analysis 
undertaken in this thesis due to insufficient power.  
Table 24: The relationship between smoking and ASL outcomes in midlife. 
Smoking 
status 
ASL measure Model β coefficient 
(S.E) 
p 
Smoker Mean cortex CBF  Unadjusted Model -1.41 (1.63) 0.39 
  Adjusted (Model 1) -0.98 (1.59) 0.54 
  Adjusted (Model 2) -2.25 (1.87) 0.23 
Non-smoker Mean cortex CBF   0 (Reference)  
Smoker Hippocampal CBF Unadjusted Model -1.17 (2.07) 0.57 
  Adjusted (Model 1) -0.79 (2.07) 0.70 
  Adjusted (Model 2) -1.46 (2.44) 0.55 
Non-smoker Hippocampal CBF  0 (Reference)  
Smoker ACC CBF   Unadjusted Model -1.59 (2.18) 0.47 
  Adjusted (Model 1) -1.08 (2.19) 0.62 
  Adjusted (Model 2) -1.95 (2.51) 0.44 
Non-smoker ACC CBF    0 (Reference)  
ACC = Anterior cingulate cortex, CBF = Cerebral blood flow 
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Substance misuse 
The results from the linear regression models for substance misuse 
are presented in Table 25. Estimates of the univariate and multivariate 
association between substance misuse and both mean cortex cerebral blood 
flow and hippocampal blood flow do not emerge as statistically significant nor 
do they show a trend in the direction of association.  
On all three linear regression models, the results show that compared 
to being a non-substance misuser, being a current or ex-substance misuser 
is associated with a reduced ACC CBF. This is likely to represent a 
neurodegenerative effect associated with substance misuse. On the 
unadjusted model, there is a statistically significant (p = 0.02) reduction in 
ACC CBF of -5.13 mL/100g/min (S.E 2.25). The effect size is small 
(Pearson’s correlation coefficient = 0.18). On adjusted model 1, individuals 
who are current or ex-substance misusers have a statistically significant (p = 
0.02) reduction in ACC CBF of -5.58 mL/100g/min (S.E 2.33). Again, the 
effect size is small (Pearson’s correlation coefficient = 0.29). On adjusted 
model 2, there is a statistically significant (p = 0.02) reduction in ACC CBF of 
-5.58 mL/100g/min (S.E 2.33) and the effect size is medium (Pearson’s 
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Table 25: The relationship between substance misuse and ASL outcomes in midlife. 
Substance misuse 
status 







Unadjusted Model 1.41 (1.70) 0.41 
  Adjusted (Model 1) 1.88 (1.72) 0.28 





 0 (Reference)  
Current or ex-
substance misuser  
Hippocampal 
CBF 
Unadjusted Model 1.87 (2.16) 0.39 
  Adjusted (Model 1) 1.60 (2.24) 0.48 





 0 (Reference)  
Current or ex-
substance misuser 
ACC CBF   Unadjusted Model -5.13 (2.25) 0.02* 
  Adjusted (Model 1) -5.58 (2.33) 0.02* 
  Adjusted (Model 2) -7.29 (2.70) <0.01* 
Current or ex-
substance misuser 
ACC CBF    0 (Reference)  
ACC = Anterior cingulate cortex, CBF = Cerebral blood flow 
*=P ≤0.05 
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3.4 Discussion 
The discussion of the analysis of the PREVENT Dementia cohort (119) 
data is presented below and the potential mechanisms and clinical and public 
health implications are presented in chapter 5.  
3.4.1 Main findings 
The main finding of this study is an association between being a 
current or ex-substance misuser and a reduction in ACC CBF. The ACC as 
expressed on fMRI is illustrated in Figure 12. Additionally, the results from 
adjusted model 2 show that compared to being a moderate alcohol drinker, 
being a non-drinker is associated with a reduction in ACC CBF. Linear 
regression models did not show an association between physical training and 
smoking with mean cortex CBF, hippocampal CBF and ACC CBF.  
 
Figure 12: Anterior Cingulate Cortex on functional Magnetic Resonance Imaging (165). 
3.4.2 Comparison with other literature 
The studies showing a relationship between lifestyle and 
neurodegeneration in midlife as expressed on fMRI are summarised in 
Chapter 2. Please see section 2.3.3 (Studies included in qualitative 
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synthesis) for full details. Multiple studies identified by the systematic review 
have shown a relationship between lifestyle factors and neurodegeneration in 
the ACC in midlife as expressed on fMRI. Of note, in a cross-sectional, 
resting state fMRI study of 24 chronic heroin users and 24 normal controls, 
Jiang et al. demonstrated decreased amplitude low-frequency fluctuate 
(ALFF), a measure of abnormal activity, in multiple brain regions. More 
specifically, the study found that compared with controls, individuals who 
were addicted to heroin had decreased ALFF in the ACC, which is thought to 
be abnormal (94). Furthermore, in a cross-sectional multi-modal MRI study of 
20 cocaine-addicted individuals and 19 age-matched controls, Wang et al. 
demonstrated that compared to controls, individuals addicted to cocaine 
showed a hypo-status in multiple brain regions. Amongst these results, the 
ACC showed a correlation between high drug craving scores and low tissue 
volume and low CBF. (107). Using data from the PREVENT Dementia cohort 
(119), an assessment of the correlation between fMRI and sMRI findings 
would be helpful to determine if a reduced ACC CBF corresponds to reduced 
ACC tissue volume in substance misusers, however this data was not 
available for my analysis. 
Although the systematic review identified six studies (88, 90, 96, 105, 
106, 108) that show an association between high alcohol consumption and 
neurodegeneration, the association found in this data analysis between being 
a non-drinker and a reduction in the ACC CBF was not identified by the 
systematic review. 
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The systematic review identified five studies that showed a potential 
neuroprotective effect associated with physical training (84, 86, 99, 101, 
109), one study that showed no effect (91) and one study that described a 
possible neurodegenerative effect (89). In the study that showed no effect, 
Hotting et al. (91) assessed the effects of cognitive training and physical 
training on spatial learning and associated brain activation. The physical 
training interventions involved indoor-cycling on stationary bicycles and 
stretching and coordination training. Spatial learning was assessed with a 
virtual maze task, and at the same time neural correlates were measured 
with fMRI. The physical intervention group did not improve performance in 
the maze task. In line with this study, the analysis of the PREVENT Dementia 
cohort (119) did not show an association between physical training and CBF 
as expressed on fMRI. However, the measure of physical training, used in 
my analysis, a physical training score based on frequency and intensity of 
physical training is different to the physical training intervention used in the 
study by Hotting et al. (91). Furthermore fMRI outcome measures used in my 
analysis -  mean cortex CBF, hippocampal CBF and ACC CBF, are different 
to the fMRI outcome measure used in the study by Hotting et al. (91). The 
systematic review identified three cross-sectional studies (87, 88, 103) that 
demonstrated a neurodegenerative effect associated with smoking on brain 
health as expressed on fMRI. This finding was not replicated in my data 
analysis which did not show an association between smoking and mean 
cortex CBF, hippocampal CBF and ACC CBF. 
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3.4.3 Linear regression model covariates 
In accordance with guidance by Smith, the covariates for the linear 
regression models have been stated a priori and stepwise regression has not 
been undertaken (166). The reason for this is that in stepwise regression, 
some real explanatory variables that have causal effects on the dependent 
variable may happen to not be statistically significant, while nuisance 
variables may be coincidentally significant. As a result, the model may fit the 
data well in-sample, but do poorly out of sample (166). The potential for bias 
when covariates are chosen by data dependent methods has been 
acknowledged by the International Conference on Harmonization (ICH) 
guidelines on statistical principles for clinical trials (167).  
The decision as to which covariates to include in the analysis were 
based on data from studies identified in the systematic review of the 
relationship between lifestyle and neurodegeneration in midlife as expressed 
on fMRI and established non-modifiable risk factors for Alzheimer’s 
dementia. However it is worth bearing in mind that stating the linear 
regression coefficients a priori, introduces the risk of overlooking a hidden 
confounder that has not been anticipated. (168) 
3.4.4 Strengths and limitations 
Important limitations of this cross-sectional data analysis of the 
PREVENT Dementia cohort data (119) are that causation cannot be inferred 
and that low power may have contributed to a reduced chance of detecting a 
true effect in the statistical analysis (169). Based on guidance by Cohen on 
statistical power analysis (170), the standard α-level of 0.05 and the 
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recommended power of 0.8 have been used, therefore 783 participants 
would be needed to detect a small effect size, 85 participants to detect a 
medium effect size and 28 participants to detect a large effect size. In this 
data analysis, consideration was given to using the Bonferroni adjustment to 
reduce the possibility of a Type I error. However, the decision was made not 
to use the Bonferroni adjustment, as it implies that a given comparison will be 
interpreted differently according to how many other tests were performed and 
although it would decrease the number of type I errors, it would increase the 
number of type II errors (171). Therefore in accordance with guidance by 
Perneger (171), the approach that has been adopted is to describe what 
analysis has been undertaken and why. Then the possible interpretations of 
each result have been explored. The intention of this approach is to enable 
the reader to reach a reasonable conclusion without the help of the 
Bonferroni adjustment. 
A further limitation of this analysis is the use of self-reported measures 
of physical training, alcohol, smoking and substance misuse in the PREVENT 
Dementia cohort (119). Self-reported measures are a source of response 
bias. Additionally, the PREVENT Dementia cohort (119) physical training 
score which takes into account the frequency and intensity of physical 
training, has not been validated in past literature. It is noteworthy that 
individuals who volunteered to be part of the PREVENT Dementia cohort 
(119) baseline population in London were mainly Caucasian (90%) and 
highly educated; the mean number of years of education was 16. This limits 
the generalisability of the findings of this cross- sectional analysis. An 
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important strength of this analysis is the large number of participants for 
whom ASL data has been collected and assessed. This compares favourably 
to 27 of the 29 studies (81-92, 94-107, 109) identified in the systematic 
review. Furthermore there is little missing data in the PREVENT Dementia 
cohort (119) data analysis. 
3.4.5 Conclusions 
Previous studies have shown a relationship between multiple lifestyle 
factors – substance misuse, smoking, alcohol, physical and cognitive training 
and neurodegeneration in the ACC in midlife as expressed on fMRI. The 
analysis of the data from the PREVENT Dementia cohort (119) has 
demonstrated associations between substance misuse and alcohol, and ASL 
CBF in the ACC. No associations between physical training and smoking, 
and mean cortex CBF, hippocampal CBF and ACC CBF were detected. 
3.4.6 Implications of research 
This analysis of the PREVENT Dementia cohort (119), demonstrated 
associations between being a current or ex-substance misuser and ACC 
CBF and not drinking alcohol and ACC CBF. As the analysis is cross 
sectional, causation cannot be inferred and it is worth emphasizing that the 
results are of limited generalisability. This is partly due to the inclusion criteria 
for the cohort and the participant characteristics. The inclusion criteria means 
the cohort only includes participants aged 40 to 59 years old. The participant 
characteristics show that the participants in the PREVENT Dementia cohort 
(119) are a select group of volunteers who are mainly Caucasian, highly 
education and physically fit.




4 Analysis of the relationship between lifestyle and 
structural magnetic resonance imaging outcomes in 
midlife using data from the PREVENT Dementia cohort 
Chapter abstract 
INTRODUCTION: The linear regression models used to analytically assess 
the relationship between lifestyle factors and neurodegeneration in midlife, as 
expressed using ASL, were adapted to undertake  analysis of the relationship 
between lifestyle and neurodegeneration in midlife as expressed on structural 
MRI (sMRI) using data from the PREVENT Dementia cohort.  
METHODS: Three linear regression models were constructed to evaluate the 
relationship between lifestyle and neurodegeneration as expressed on sMRI. 
The first model adjusted for intracranial volume. The second model also took 
into account non modifiable risk factors for dementia. The third model 
adjusted for intracranial volume, non modifiable risk factors for dementia and 
lifestyle factors. 
RESULTS: There were 193 individuals in the PREVENT Dementia cohort 
with sMRI data. The linear regression models demonstrated three key 
associations - a medium physical training score was associated with an 
increased hippocampal grey matter volume, a low physical training score was 
associated with an increased PVH Fazekas score and being a smoker was 
associated with reduced grey matter volume.  
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DISCUSSION: This exploratory analysis represents a preliminary step in the 
investigation of the relationship between lifestyle factors and 
neurodegeneration in midlife as expressed on sMRI. There is scope to build 
on this exploratory analysis by completing a systematic review of the 
relationship between lifestyle and neurodegeneration in midlife as expressed 
on sMRI and refinement of the linear regression models. 




The systematic review (chapter 2) identified five key lifestyle factors – 
physical training, cognitive training, smoking, alcohol and substance misuse 
associated with neurodegeneration. Based on the findings of the systematic 
review, linear regression models were constructed to analytically assess the 
relationship between lifestyle and neurodegeneration in midlife as expressed 
on ASL using the PREVENT Dementia cohort data (119) (chapter 3). The 
ASL linear regression models were then optimised to undertake  analysis of 
the relationship between lifestyle and neurodegeneration in midlife as 
expressed on sMRI using the PREVENT Dementia cohort data (119). The 
following hypothesis were tested: 
1. Physical training is associated with increased GMV, WMV, 
hippocampal grey matter volume and parahippocampal grey matter 
volume. 
2.  Physical training is associated with a decreased periventricular 
hyperintensities (PVH) Fazekas score and deep white matter 
hyperintensities (DWMH) Fazekas score (158). 
3. Substance misuse, alcohol and smoking are associated with 
decreased GMV, WMV, hippocampal grey matter volume and 
parahippocampal grey matter volume. 
4. Substance misuse, alcohol and smoking are associated with an 
increased PVH and DWMH Fazekas score (158). 




Baseline data from the PREVENT Dementia cohort (119) were used to 
assess the relationship between lifestyle and neurodegeneration in midlife as 
expressed on sMRI. A full description of the PREVENT Dementia cohort 
(119) is available in Section 3.2.1 (The Prevent Dementia cohort). The 
covariates used in the linear regression models have been chosen in 
advance based on the systematic review of the relationship between lifestyle 
and neurodegeneration in midlife as expressed on fMRI and established non-
modifiable risk factors for Alzheimer’s dementia. Additionally, intracranial 
volume (ICV) was used as a covariate. This has been included as 
normalization of regional volumes by ICV can aid the assessment of 
neurodegenerative changes on sMRI (172).  
The covariates used in the statistical models to assess the relationship 
between lifestyle and neurodegeneration in midlife as expressed on sMRI are 
shown in Table 26. Three linear regression models were constructed and the 
covariates used were ICV, age, gender, years of education, APOE 4 allele, 
number of parents with dementia, physical training score, smoking status, 
alcohol drinking status and substance misuse status. The sMRI outcome 
measures assessed were the available sMRI measures from the Prevent 
Dementia cohort  (119) - GMV, WMV, hippocampal grey matter volume, 
parahippocampal grey matter volume, PVH Fazekas score and DWMH 
Fazekas score (158). 
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Table 26: Covariates for the statistical models used to assess the relationship 
between lifestyle and neurodegeneration in midlife as expressed on structural MRI. 
Statistical model Covariates 
Unadjusted linear regression model  ICV. 
Adjusted linear regression model 1 ICV + age + gender + years of education + 
APOE 4 allele + number of parents with 
dementia. 
Adjusted linear regression model 2 ICV + age + gender + years of education + 
APOE 4 allele + number of parents with 
dementia + physical training score + smoking 
status + alcohol drinking status + substance 
misuse status. 
ICV = Intracranial volume, APOE = Apolipoprotein 
4.3 Results 
The structural MRI summary statistics for the 193 participants in the 
PREVENT Dementia cohort (119) with sMRI data are presented in Table 27. 
The table shows the mean, median and range for GMV, WMV, hippocampal 
grey matter volume, parahippocampal grey matter volume, PVH Fazekas 
score and DWMH Fazekas score (158). 
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Table 27: Structural MRI summary statistics. 
Summary measures  
GMV mean ± SD 642.9 ± 56.07 cm3 
GMV median / Interquartile range 638 / 73.8 cm3 
GMV range 478.4 to 842.9 cm3 
WMV mean ± SD 516.3 ± 61.78 cm3 
WMV median / Interquartile range 515 / 74.2 cm3 
WMV range 346.6 to 683.9 cm3 
ICV mean ± SD 1389 ± 131.11 cm3 
ICV median / Interquartile range 1382 / 179.1 cm3 
ICV range 1088 to 1804 cm3 
Hippocampal grey matter volume mean ± SD 3.73 ± 0.34  
Hippocampal grey matter volume median / 
Interquartile range 
3.69 / 0.45 
Hippocampal grey matter volume range 2.77 to 4.71 
Parahippocampal grey matter volume mean ± SD 3.73 ± 0.35  
Parahippocampal grey matter volume median / 
Interquartile range 
3.68 / 0.50 
Parahippocampal grey matter volume range 2.98 to 4.64 
PVH mean ± SD 1.13 ± 0.42 
DWMH mean ± SD 0.68 ± 0.57 
DWMH = Deep white matter hyperintensities, ICV = Intracranial volume, GMV = Grey matter 
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Participant characteristics  
The PREVENT Dementia cohort (119) included 210 participants who 
had completed the baseline visit at the pilot site. Of the 210 participants, 193 
had MRI data available. There were 17 participants who did not complete the 
MRI scan. This was due to claustrophobia (n=8), withdrawal of consent 
(n=1), did not attend (n=1), metal implant (n=1), scanner not available (n=1) 
and other reasons not specified (n=5).  
The descriptive characteristics for both the full (N=210) and analysed 
data (N=193) sets are shown in Table 28. There were no significant 
differences between the demographics of the full data set and the analysed 
data set. In the analysed data set, the average age of participants was 52 
years old. There were 58 (30%) male and 135 (70%) female participants. 
There were 70 (36.3%) participants who had at least one APOE 4 allele and 
121 (62.7%) participants had no APOE 4 allele. The mean number of years 
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Table 28: Summary of Prevent Dementia cohort demographic characteristics. 
Demographics N=210  
(full data set) 
N=193 
(analysed data set) 
Age - mean ± SD 52.0 ± 5.5 52.0 ± 5.4 
Gender: M / F - N (% of total sample) 62 (29.5) / 148 (70.5) 58 (30) / 135 (70) 
APOE 4 allele: No APOE 4 / APOE 4 ≥ 
1 – N (% of total sample) 
133 (63.9) / 75 (36.1) 121 (62.7) / 70 (36.3) 
Race: Caucasian / other - N (% of total 
sample) 
188 (89.5) / 22 (10.5) 175 (91) / 18 (9)  
Number of years of education: mean + 
SD 
15.9 ± 3.4 15.9 ± 3.4 
Domiciliary status: lives with others / lives 
alone  
– N (% of total sample) 
180 (85.7) / 30 (14.3) 166 (86) / 27 (14)  
 
Low Physical Training Score 
The results from the linear regression models for a low physical 
training score are presented in Table 29. Although estimates of the 
association between physical training and volumetric sMRI outcomes (GMV, 
WMV, Hippocampal volume, Parahippocampal volume) do not emerge as 
statistically significant, there is a negative trend in the direction of the 
association. Contrastingly there is a positive trend in the direction of 
association between physical training and Fazekas scores (PVH and DWMH) 
(158). Furthermore, on all models, the results show that compared to having 
a high physical training score, a low physical training score is associated with 
a statistically significant higher PVH Fazekas score (158).  A higher PVH 
Fazekas score (158) represents increased white matter lesions, which 
suggests a reduction in brain health.
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Table 29: The relationship between physical training score (low vs high) and 
structural MRI outcomes in midlife. 
Physical 
training Score 
sMRI measure Model β coefficient 
(S.E) 
p 
Low GMV Unadjusted model -8.71 (6.97) 0.21 
  Adjusted (Model 1) -7.80 (6.84) 0.26 
  Adjusted (Model 2) -10.81 (6.87) 0.12 
High GMV  0 (Reference)  
Low WMV Unadjusted model -7.92 (9.13) 0.39 
  Adjusted (Model 1) 0.77 (3.64) 0.83 
  Adjusted (Model 2) -4.13 (3.40) 0.23 
High WMV  0 (Reference)  
Low Hippocampal volume Unadjusted model -0.04 (0.06) 0.5 
  Adjusted (Model 1) -0.05 (0.06) 0.46 
  Adjusted (Model 2) -0.07 (0.062)   0.23 
High Hippocampal volume  0 (Reference)  
Low Parahippocampal 
volume   
Unadjusted model -0.05 (0.06) 0.47 
  Adjusted (Model 1) -0.04 (0.06) 0.49 
  Adjusted (Model 2) -0.03 (0.07) 0.66 
High Parahippocampal 
volume   
 0 (Reference)  
Low PVH Fazekas score  Unadjusted model 0.45 (0.13) <0.01* 
  Adjusted (Model 1) 0.44 (0.12) <0.01* 
  Adjusted (Model 2) 0.45 (0.13) <0.01* 
High PVH Fazekas score  0 (Reference)  
Low DWMH Fazekas 
score  
Unadjusted model 0.04 (0.18) 0.81 
  Adjusted (Model 1) 0.06 (0.18) 0.72 
  Adjusted (Model 2) 0.06 (0.18)    0.75 
High DWMH Fazekas 
score 
 0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 
Periventricular hyperintensities, S.E = Standard error, WMV = White matter volume 
*=P ≤0.05 
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Medium Physical Training Score 
The results from the linear regression models for a medium physical 
training score are presented in Table 30. Estimates of the association 
between physical training and sMRI outcomes do not show a general clear 
trend in the direction of association. However, on all the models, the results 
show that compared to having a high physical training score, a medium 
physical training score is associated with a reduction in hippocampal volume, 
which likely represents neurodegeneration.
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Table 30: The relationship between medium physical training score (medium vs high) 
and structural MRI outcomes in midlife. 
Physical 
training score 
sMRI measure Model β coefficient 
(S.E) 
p 
Medium GMV Unadjusted model -4.26 (3.32) 0.20 
  Adjusted (Model 1) -3.41 (3.37) 0.31 
  Adjusted (Model 2) -4.13 (3.40) 0.23 
High GMV  0 (Reference)  
Medium WMV Unadjusted model 0.17 (3.71) 0.96 
  Adjusted (Model 1) 0.77 (3.64) 0.83 
  Adjusted (Model 2) 0.58 (3.78)    0.88 
High WMV  0 (Reference)  
Medium Hippocampal volume Unadjusted model -0.07 (0.03) 0.02* 
  Adjusted (Model 1) -0.07 (0.03) 0.03* 
  Adjusted (Model 2) -0.07 (0.03) 0.02 * 
High Hippocampal volume  0 (Reference)  
Medium Parahippocampal 
volume   
Unadjusted model 0.01 (0.03) 0.74 
  Adjusted (Model 1) 0.02 (0.03) 0.53 
  Adjusted (Model 2) 0.02 (0.03) 0.56 
High Parahippocampal 
volume   
 0 (Reference)  
Medium PVH Fazekas score  Unadjusted model -0.1 (0.06) 0.83 
  Adjusted (Model 1) 0.02 (0.07) 0.75 
  Adjusted (Model 2) 0.02 (0.07) 0.80 
High PVH Fazekas score  0 (Reference)  
Medium DWMH Fazekas score  Unadjusted model 0.03 (0.08) 0.68 
  Adjusted (Model 1) -0.02 (0.09) 0.85 
  Adjusted (Model 2) -0.01 (0.09) 0.95 
High DWMH Fazekas score  0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 








The results from the linear regression models for smoking are 
presented in Table 31. The association between smoking and sMRI 
outcomes do not show a general clear trend in the direction of association. 
However, on all the models, the results show that compared to being a non-
smoker, being a smoker is associated with a reduction in GMV. Furthermore, 
on the unadjusted model, individuals who are smokers, have a statistically 
significant (p=0.03) increase in WMV of 7.82 (3.61). Both these changes 
likely represent neurodegeneration.
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Table 31: The relationship between smoking status (smoker vs non-smoker) and 
structural MRI outcomes in midlife. 
Smoking 
status 
sMRI measure Model β coefficient 
(S.E) 
p 
Smoker GMV Unadjusted model -10.21 (3.19) <0.01* 
  Adjusted (Model 1) -10.29 (3.19) <0.01* 
  Adjusted (Model 2) -9.77 (3.75) 0.01* 
Non-smoker GMV  0 (Reference)  
Smoker WMV Unadjusted model 7.82 (3.61) 0.03* 
  Adjusted (Model 1) 5.92 (3.52) 0.09 
  Adjusted (Model 2) 5.46 (4.17)    0.19 
Non-smoker WMV  0 (Reference)  
Smoker Hippocampal volume Unadjusted model 0.01 (0.03) 0.61 
  Adjusted (Model 1) 0.02 (0.03) 0.41 
  Adjusted (Model 2) 0.04 (0.03) 0.20 
Non-smoker Hippocampal volume  0 (Reference)  
Smoker Parahippocampal 
volume   
Unadjusted model 0.03 (0.03) 0.25 
  Adjusted (Model 1) 0.04 (0.03) 0.25 
  Adjusted (Model 2) 0.04 (0.04)   0.33 
Non-smoker Parahippocampal 
volume 
 0 (Reference)  
Smoker PVH Fazekas score  Unadjusted model 0.07 (0.06) 0.29 
  Adjusted (Model 1) 0.07 (0.06) 0.24 
  Adjusted (Model 2) 0.07 (0.07) 0.36  
Non-smoker PVH Fazekas score  0 (Reference)  
Smoker DWMH Fazekas score  Unadjusted model 0.01 (0.08) 0.86 
  Adjusted (Model 1) 0.03 (0.08) 0.74 
  Adjusted (Model 2) 0.02 (0.10) 0.81   
Non-smoker DWMH Fazekas score  0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 
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High Consumption Alcohol Drinker 
The results from the linear regression models for being a high 
consumption alcohol drinker are presented in Table 32. Estimates of the 
association between high consumption and volumetric sMRI outcomes 
(GMV, WMV, Hippocampal volume, Parahippocampal volume) do not show a 
clear trend in the direction of association. However, there is a positive trend 
in the direction of association between high consumption and Fazekas 
scores (PVH and DWMH) (158).  Additionally on the unadjusted model, the 
association between high alcohol consumption and an increased DWMH 
Fazekas score (158) is approaching significance (p=0.18).
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Table 32: The relationship between alcohol drinking status (alcohol drinker – high vs 
alcohol drinker - moderate) and structural MRI outcomes in midlife. 
Alcohol drinking 
status 





GMV Unadjusted model -2.37 (3.85) 0.54 
  Adjusted (Model 1) 0.98 (3.51) 0.78 
  Adjusted (Model 2) 0.51 (3.89) 0.90  
Alcohol drinker 
– moderate 
GMV  0 (Reference)  
Alcohol drinker 
– high 
WMV Unadjusted model -1.51 (4.29) 0.72 
  Adjusted (Model 1) 0.38 (4.16) 0.93 
  Adjusted (Model 2) -0.50 (4.33) 0.91 
Alcohol drinker 
– moderate 
WMV  0 (Reference)  
Alcohol drinker 
– high 
Hippocampal volume Unadjusted model 0.02 (0.03) 0.47 
  Adjusted (Model 1) 0.02 (0.03) 0.51 
  Adjusted (Model 2) 0.02 (0.04) 0.61 
Alcohol drinker 
– moderate 




volume   
Unadjusted model -0.01 (0.04) 0.89 
  Adjusted (Model 1) -0.01 (0.04) 0.84 




volume   
 0 (Reference)  
Alcohol drinker 
– high 
PVH Fazekas score  Unadjusted model 0.06 (0.07) 0.41 
  Adjusted (Model 1) 0.05 (0.07) 0.48 
  Adjusted (Model 2) 0.01 (0.08) 0.88 
Alcohol drinker 
– moderate 
PVH Fazekas score  0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 
Periventricular hyperintensities, S.E = Standard error, WMV = White matter volume 










DWMH Fazekas score  Unadjusted model 0.13 (0.10) 0.18 
  Adjusted (Model 1) 0.10 (0.1) 0.33 
  Adjusted (Model 2) 0.09 (0.10) 0.40 
Alcohol drinker 
– moderate 
DWMH Fazekas score  0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 
Periventricular hyperintensities, S.E = Standard error, WMV = White matter volume 




The results from the linear regression models for being a non-drinker 
are presented in Table 33. The association between non-drinker and sMRI 
outcomes do not show an obvious trend in the direction of association. 
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Table 33: The relationship between alcohol drinking status (non-drinker vs alcohol 
drinker – moderate) and structural MRI outcomes in midlife. 
Alcohol drinking 
status 
sMRI measure Model β coefficient 
(S.E) 
p 
Non-drinker GMV Unadjusted model -3.12 (5.67) 0.58 
  Adjusted (Model 1) 0.07 (5.6) 0.99 
  Adjusted (Model 2) -3.10 (5.66) 0.58  
Alcohol drinker – 
moderate 
GMV  0 (Reference)  
Non-drinker WMV Unadjusted model 1.16 (6.31) 0.85 
  Adjusted (Model 1) 2.93 (6.08) 0.63 
  Adjusted (Model 2) 4.56 (6.29)  0.47 
Alcohol drinker – 
moderate 
WMV  0 (Reference)  
Non-drinker Hippocampal 
volume 
Unadjusted model 0.01 (0.05) 0.86 
  Adjusted (Model 1) 0.01 (0.05) 0.86 
  Adjusted (Model 2) 0.01 (0.05) 0.82 




 0 (Reference)  
Non-drinker Parahippocampal 
volume   
Unadjusted model 0.03 (0.05) 0.57 
  Adjusted (Model 1) 0.03 (0.05) 0.58 
  Adjusted (Model 2) 0.04 (0.05) 0.46 
Alcohol drinker – 
moderate 
Parahippocampal 
volume   
 0 (Reference)  
Non-drinker PVH Fazekas 
score  
Unadjusted model -0.14 (0.11) 0.20 
  Adjusted (Model 1) -0.16 (0.11) 0.14 
  Adjusted (Model 2) -0.14 (0.11)    0.22 




 0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 











sMRI measure Model β coefficient 
(S.E) 
p 
Non-drinker DWMH Fazekas 
score  
Unadjusted model -0.03 (0.14) 0.82 
  Adjusted (Model 1) -0.08 (0.14) 0.57 
  Adjusted (Model 2) -0.06 (0.15) 0.71 




 0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 
Periventricular hyperintensities, S.E = Standard error, WMV = White matter volume 




The linear regression models for the relationship between being a 
current or ex-substance misuser compared to individuals who never misused 
substances are presented in Table 34. Of note, on adjusted model 1, 
individuals who are current or ex-substance misusers, have a statistically 
significant (p=0.05) reduction in GMV of -6.99 (S.E 3.50). This is likely to 
represent a pathological change associated with substance misuse.
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Table 34: The relationship between substance misuse status (Current or ex-substance 
misuser vs never misused substances) and structural MRI outcomes in midlife. 





GMV Unadjusted model -3.77 (3.46) 0.28 
  Adjusted (Model 1) -6.99 (3.50) 0.05* 
  Adjusted (Model 2) -1.80 (4.00) 0.65 
Never misused 
substances 
GMV  0 (Reference)  
Current or ex-substance 
misuser  
WMV Unadjusted model 3.29 (3.87) 0.40 
  Adjusted (Model 1) 4.57 (3.81) 0.23 
  Adjusted (Model 2) 2.04 (4.45) 0.65 
Never misused 
substances 
WMV  0 (Reference)  




Unadjusted model -0.03 (0.03) 0.33 
  Adjusted (Model 1) -0.02 (0.03) 0.50 





 0 (Reference)  
Current or ex-substance 
misuser  
Parahippocam
pal volume   
Unadjusted model 0.03 (0.03) 0.35 
  Adjusted (Model 1) 0.02 (0.03) 0.51 





 0 (Reference)  




Unadjusted model 0.03 (0.07) 0.64 
  Adjusted (Model 1) 0.05 (0.07) 0.43 





 0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 




Lifestyle and neurodegeneration  
147 
Exploratory Analysis 
Substance misuse status sMRI measure Model β coefficient 
(S.E) 
p 
Current or ex-substance 
misuser  
DWMH 
Fazekas score  
Unadjusted model -0.03 (0.09) 0.77 
  Adjusted (Model 1) -0.01 (0.09) 0.99 





 0 (Reference)  
DWMH = Deep white matter hyperintensities, GMV = Grey matter volume, PVH = 
Periventricular hyperintensities, S.E = Standard error, WMV = White matter volume 




The discussion of the results of the PREVENT Dementia sMRI data is 
presented below. The potential mechanisms and clinical and public health 
implications are presented in chapter 5. 
4.4.1 Main findings 
The findings that were significant across all the models (unadjusted 
and adjusted) from the analysis of the relationship between lifestyle and 
midlife sMRI outcomes are shown in Table 35.  
Table 35: Summary of the results from the linear regression models of the relationship 
between lifestyle factors in midlife as expressed on structural MRI. 
Lifestyle Factor Structural 
MRI 
Outcome  
Model β coefficient 
(S.E) 
p 





Unadjusted model -0.07 (0.03) 0.02* 
  Adjusted (Model 1) -0.07 (0.03) 0.03* 
  Adjusted (Model 2) -0.07 (0.03) 0.02 * 
Physical training score 




Unadjusted model 0.45 (0.13) <0.01* 
  Adjusted (Model 1) 0.44 (0.12) <0.01* 
  Adjusted (Model 2) 0.45 (0.13) <0.01* 
Smoker  GMV Unadjusted model -10.21 (3.19) <0.01* 
  Adjusted (Model 1) -10.29 (3.19) <0.01* 
  Adjusted (Model 2) -9.77 (3.75) 0.01* 
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Physical Training  
The results from the unadjusted model, adjusted model 1 and adjusted 
model 2 show that compared to a high physical training score, a medium 
physical training score is associated with a smaller hippocampal grey matter 
volume. The hippocampus is located in the medial temporal lobe and the 
hippocampus as expressed on sMRI is shown in Figure 13.The hippocampus 
has an important role in the consolidation of information from short-term 
memory to long-term memory and in spatial memory (173). 
 
Figure 13: Hippocampus as expressed on sMRI in axial, sagittal and coronal sections 
(174). 
 
Compared to a high physical training score, a low physical training 
score is associated with an increased PVH Fazekas score (158). The PVH 
Fazekas score is used to quantify the amount of white matter hyperintense 
lesions, these are usually due to chronic small vessel ischaemia (158). The 
PVH Fazekas scoring system is shown in Figure 14. A score of zero 
corresponds to an absence of white matter hyperintense lesions. A score of 
one, corresponds to pencil-thin lining around ventricles, two corresponds to a 
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smooth halo around ventricles (6-10mm regular margins) and three 
corresponds to an irregular halo > 10mm. White matter lesions, especially in 
the periventricular region are associated with an increased risk of dementia 
(175). 
 
Figure 14: PVH Fazekas scoring system (176). 
Smoking 
The results from unadjusted model, adjusted model 1 and adjusted 
model 2 show that compared to being a non-smoker, being a smoker is 
associated with a reduction in GMV. Before symptom onset in Alzheimer’s 
dementia, grey matter volume loss is detectable in specific regions, namely 
the anterior hippocampus and amygdala (177). 
Additional findings 
The results from the unadjusted model show that compared to being a 
non-smoker, being a smoker is associated with increased WMV. The results 
from adjusted model 1 show that compared to being a non-substance 
misuser, being a current or ex-substance misuser is associated with a 
reduction in GMV. 
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Linear regression model covariates 
Historically, a combination of structural and functional brain imaging has 
been used for the purpose of analysing functional activity in a priori defined 
brain region. The sMRI image is used as a reference for locating regions of 
interest for fMRI analysis. However, a central assumption of systems 
neuroscience is that the structure of the brain is related to functional 
connectivity (178). The findings of Segall et al. (179) support this 
hypothesis. A cohort of 603 healthy participants underwent structural and 
functional scanning. Spatial independent component analysis was applied 
separately to both the structural MRI data and the resting state fMRI 
data. The results showed a correspondence between a single structural 
component and several resting-state functional components. Therefore the 
covariates identified in the systematic review of the relationship between 
lifestyle and neurodegeneration in midlife as expressed on fMRI have been 
used in the analysis of the PREVENT Dementia cohort (119) sMRI data. 
Comparison with other literature 
The main findings of this data analysis are supported by previous 
studies assessing the relationship between lifestyle factors and 
neurodegeneration as expressed on sMRI. In a randomised control trial of 
120 late life adults, Erickson et al. (180) demonstrated that moderate 
intensity exercise on three days per week for one year increased the size of 
the anterior hippocampus.  
Exercise training increased hippocampal volume by 2%. In the control 
group, Hippocampal volume declined by 1.4%, suggesting that moderate 
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intensity exercise protects against hippocampal volume loss. In a longitudinal 
cohort study of 299 late life adults, Erickson et al. (181) demonstrated that 
high volume low intensity exercise - walking, is associated with increased 
grey matter volume. In the study, 299 adults (mean age 78 years), were 
assessed for their level of physical activity. This was quantified by the 
number of blocks walked over one week. Walking amounts ranged from 0 to 
300 blocks (mean 56.3; SD 69.7). After splitting the participants into quartiles 
(Q1, Q2, Q3, Q4) based on the number of blocks walked, the study found 
that GMV in the highest quartile (Q4) was greater than GMV in the other 
three quartiles (p <0.05).  
Additionally, in a cross-sectional study of 37 alcohol dependent 
individuals in midlife, Gazdzinski et al. (182) demonstrated that chronic 
cigarette smoking is associated with reduced parietal and temporal grey 
matter volume and increased temporal white matter volume (p < 0.05). In the 
study, it was hypothesised that chronic cigarette smoking had an 
independent effect on regional GMV, perhaps reflecting neurotoxicity and 
subclinical oedematous processes associated with the direct and indirect 
effects of the many cytotoxic compounds found in cigarette smoke.  
4.4.2 Strengths and limitations 
There are important limitations in this analysis of the relationship 
between lifestyle and neurodegeneration in midlife as expressed on sMRI. 
The analysis is based on the findings of the systematic review of the 
relationship between lifestyle factors and neurodegeneration in midlife as 
expressed on fMRI. The linear regression models could be further refined if 
Lifestyle and neurodegeneration  
153 
Exploratory Analysis 
they were based on a systematic review of the relationship between lifestyle 
factors and neurodegeneration in midlife as expressed on sMRI. Additionally, 
it is worth noting that although the linear regression models show a 
relationship between lifestyle factors and neurodegeneration in midlife as 
expressed on sMRI, causation cannot be inferred from the PREVENT 
Dementia cohort (119) cross-sectional data. Furthermore low power may 
have contributed to a reduced chance of detecting a true effect in the 
statistical analysis (169). A strength of this analysis is the large number of 
participants for whom sMRI data has been collected and assessed. 
4.4.3 Summary 
This exploratory analysis shows that multiple lifestyle factors in midlife 
are associated with neurodegeneration as expressed on sMRI. This analysis 
represents an early step in understanding the interplay between lifestyle 
factors and neurodegeneration in midlife as expressed on sMRI. 
4.4.4 Implications of research 
Although a number of associations were demonstrated by this data 
analysis, results to support all the hypotheses outlined at the start of the 
chapter were not ascertained.  This may be due to low power in the statistical 
analysis. Looking to the future, this research could be expanded to look at 
how the changes in various biomarkers of lifestyle and neurodegeneration 
including ASL CBF and sMRI are related to each other. This was beyond the 
scope of this data analysis as the regions chosen for the ASL CBF analysis 
were based on the systematic review (chapter 2) and the regions assessed 
for the sMRI analysis were based on available measures from the PREVENT 
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Dementia cohort. Subsequently there was not an overlap in the regions 
available for both ASL CBF and sMRI analysis.      





The research presented in this thesis, namely the systematic review 
(chapter 2), analysis of the PREVENT Dementia cohort ASL data (chapter 3) 
and sMRI data analysis (chapter 4) have led to important findings on the 
relationship between lifestyle and neurodegeneration in midlife. The 
systematic review identified five lifestyle factors associated with 
neurodegeneration in midlife as expressed on fMRI. The analysis of the 
PREVENT Dementia cohort ASL data has shown that that compared to being 
a non-substance misuser, being a current or ex-substance misuser is 
associated with a reduced ACC CBF. Also, compared to being a moderate 
alcohol drinker, being a non-drinker is associated with a reduction in ACC 
CBF. The ACC is thought to have an important role in ageing by mediating 
resistance of memory circuits to the deleterious processes of ageing. There 
was no significant association between physical training and smoking with 
CBF. Additionally, the sMRI linear regression analysis has identified multiple 
associations between lifestyle and neurodegeneration in midlife. The findings 
from this thesis could guide future analyses of PREVENT Dementia cohort 
data and test the hypothesis that substance misuse causes 
neurodegeneration in the ACC. Critically, causation cannot be inferred from 
any of the findings from this thesis, however the findings could be shared 
with the public through the NHS Health Check in England and the Keep Well 
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Programme in Scotland, to help make people aware of the relationship 
between lifestyle and brain health in midlife. 
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5.1 Key findings from my thesis on the relationship between 
lifestyle and neurodegeneration in midlife as expressed on 
ASL and sMRI 
Systematic review 
This systematic review of the relationship between lifestyle and 
neurodegeneration in midlife as expressed on fMRI, identified seven lifestyle 
factors - physical training, cognitive training, fasting, substance misuse, 
alcohol, smoking and excessive internet use, associated with brain health in 
midlife. Cognitive training and physical training appear to be associated with 
a neuroprotective effect, whereas alcohol misuse, smoking and substance 
misuse appear to be associated with neurodegeneration. Further research is 
required into the effects of excessive internet use and fasting.  
Analysis of PREVENT Dementia cohort ASL data 
The analysis of the relationship between lifestyle and 
neurodegeneration as expressed on ASL in midlife was undertaken using 
data from the PREVENT Dementia cohort (119). The results from the 
unadjusted model, adjusted model 1 and adjusted model 2 show that 
compared to being a non-substance misuser, being a current or ex-
substance misuser is associated with a reduced ACC CBF. Additionally, the 
results from model 2 shows that compared to being a moderate alcohol 
drinker, being a non-drinker is associated with a reduction in ACC CBF. No 
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association was found between physical training and smoking with mean 
cortex CBF, ACC CBF and hippocampal CBF. 
Structural magnetic resonance imaging analysis 
In the analysis of the relationship between lifestyle and 
neurodegeneration as expressed on sMRI, the results from the unadjusted 
model and adjusted models show that compared to a high physical training 
score, a medium physical training score is associated with a reduced 
hippocampal grey matter volume; compared to a high physical training score, 
a low physical training score is associated with an increased PVH Fazekas 
score (158) and compared to being a non-smoker, being a smoker is 
associated with a reduced GMV. Additionally, on the unadjusted model, 
compared to being a non-smoker, being a smoker is associated with 
increased WMV and on adjusted model 1, compared to being a non-
substance misuser, being a current or ex-substance misuser is associated 
with a reduction in GMV. 
5.2 What this thesis adds to the field of dementia prevention 
The information retrieved by the systematic review has been used as a 
basis for the analysis of lifestyle and neuroimaging data in the PREVENT 
Dementia cohort (119). The systematic review guided the choice of lifestyle 
factors, conceptualization of lifestyle factors and choice of covariates for the 
linear regression models. The systematic review could be used as a basis for 
further data analysis, including the two year follow-up data from the 
PREVENT Dementia cohort (119). The systematic review could help guide 
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the choice of lifestyle interventions and biomarkers in future dementia 
prevention studies. Furthermore, the systematic review has been published 
(183). Through publication, the systematic review can more broadly 
contribute to research in the fields of lifestyle, neurodegeneration and fMRI. 
For example, the systematic review has been cited by Huang et al. in their 
study of ‘The correlation of asymmetrical functional connectivity with 
cognition and reperfusion in carotid stenosis patients (184)’. It has also been 
cited by Hadar et al. in their review of peripheral transcriptomic biomarkers 
for early detection of sporadic Alzheimer’s dementia (185). 
The a priori hypothesis that substance misuse is associated with 
neurodegeneration in midlife as expressed on ASL, was based on the 
findings of the systematic review. The systematic review captured studies 
that showed that heroin, cocaine and polysubstance use are associated with 
reduced activity in the ACC in midlife as expressed on fMRI (94, 102, 107, 
115). The analysis of the PREVENT Dementia cohort data supported the a 
priori hypothesis, by demonstrating that compared to non-substance 
misusers, being a substance misuser is associated with a reduction in the 
ACC CBF in midlife as expressed on ASL. This is likely to represent early 
neurodegenerative changes in the ACC. To my knowledge, this is a unique 
finding in the literature and opens up a gateway for further research to be 
undertaken into the relationship between substance misuse and 
neurodegeneration as expressed on ASL. There is scope for further research 
into the effect of different substances, duration of use and method of 
administration of drug e.g. oral, intravenous and smoking on brain health. 
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However, it is worth considering that the association between being a 
substance misuser and a reduction in the ACC CBF may represent a type I 
error, as no association was found between smoking and physical training 
with mean cortex CBF, ACC CBF and hippocampal CBF. 
The PREVENT Dementia cohort (119) analysis also showed that 
compared to having moderate alcohol consumption, being a non-drinker is 
associated with a reduced ACC CBF. This finding adds to the findings from a 
study by Kim et al. (96) which assessed the relationship between alcohol and 
neurodegeneration in midlife as expressed on fMRI. In this study, Kim et al. 
(96) assessed ReHo in outpatients with alcohol use disorder. The ReHo 
value indicates the local connectivity of the temporal correlations between a 
given voxel and adjacent voxels (186, 187). The study results showed a 
significant reduction in ReHo in the ACC of patients with AUD. This may 
represent abnormal ReHo, which is thought to be related to pathological 
changes (188). Together, these findings build on literature which suggests 
that moderate alcohol consumption may be beneficial for brain health and 
excessive consumption may have a detrimental effect on brain health (35).  
The findings from the analysis of the relationship between lifestyle and 
neurodegeneration as expressed on sMRI found multiple associations 
between lifestyle factors and fMRI outcomes. This represents an important 
initial step in unravelling the relationship lifestyle factors and 
neurodegeneration in midlife as expressed on sMRI.  
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5.3 Potential mechanisms 
5.3.1 Arterial spin labelling findings  
The anterior cingulate cortex and substance misuse 
The anterior cingulate cortex resides in the medial wall of the cerebral 
hemispheres, immediately above the corpus callosum and is shown in Figure 
15. The cingulate cortex can be broadly divided into the anterior cingulate, 
mid cingulate and posterior cingulate. As a whole, the cingulate cortex 
integrates input related to motivation, evaluation of error, cognition and 
emotion (189). More specifically, the ACC is involved in a variety of cognitive 
and emotional tasks including pain processing, visuospatial processing and 
memory retrieval (189). 
 
Figure 15: Anterior cingulate cortex as expressed on fMRI (190).  
Studies identified by the systematic review of the relationship between 
lifestyle and neurodegeneration in midlife as expressed on fMRI have shown 
an association between substance misuse and reduced activity in the ACC 
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(94, 102, 107, 115). These studies are described in Chapter 2 and 
hypothesize that the direction of the association, is that reduced activity in the 
ACC results in individuals being more likely to misuse substances. This 
direction of association is supported by research by Lee et al. that found 
decreased activity in dorsal ACC was associated with impulsive 
characteristics of heroin users (191). The dorsal ACC is the cognitive 
subdivision of the ACC and is responsible for inhibition controlling and 
conflict monitoring. The studies do not put forward a hypothesis for why there 
might be reduced activity in the ACC. 
A potential mechanism for the reduction in ACC CBF associated with 
substance misuse identified in the PREVENT Dementia cohort data (119), is 
related to overstimulation of glutamate receptors. Substance misuse can 
result in over activation of several neurotransmitter pathways, including the 
glutamatergic pathway (192). Overstimulation of glutamate receptors results 
in an uncontrolled increase of calcium that causes damage to proteins, 
nucleic acids, lipids and the cell membrane. This subsequently leads to 
apoptotic or necrotic neuronal death (192). The full pathway for the cellular 
and molecular alterations induced by substance misuse that result in 
apoptotic or necrotic neuronal death is shown in Figure 16 (192).  




Figure 16: Cellular and molecular alterations induced by substance misuse resulting 
in an uncontrolled increase of calcium and apoptotic or necrotic neuronal death (192). 
A hypothesis, that could be tested by future analyses of the PREVENT 
Dementia cohort follow-up data, is that the direction of association is that 
substance misuse causes neurodegeneration in the ACC. It is important to 
better understand the direction of association, as the ACC is thought to play 
a key role in brain health. Harrison et al. demonstrated that prominence of 
the ACC as expressed on sMRI has been linked to successful cognitive 
ageing (193). In the study, cognitive ‘SuperAgers’ were assessed for cortical 
brain volume loss using sMRI. ‘SuperAgers’ were defined as individuals over 
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the age of 80 years old with episodic memory performance at least as good 
as normative values for 50 to 65 year olds. Cortical morphometry of the 
‘SuperAgers’ were compared to two cognitively normal cohorts: age matched 
elderly and 50 to 65 year olds. The ‘SuperAgers’ cerebral cortex was 
significantly thicker than their healthy age matched peers and displayed no 
atrophy compared to the 50 to 65 year old healthy group. Unexpectedly, a 
region of left anterior cingulate cortex was significantly thicker in the 
‘SuperAgers’ than in both elderly and middle aged controls. The authors 
hypothesised that the ACC may mediate resistance of memory circuits to the 
deleterious processes of ageing (193).  
5.3.2 Structural MRI findings that were statistically significant across 
all models (unadjusted and adjusted) 
 
Physical training and hippocampal volume  
Cell proliferation or increased dendritic branching in response to 
exercise may explain the association between increased hippocampal 
volume and increased physical training in midlife. This hippocampus is rich in 
brain derived neurotrophic factor (BDNF). BDNF is a mediator of 
neurogenesis and contributes to dendritic expansion and cell proliferation 
(194, 195). Ramussen et al. demonstrated that BDNF levels increase with 
exercise (196). In the study, eight volunteers rowed for four hours while 
simultaneous blood samples were obtained. The internal jugular venous 
BDNF concentration increased from 442 ± 272 pg ml−1 at rest to 1172 ± 968 
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pg ml−1 after four hours of exercise (P < 0.05) and returned to the resting 
level after one hour of recovery (P < 0.05).   
Physical training and PVH Fazekas score 
Increased physical training may help manage an individual’s vascular 
risk factors and subsequently reduce their Fazekas score (158) which is a 
measure of white matter lesions. Multiple studies have shown that physical 
training decreases vascular risk factors including hypercholesterolemia and 
hypertension. In a review of the relationship between cholesterol and 
exercise, Pedersen et al., citing 13 meta-analyses, reported improvements 
in the lipid profile following exercise (197). Interventional studies by 
Rodríguez-Rodríguez et.al and Atkinson et al. have demonstrated that 
increased physical activity reduces blood pressure in hypertensive and 
normotensive individuals independently from weight loss (198, 199).  
Smoking and grey matter volume 
Smoking contributing to increased atherosclerosis and causing a direct 
effect on brain morphology could account for the relationship between 
smoking and GMV in midlife as expressed on sMRI. There is evidence that 
smoking is associated with an increased risk of atherosclerosis. This was 
demonstrated in a study by Howard et al., where 10,914 participants from the 
Atherosclerosis Risk in Communities (ARIC) were assessed for change in 
atherosclerosis from baseline to the 3-year follow-up (200). Change in 
atherosclerosis was measured using intimal-medial thickness of the carotid 
artery. Relative to non-smokers and after adjustment for demographic 
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characteristics, cardiovascular risk factors, and lifestyle variables, smoking 
was associated with a 50% increase in the progression of atherosclerosis. 
The mean progression rate over 3 years was 43.0 µm for current and 28.7 
µm for non-smokers. Decreased cerebral blood flow due to atherosclerosis 
could account for a reduction in grey matter volume (201). Additionally, 
smoking which results in a toxic and carcinogenic mixture of more than 5,000 
chemicals, has been hypothesized to have direct effects on brain morphology 
(202). This could also could account for the reduction in grey matter volume. 
5.4 Future research 
There is scope to expand the analysis undertaken in this thesis as 
further data becomes available from the PREVENT Dementia study (119). 
Recently cerebral microbleed data has become available for analysis. 
Cerebral microbleeds are downstream markers of brain damage caused by 
both vascular and amyloid pathological mechanisms. In the Rotterdam Study, 
the presence, number, and location of microbleeds at baseline (2005–2011) 
on sMRI scans in 4,841 participants aged over 45 years old were assessed. 
Participants were followed up for incident dementia throughout the study 
period until 2013. The study found that the presence of microbleeds were 
associated with an increased risk of dementia (HR 2.02, 95% CI 1.25 - 3.24), 
including Alzheimer’s dementia (HR 2.10, 95% CI 1.21 - 3.64) (203). 
In the future, a larger volume of PREVENT Dementia cohort (119) 
data patient data will become available thereby increasing the statistical 
power of future analysis. Data is currently being collected across five study 
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sites in the UK and Ireland. The study sites are at the Universities of 
Edinburgh, Oxford, Cambridge, Imperial College London and Trinity College 
Dublin.  
An alternate approach that may be of benefit in the analysis of the 
PREVENT Dementia cohort (119) data is to form a composite risk score for 
brain health. This approach was adopted by the Caerphilly Prospective Study 
(CaPS). The CaPS is based on a cohort of men in a small town in South 
Wales UK. The men have been repeatedly questioned and examined for over 
30 years. The study assessed the correlation between lifestyle behaviours 
and cognitive impairment in CaPS. The healthy lifestyles behaviours that 
were assessed were non-smoking, an acceptable BMI, a high fruit and 
vegetable intake, regular physical activity and low to moderate alcohol intake. 
The study found that the OR for men following four or five healthy behaviours 
was 0.36 (95% CI: 0.12 - 1.09; P = <0.01) for cognitive impairment, and 0.36 
(95% CI: 0.07 - 1.99; P = 0.02) for dementia (68). Using the PREVENT 
Dementia cohort, a similar composite risk score could be formed based on 
the lifestyle factors used in the analysis undertaken in chapter 3, namely 
smoking, alcohol, physical training and substance misuse.  
5.5. Clinical and public health implications 
There are 850,000 people with dementia in the UK (12). This figure is 
estimated to pass one million by 2025 and exceed two million by 2050. The 
annual cost of dementia to society in the UK is estimated at £26.3 billion. 
This is higher than the cost of cancer, heart disease, or stroke (12). Given the 
Lifestyle and neurodegeneration  
 168 
Conclusion 
significant burden of dementia on society, ongoing research to reduce the 
incidence of dementia is essential. In the NHS 5 year Forward View it was 
noted that we can reduce the incidence of dementia through tackling lifestyle 
risks (204). Research in my thesis has shown an association between 
lifestyle and neurodegeneration in midlife as expressed on ASL and sMRI. It 
is worth reiterating that this cross sectional analysis cannot prove causality, 
however it can help generate causal hypothesis. Based on my thesis, I 
propose that lifestyle modification could potentially alter neurodegeneration in 
midlife and thereby reduce an individual’s risk of late life dementia. Long term 
randomised controlled trials are needed to test this hypothesis. If future trials 
show sufficient evidence to support this hypothesis, the NHS Health Check in 
England (205) and the Keep Well Programme in Scotland (206) would 
provide valuable opportunities for GPs and other healthcare professionals to 
offer advice to promote lifestyle interventions to optimise brain health. The 
NHS Health Check is a check-up for individuals in England aged 40 to 74 
years old. It is designed to identify early signs of stroke, kidney disease, heart 
disease, type 2 diabetes or dementia and designed to identify ways to lower 
the risks of these conditions (205). The Keep Well Programme in Scotland 
aims to increase the rate of health improvement in individuals’ aged 40 to 64 
in deprived communities by enhancing primary care services to deliver 
anticipatory care. The checks include screening for cardiovascular disease 
and its main risk factors, such as high blood pressure, cholesterol, smoking, 
diet as well as discussions around wider life circumstances such as 
employment and literacy (206). The discussions could be extended to include 
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discussion around lifestyle interventions in midlife. Clinical Commissioning 
Groups (CCG) can play a key role in promoting dementia risk reduction. CCG 
can achieve this by using Public Health England’s dementia profile tool which 
can identify local risk factors for dementia such as smoking prevalence, 
physical inactivity, excess weight and alcohol-related hospital admissions 
(207). This will help to prioritise efforts to reduce such risk factors. 
Furthermore, health and social care providers, in addition to public and third 
sector providers, such as local authorities, leisure services and emergency 
services could use routine appointments to identify people at risk of 
dementia, promote healthy behaviours and give advice on how to reduce the 
risk factors for dementia whenever the opportunity arises. 
5.6. Final Conclusions 
The clinical and economic need to prevent dementia and the failure of 
medication breakthroughs to treat Alzheimer’s dementia have led to 
considerable research in the field of optimising brain health. The evidence on 
the relationship between lifestyle and brain health has now reached a point 
that it can no longer remain simply an exercise in academic discussion. The 
evidence should be shared with the public. The public should know that there 
is a relationship between lifestyle and brain health. Looking to the future, this 
thesis forms an exciting platform for further research in the field of lifestyle 
and neurodegeneration as expressed on neuroimaging to build upon and 
continue our drive to reduce the worldwide incidence of dementia.
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1.  "lifestyle and related phenomena"/ or lifestyle/ or lifestyle modification/ or sedentary 
lifestyle/  
2. lifestyle*.mp.  
3. drinking behavior/  
4. addiction/ or alcoholism/ or exp drug dependence/ or tobacco dependence/  
5.  exp smoking/ or "tobacco use"/  
6.  cigarette smoking.ti,ab.  
7.  exp health behavior/  
8.  exp exercise/  
9.  exp recreation/  
10.  meditation/  
11.  mindfulness/  
12. yoga/  
13.  Tai Chi/  
14.  exp diet/  
15.  or/1-14  
16. nuclear magnetic resonance imaging/ or diffusion weighted imaging/ or functional 
magnetic resonance imaging/ or perfusion weighted imaging/  
17.  neuroimaging/ or functional neuroimaging/  
18. spin labeling/  
19. tempone/  
20.  arterial spin label*.tw.  
21.  nuclear magnetic resonance spectroscopy/  
22.  (magnetic resonance tomograph$ or magnetic resonance scan$ or magnetic 
resonance imag$ or magnetic resonance spectroscop$ or mr tomograph$ or mr scan$ 
or mr imag$ or mr spectroscop$ or fmri or mri or nmr or mrs).tw.  
23.  16 or 17 or 18 or 19 or 20 or 21 or 22  
24. brain perfusion/ 
25. brain blood flow/  
26.  blood oxygenation/ or oxygenation/  
27.  brain circulation/ or brain microcirculation/  
28.  brain oxygen consumption/  
29.  metabolism/  
30.  brain chemistry/  
31. blood volume/  
32. (cerebral perfusion or hyperperfusion or hypoperfusion or cerebral blood flow).tw.  
33. or/24-32  
34. Animals/ not Human/  
35. ("conference review" or editorial or letter or note or report or short survey or trade 
journal).pt.  
36. 34 or 35  
37. 15 and 23 and 33  
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1.  exp magnetic resonance imaging/ or exp Neuroimaging/  
2. spin labels/ or triacetoneamine-n-oxyl/  
3. arterial spin label*.tw.  
4. exp Magnetic Resonance Spectroscopy/  
5.  (magnetic resonance tomograph$ or magnetic resonance scan$ or magnetic resonance 
imag$ or magnetic resonance spectroscop$).ti,ab.  
6.  (mr tomograph$ or mr scan$ or mr imag$ or mr spectroscop$).ti,ab.  
7.  (fmri or mri or nmr or mrs).ti,ab.  
8.  or/1-7  
9.  (brain perfusion or cerebral perfusion or hyperperfusion or hypoperfusion or 
oxygenation or cerebral blood flow).mp.  
10.  cerebrovascular circulation/ or neurovascular coupling/  
11.  metabolic phenomena/ or brain chemistry/ or metabolism/ or oxygen consumption/  
12. Brain/me [Metabolism]  
13.  Blood Volume/  
14.  or/9-13  
15.  exp Life Style/  
16. lifestyle*.mp.  
17.  exp Alcohol Drinking/  
18. exp Substance-Related Disorders/  
19. "tobacco use"/ or smoking/  
20.  Health Behavior/  
21.  exp Exercise/  
22.  exp Leisure Activities/  
23.  meditation/ or tai ji/ or yoga/ or Mindfulness/  
24.  exp Diet/  
25. or/15-24  
26.  Comment/ or Letter/ or Editorial/ or Autobiography/ or Biography/ or Bibliography/ or 
Dictionary/ or Directory/ or Interactive Tutorial/ or Lectures/  
27.  Animals/ not Humans/  
28.  26 or 27  
29.  8 and 14 and 25  
30.  29 not 28  
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1.  exp neuroimaging/  
2. neuroimag*.ti,ab,id.  
3. (arterial spin label* or magnetic resonance tomograph$ or magnetic resonance scan$ or 
magnetic resonance imag$ or magnetic resonance spectroscop$ or mr tomograph$ or mr 
scan$ or mr imag$ or mr spectroscop$ or fmri or mri or nmr or mrs).ti,ab,id.  
4. "Brain Imaging".md.  
5.  or/1-4  
6.  exp lifestyle/  
7.  (lifestyle* or life style*).ti,ab,id.  
8.  addiction/ or exp alcoholism/ or exp drug addiction/  
9.  exp drug usage/  
10.  exp tobacco smoking/  
11.  Health Behavior/  
12. exp exercise/ or physical fitness/ or physical activity/  
13.  exp recreation/  
14.  meditation/ or mindfulness/ or tai chi.ti,ab,id.  
15.  diets/  
16.  or/6-15  
17.  cerebral blood flow/  
18. exp neurochemistry/  
19. metabolism/  
20.  blood volume/ or blood circulation/ or exp blood flow/  
21.  oxygenation/  
22.  (brain perfusion or cerebral perfusion or hyperperfusion or hypoperfusion or cerebral blood 
flow or oxygenation or brain metabolism).ti,ab,id.  
23.  or/17-22  
24.  (animal not human).po.  
25,  5 and 16 and 23  











































Lifestyle and neurodegeneration  
253 
 
Individual studies excluded at full text screening. 
Insufficient information 
Allen et al. (208), Bowman et al. (209), Wagner et al. (210), Boots et al. (211),  
Conference abstracts 
Adinoff et al. (212), Alfini et al. (213), Boileau et al. (214), Bosak et al. (215), 
Breitner et al. (216), Bronzwaer et al. (217), Carhart-Harris. (218), Cheah et al. 
(219), Cheah et al. (220), Cheah et al. (221), Chen et al. (222), Childress et al. (223), 
Childress et al. (224), DeMarco et al. (225), Denier et al. (226), Elbejjani et al. (227), 
Franklin. (228), Gu et al. (229), Jagannathan et al. (230), Janse Van Rensburg et al. 
(231), Kroemer et al. (232), Leddy et al. (233), Lee et al. (234), Legget et al. (235), 
Mon et al. (236), Murray et al. (237), Nickerson et al. (238), Padula et al. (239), 
Rickenbacher et al. (240), Robertson et al. (241), Robertson et al. (242), Smith et al. 
(243), Sneider et al. (244), Stein et al. (245), Swardfager et al. (246), Tang et al. 
(247),  Van Der Kleij (248), Weafer et al. (249) and Young et al. (250). 
Not an original human research study 
Abbott. (251), Anonymous. (252), Anonymous. (253), Asmaro et al. (254), 
Bhagavati et al. (255), Bhattacharyya et al. (256), Bogousslavsky et al. (257), 
Caldemeyer et al. (258), Calhoun. (259), Estruch et al. (260), Gatley et al. (261), 
Gottschalk et al. (262), Hurley et al. (263) and Lim et al. (264). 
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Study population does not include a lifestyle factor in midlife 
Benwell et al. (265), Berkovich-Ohana et al. (266), Binder et al. (267), Boraxbekk 
et al. (268), Bray et al. (269), Chen et al. (270), Fang et al. (271), Farrell et al. 
(272), Gauthier et al. (273), Huang et al. (274), Jiang et al. (275), Jin et al. (276), 
Ludman et al. (277), Robertson et al. (278) and St-Onge et al. (279). 
Study population does not include individuals in midlife 
Bauernfeind et al. (280), Becker et al. (281), Berman et al. (282), Bothe et al. 
(283), Boujraf et al. (284), Burdette et al. (285), Buschkuehl et al. (286), Calhoun 
et al. (287), Chambers et al. (288), Chang et al. (289), Chang et al. (290), Chan et 
al. (291), Charboneau et al. (292), Ely et al. (293), Esposito et al. (294), Frank et 
al. (295), Fusar-Poli et al. (296), Han et al. (297), Hu et al. (298), Jager et al. (299), 
Kang et al. (300), Kim et al. (301), Koeneke et al. (302), Lawrence et al. (303), 
Leddy et al. (304), Lee et al. (305), Liu et al. (306), Lou et al. (307), Luijten et al. 
(308), Luijten et al. (309), Marinkovic et al. (310), Marinkovic et al. (311), Oberlin 
et al. (312), Olsson et al. (313), Paulus et al. (314), Pelchat et al. (315), Raj et al. 
(316), Rickenbacher et al. (317), Roberts et al. (318), Salomon et al. (319), 
Schouw et al. (320), Snel et al. (321), Tang et al. (322), Tolentino et al. (323), 
Valdes et al. (324), Van Hell (325), Vingerhoets et al. (326), Weafer et al. (327), 
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Study does not include an fMRI outcome in midlife 
Adinoff et al. (331), Breteler. (332), Domino et al. (333), Edward Roberts et al. 
(334), Ernst et al. (335), Fink et al. (336), Newberg et al. (337), Olin et al. (338), 
Voytek et al. (339), Yamashita et al. (340),  
The fMRI outcome is not a proxy for neurodegeneration or neuroprotection 
Addicott et al. (341), Adinoff et al. (342), Asensio et al. (343), Asensio et al. (80), 
Bjork et al. (344), Camchong et al. (345), Claus et al. (346), Falcone et al. (347), 
Froeliger et al. (348), George et al. (349), Goldstein et al. (350), Goudriaan et al. 
(351), Gowin et al. (352), Hu et al. (353), Hyatt et al. (354), Khushu et al. (355), 
Laurienti et al. (356), Lee et al. (357), Loughead et al. (358), Maas et al. (359), 
McHugh et al. (360), Monti et al. (285), Park et al. (361), Sinha et al. (362), 
Sjoerds et al. (363), Wang et al. (364), Xie et al. (365), Yamamoto et al. (366), 
Yang et al. (367) and Zijlstra et al. (368). 
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The aim of the study is not to look at the effect of a lifestyle factor on an fMRI 
outcome 
Ances et al. (369), Archibald et al. (370), Ashare et al. (371), Blum et al. (79), 
Caldwell et al. (372), Carroll et al. (373), Courtney et al. (374), Denier et al. (375), 
Denier et al. (376), Durazzo et al. (377), Elman et al. (378), Franklin et al. (379), 
Franklin et al. (380), Franklin et al. (381), Franklin et al. (382), Friedman et al. 
(383), Hahn et al. (384), Hermann et al. (110), Herremans et al. (385), Janes et al. 
(386), Karch et al. (387),  Karoly et al. (388), Kiefer et al. (389), Kobiella et al. 
(390), Kozink et al. (391), Kufahl et al. (392), Kwako et al. (393), Lam et al. (394), 
Langleben et al. (395), Langosch et al. (396), Loughead et al. (397), Loughead et 
al. (398), Lutz et al. (399), McClernon et al. (400), Meunier et al. (401), Moeller et 
al. (402), Myrick et al. (403), Myrick et al. (404), Risinger et al. (405), Salloum et 
al. (406), Schacht et al. (407), Schmidt et al. (408), Schmidt et al. (115), Sell et al. 
(409), Suh et al. (410), Tarumi et al. (411), Tomasi et al. (412), Van Laar et al. 
(413), Vatsalya et al. (414), Versace et al. (415), Wang et al. (416), Wang et al. 
(417), Wang et al. (418), Wang et al. (419), Warbrick et al. (420), Wetherill et al. 
(421), Wetherill et al. (422), Wexler et al. (423), Wiers et al. (424), Wilcox et al. 
(425), Xiao et al. (426) and Zlatar et al. (427). 
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#Linear Regression Models 
 
#Variables used in analysis 
#Cortex CBF 
`mean cortex CBF` 
#Hippocampus CBF 
`Hippocampus mean (average of L+R)` 
#Anterior Cingulate Cortex CBF 









#PVH Fazekas score 
PVH_Fazekas 




#Number of years of education 
nbeduc 
#Number of parents with dementia 
number_parents_dementia 
 




# Unadjusted Linear Regression Models for Cortex CBF 
reg<-lm(`mean cortex  CBF`~PTS1to5,datos) 
summary(reg) 
reg<-lm(`mean cortex  CBF`~PTS6to10,datos) 
summary(reg) 
reg<-lm(`mean cortex  CBF`~smoker01,datos) 
summary(reg) 
reg<-lm(`mean cortex  CBF`~ETOHhigh,datos) 
summary(reg) 
reg<-lm(`mean cortex  CBF`~ETOH0,datos) 
summary(reg) 
reg<-lm(`mean cortex  CBF`~druguse01,datos) 
summary(reg) 
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# Unadjusted Linear Regression Models for Hippocampus CBF 
reg<-lm(`Hippocampus mean (average of L+R)`~PTS1to5,datos) 
summary(reg) 
reg<-lm(`Hippocampus mean (average of L+R)`~PTS6to10,datos) 
summary(reg) 
reg<-lm(`Hippocampus mean (average of L+R)`~smoker01,datos) 
summary(reg) 
reg<-lm(`Hippocampus mean (average of L+R)`~ETOHhigh,datos) 
summary(reg) 
reg<-lm(`Hippocampus mean (average of L+R)`~ETOH0,datos) 
summary(reg) 
reg<-lm(`Hippocampus mean (average of L+R)`~druguse01,datos) 
summary(reg) 
 
# Unadjusted Linear Regression Models for Anterior Cingulate Cortex CBF 
reg<-lm(`Anterior cingulate cortex mean CBF`~PTS1to5,datos) 
summary(reg) 
reg<-lm(`Anterior cingulate cortex mean CBF`~PTS6to10,datos) 
summary(reg) 
reg<-lm(`Anterior cingulate cortex mean CBF`~smoker01,datos) 
summary(reg) 
reg<-lm(`Anterior cingulate cortex mean CBF`~ETOHhigh,datos) 
summary(reg) 
reg<-lm(`Anterior cingulate cortex mean CBF`~ETOH0,datos) 
summary(reg) 
reg<-lm(`Anterior cingulate cortex mean CBF`~druguse01,datos) 
summary(reg) 
 
# Adjusted Linear Regression Model 1 for Cortex CBF, Hippocampus CBF, 
Anterior Cingulate Cortex CBF 
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# Adjusted Linear Regression Model 2 for Cortex CBF, Hippocampus CBF, 
Anterior Cingulate Cortex CBF 













#sMRI Linear Regression Model  
datos<-Combined_data_151017 
print(summary(reg),digits=3) 
         
# Unadjusted Linear Regression Model for Grey Matter, White Matter, 
Hippocampal volume, Parahippocampal volume, PVH Fazekas score, 
















































































# Adjusted Linear Regression Model 1 for Grey Matter, White Matter, 
Hippocampal volume, Parahippocampal volume, PVH Fazekas score, 



























































































































































# Adjusted Linear Regression Model 2 for Grey Matter, White Matter, 
Hippocampal volume, Parahippocampal volume, PVH Fazekas score, 
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Linear regression diagnostic plots 
To draw conclusions about a midlife population based on regression 
analysis undertaken on the PREVENT Dementia cohort (119), several 
assumptions must be true (428): 
 Variable types: All predictor variables must be quantitative or 
categorical, with two categories. The outcome variable must be 
quantitative and continuous (428). 
 Non-zero variance: The predictors should have some variation in 
value (428).  
 No perfect multicollinearity: There should be no perfect linear 
relationship between two or more of the predictors (428).  
 Predictors are uncorrelated with external variables: External variables 
are variables that haven't been included in the regression model which 
influence the outcome variable. This assumption means that there 
should be no external variables that correlate with any of the variables 
included in the regression model (428). 
 Homoscedasticity: The residuals at each level of the predictors should 
have the same variance. The residual is the difference between the 
observed value of the dependent variable and the predicted value.  
 Independent errors: For any two observations the residual terms 
should be uncorrelated (428). 
 Normally distributed errors: It is assumed that the residuals in the 
model are random, normally distributed variables with a mean of 0. 
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 Independence: It is assumed that all of the values of the outcome 
variable are independent (428). 
 Linearity: It is assumed that the relationship that is being modelled is a 
linear one (428). 
There were four diagnostic plots used to evaluate the linear regression 
model assumptions: 
1. Residuals vs Fitted: If the assumptions of linearity and 
homoscedasticity are met, the diagnostic plot will look like a random 
array of dots dispersed around zero (150). 
2. Normal Q-Q: Used to examine whether the residuals are normally 
distributed. The straight line in this plot represents a normal distribution, 
and the points represent the observed residuals. Therefore, in a perfectly 
normally distributed data set, all points will lie on the line (150). 
3. Scale-Location: The diagnostic plot is used to check the assumption of 
homoscedasticity, it shows if residuals are spread equally along the 
ranges of predictors (429). 
4. Residuals vs Leverage: Used to identify influential cases, that is 
extreme values that might influence the regression results (429). Cook’s 
distance is shown on the diagnostic plot. Cook's distance is a measure of 
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Diagnostic plots for the unadjusted linear regression model of the relationship between current 
and ex-substance misuse and anterior cingulate cortex cerebral blood flow in midlife as 
expressed on fMRI 
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Diagnostic plots for the adjusted multiple linear regression (model 1: age + gender + education + 
APOE 4 allele+ number of parents with dementia) of the relationship between current and ex-
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Diagnostic plots for the adjusted linear regression (model 2: adjusted for age + gender + 
education + APOE 4 allele + number of parents with dementia + physical training score + 
smoking status + alcohol drinking status + substance misuse status) of the relationship between 
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